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Resumo 
 
 xv 
A doença de Alzheimer (AD) é uma doença neurodegenerativa caracterizada 
pela ocorrência de perturbações na função sináptica e perda massiva de neurónios nas 
regiões cerebrais relacionadas com as funções cognitivas, como o hipocampo e o córtex 
cerebral.  A deposição do péptido β amilóide (Aβ) na AD foi desde cedo reportada 
como sendo um aspeto crucial nos fenómenos patológicos da doença, nomeadamente na 
formação de placas senis.  Vários estudos mostram que o stress oxidativo, a inflamação, 
a perturbação dos fluxos de cálcio e a morte celular programada estão envolvidos na 
toxicidade induzida pelo Aβ.  Contudo, os mecanismos pelos quais o péptido Aβ 
desencadeia a morte neuronal não são, ainda, completamente conhecidos.  Um melhor 
conhecimento desses mecanismos básicos, desencadeados pelo péptido Aβ, poderá 
constituir um importante contributo para retardar, ou até prevenir, a 
neurodegenerescência associada à AD.  Por outro lado, alguns dos fatores associados ao 
processo apoptótico podem também modular a proliferação e a diferenciação.  Os 
mecanismos regulatórios desta tomada de decisão, quanto ao destino das células, 
dependem do balanço e da conjugação de sinais de sobrevivência e de morte celular.  
De facto, o nosso grupo demonstrou já que caspases, calpaínas, p53 e microRNAs 
associados à apoptose aceleram o processo de diferenciação neural.  Além disso, foi 
recentemente sugerido que o péptido Aβ pode também regular a proliferação e 
diferenciação de células estaminais neurais (NSCs).  Estas células são capazes de 
originar os principais tipos de células neurais, incluindo neurónios e células da glia, 
como os astrócitos e os oligodendrócitos.  Em cada divisão celular, as NSCs podem 
seguir destinos celulares diferentes, nomeadamente continuar o processo proliferativo, 
ou iniciar a diferenciação.  Assim, propusémo-nos identificar e caracterizar novos 
fatores e vias moleculares envolvidas na regulação da apoptose e da diferenciação 
neural, que sejam relevantes no contexto da AD. 
Explorámos, inicialmente, mecanismos moleculares subjacentes à apoptose 
induzida pelo Aβ em células neuronais PC12 e em neurónios corticais de cultura 
primária.  A incubação com o péptido Aβ resultou na estabilização da isoforma pro- 
-apoptótica da proteína p63, pertencente à família p53, TAp63, bem como na 
degradação da isoforma anti-apoptótica, ∆Np63, através de um mecanismo dependente 
do proteossoma e de cinases de proteínas ativadas pelo mitogénio.  Este efeito 
encontrou-se associado a um aumento dos níveis proteicos de c-Jun, um fator de 
transcrição envolvido na regulação do destino das células, já anteriormente reportado 
como sendo modulador da abundância de TAp63.  Curiosamente, a pré-incubação das 
 xvi 
células com um agente anti-apoptótico, o ácido tauro-ursodesoxicólico (TUDCA), 
reverteu o efeito do Aβ nas proteínas TAp63 e c-Jun.  De igual forma, em células 
tratadas com compostos genotóxicos, como a cisplatina e a doxorrubina, verificámos 
um aumento da expressão de c-Jun, associado a uma redução dos níveis proteícos da 
isoforma ΔNp63.  A expressão endógena e ectópica de ΔNp63 foi também 
dramaticamente reduzida aquando da sobrexpressão de c-Jun.  Recorrendo à tecnologia 
de silencimento com siRNAs, silenciámos c-Jun em células tratadas com Aβ, o que 
preveniu a degradação da isoforma ΔNp63.  Por outro lado,  a sobreexpressão de c-Jun 
originou a redução dos níveis de ΔNp63.  Por fim, verificámos que o tempo de semi-
vida de ΔNp63 foi significantemente reduzido na presença de c-Jun, confirmando assim 
o papel de c-Jun na regulação da estabilidade de ΔNp63.  Estes resultados indicaram 
que a abundância de ΔNp63, em resposta à morte apoptótica induzida pelo Aβ, é 
regulada por um mecanismo dependente de c-Jun. 
De seguida, investigámos o envolvimento da proteína p63 na regulação do 
potencial de proliferação e diferenciação de NSCs.  De facto, a proteína p53, homóloga 
de p63, foi recentemente descrita como fator limitante do potencial proliferativo das 
células estaminais, desempenhando mesmo um papel crucial durante a neurogénese.  
Por outro lado, foi também demonstrado que os efeitos pró-neurogénicos da proteína 
p53 resultam da sua interação com reguladores importantes da diferenciação neural, 
como a desmetilase JMJD3, específica para o resíduo de lisina-27 da histona 3.  
Considerando as semelhanças funcionais e estruturais entre as proteínas p53 e p63, 
investigámos uma possível interação molecular entre a desmetilase JMJD3 e a proteína 
p63 durante o processo de neurogénese.  A proteína p63 já foi descrita como estando 
envolvida na diferenciação da epiderme e de outros tecidos epiteliais.  Contudo, o seu 
envolvimento durante a diferenciação neural não foi inteiramente esclarecido.  Os 
resultados obtidos demonstraram que a isoforma TAp63γ interage diretamente com a 
desmetilase JMJD3 e que esta regula os níveis de p63, estabelecendo-se um programa 
de expressão de marcadores neurais.  De facto, a sobrexpressão de JMJD3 promoveu 
um aumento dos níveis de TAp63γ, de forma dependente da sua atividade de 
desmetilase.  A sobrexpressão de TAp63γ aumentou os níveis do marcador de neurónios 
β-III tubulina, enquanto que o silenciamento de TAp63γ resultou em efeitos 
significativamente diferentes.  Ensaios de imunoprecipitação permitiram-nos confirmar 
a interação direta entre TAp63γ e JMJD3, durante a diferenciação de NSCs, assim como 
a modulação dos níveis de metilação de TAp63γ pela JMJD3.  Curiosamente, a JMJD3 
xvii 
regulou também a estabilidade e a distribuição celular da isoforma TAp63γ, bem como 
o processo de neurogénese regulado pela TAp63γ.  Estes resultados clarificam o papel 
da proteína p63 na diferenciação das células precursoras neurais e demonstram que a 
isoforma TAp63γ é um alvo direto da JMJD3, sendo esta interação importante para a 
neurogénese.  
Por fim, avaliámos a capacidade de diferentes péptidos Aβ modularem os 
processos de proliferação e diferenciação de NSCs, clarificando o papel da autofagia 
nos efeitos mediados pelos péptidos Aβ.  De facto, embora considerados neurotóxicos, 
os péptidos Aβ estão também envolvidos em diversos eventos celulares não 
patogénicos.  Por outro lado, a autofagia tem sido implicada na sobrevivência celular 
em resposta à toxicidade do Aβ, mas também em processos de diferenciação.  Contudo, 
o seu papel concreto na diferenciação neural continua por esclarecer.  Os resultados 
obtidos demonstraram que os péptidos Aβ1-40 e Aβ1-42 promovem preferencialmente a 
neurogénese e a gliogénese, respetivamente, enquanto que o péptido Aβ25-35 não parece 
ter qualquer efeito nestes processos.  Verificámos também que o papel do Aβ1-40 na 
neurogénese é parcialmente dependente da sua função na proliferação de NSCs.  Tal foi 
comprovado pelo aumento da fase S do ciclo celular e pelo aumento da marcação com 
bromodeoxiuridina em células expostas a Aβ1-40.  Além disso, o péptido Aβ1-40 
aumentou a atividade do promotor de Tuj1, validando assim os resultados anteriores que 
mostram o papel importante do péptido Aβ1-40 na diferenciação neuronal.  Observámos 
também que o processo autofágico parece estar envolvido nos efeitos mediados pelos 
diferentes péptidos Aβ nas NSCs, independentemente da produção de espécies reativas 
de oxigénio e da ocorrência de fenómenos apoptóticos.  Inibindo a autogafia, através da 
adição do inibidor autofágico 3-metiladenina, verificou-se que os níveis proteicos de 
marcadores neuronais e gliais não aumentaram, mesmo na presença dos diferentes 
péptidos Aβ.  Assim, estes resultados suportam e clarificam o papel de diferentes 
péptidos Aβ na regulação do destino celular das NSCs e sublinham a importância da 
autofagia no controlo deste processo. 
Em conclusão, estes estudos contribuem com dados novos relativamente ao 
papel do péptido Aβ e da proteína p63 no controlo da decisão entre diferenciação e 
morte celular, os quais se poderão revelar úteis na modulação do destino celular na AD. 
Palavras-chave: Ácido tauro-ursodesoxicólico; Apoptose; Autofagia; Células 
estaminais neurais; c-Jun; Neurogénese; p63; Péptido β amilóide
  
 
 
 
 
Abstract 
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Amyloid β (Aβ) peptide accumulation and apoptosis play an important role in 
the pathogenesis of Alzheimer’s disease.  However, the mechanisms by which Aβ 
mediates neuronal apoptosis are not completely elucidated.  Mounting evidence also 
supports the involvement of specific apoptosis factors in neural stem cell (NSC) 
differentiation.  Therefore, we set to identify and characterize new molecular pathways 
involved in Aβ-induced regulation of neural apoptosis and differentiation. 
First, we further explored the molecular mechanisms of Aβ-induced neuronal 
death.  We found that Aβ elicited stabilization of the pro-apoptotic isoform of p63, 
TAp63, which in turn was partially inhibited by tauroursodeoxycholic acid.  In addition, 
in response to Aβ-induced apoptosis, the abundance of the anti-apoptotic isoform of 
p63, ΔNp63, was clearly reduced and tightly regulated in a c-Jun-dependent 
mechanism.  
Next, we investigated whether apoptosis-associated molecule p63, member of 
the p53 family, might also be involved in differentiation of NSCs.  We showed that 
TAp63γ interacted with the histone H3 lysine 27-specific demethylase JMJD3, a key 
regulator of neurogenesis, to redirect NSCs to differentiation, as an alternative to cell 
death.  In addition, both TAp63γ and JMJD3 were coordinately regulated to establish a 
neural-specific gene expression pattern during NSC differentiation.  We also found that 
JMJD3-demethylase activity was crucial in regulating TAp63γ half-life and nuclear 
accumulation.  
Finally, we evaluated the ability of Aβ peptides to modulate NSC proliferation 
and differentiation, and investigated whether autophagy was involved in Aβ-induced 
alterations of NSC fate.  We showed that Aβ1-40 and Aβ1-42 strongly enhanced 
neurogenesis and gliogenesis, respectively, while Aβ25-35 did not influence NSC fate.  
Notably, autophagy was implicated in Aβ-mediated effects in NSCs, independently of 
reactive oxygen species production and apoptosis induction.  
In conclusion, the work presented here provides additional insights into the 
molecular mechanisms implicated in Aβ- and p63-induced cell death signaling 
pathways, and extends our knowledge in considering these prime triggers of apoptosis 
as integral components of neural proliferation and differentiation. 
 
Keywords: Amyloid β peptide; Apoptosis; Autophagy; c-Jun; Neural stem cells; 
Neurogenesis; p63; Tauroursodeoxycholic acid 
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1.1 Neural Apoptosis 
The term apoptosis was first introduced in 1972 by Kerr et al. to describe 
the morphological processes leading to controlled cellular destruction (Kerr et al., 
1972).  The apoptosis term has a Greek origin, meaning "falling off” or “dropping 
off", in analogy to leaves falling off trees or petals dropping off flowers.  This 
analogy emphasizes that the death of living matter is a necessary part of the life 
cycle of organisms, being apoptosis an extremely coordinated and highly efficient 
form of cell death that plays a considerable role during physiological conditions, 
including development, differentiation, proliferation and function of the immune 
system; and in the removal of harmful cells. 
During development of the central (CNS) and peripheral nervous systems, 
naturally occurring neuronal death is required during a specific time window to 
ensure the establishment of a correct match between the neuronal numbers and 
the size of the target tissue and for morphogenetic processes, such as neural tube 
closure (Oppenheim, 1991).  The ultimate survival of any given neuron is 
determined by its capacity to sequester sufficient amounts of target-derived 
trophic factors, such as the nerve growth factor (NGF) (Kaplan and Miller, 2000).  
NGF binds to the neurotrophic tyrosine kinase receptor type 1 (TrkA) on the 
terminal axonal arbor and mediates cellular survival signaling.  A second 
neurotrophin receptor (NTR), the p75
NTR
, plays an antagonistic role in this 
system, promoting the elimination of the neurons that do not compete for target-
derived NGF.  The initial overproduction of neurons, followed by death of some, 
represents an adaptive process that provides enough neurons to form nerve cell 
circuits that are precisely matched to their functional specifications.  Neuronal 
loss subsequent to this development window is still physiologically appropriate 
but may also contribute to neurological deficits.  Notably, the cell death 
machinery has vital components of the maintenance and differentiation programs 
of adult stem cells (Aranha et al., 2009; Solá et al., 2012), which must be 
restrictively activated to assure differentiation efficiency, and carefully regulated to 
avoid cell loss.  Therefore, it is not surprising that during differentiation, specific 
cellular changes occur in a similar manner to those observed during apoptosis 
(Chasis and Schrier, 1989).  In addition, Biebl et al. (Biebl et al., 2000) have also 
reported that apoptosis may have an important regulatory function by eliminating 
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supernumerous cells from neurogenic regions, and may thus contribute to a self-
renewal mechanism in the adult mammalian brain.  Furthermore, several studies 
have demonstrated that neuronal apoptosis also occurs as a pathological event 
following excitotoxic, ischemic or traumatic nervous system injury.  Finally, there 
is increasing evidence that apoptotic cell death is one of the mechanisms leading 
to neuronal loss in neurodegenerative diseases (Yuan and Yankner, 2000), 
including Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease (AD) 
(Lassmann et al., 1995; Ohyagi et al., 2005; Smale et al., 1995; Tang et al., 2005; Yao 
and Wood, 2009).   
Deposition of amyloid β (Aβ) peptide in AD was earlier thought to initiate the 
pathological cascade of this disease, including the formation of senile plaques and 
neurofibrillary tangles (NFTs), neuronal loss, and dementia.  Previous studies have 
demonstrated that Aβ causes neurotoxicity and neuronal cell apoptosis in vivo and in 
vitro (Alvarez et al., 2004; Cancino et al., 2008; Laurén et al., 2009).  However, the 
mechanisms of Aβ-induced apoptosis remain to be clariﬁed.  
 
1.1.1 Apoptosis signaling pathways 
Classic apoptosis consists in at least two phases, initiation and execution, 
which in turn results in the activation of cysteine-dependent aspartate directed 
proteases, termed caspases.  Most morphological changes of apoptotic cells are 
caused by caspases, in a sequence of biochemical events.  The death receptor 
(extrinsic) and mitochondrial (intrinsic) apoptosis pathways represent the 
canonical routes of caspase activation during the initiation phase (Kroemer et al., 
2007).  
 
1.1.1.1. Extrinsic pathway  
Death receptors belong to the tumor necrosis factor (TNF) superfamily of cell 
surface receptors, and contain a cytoplasmic protein motif termed death domain that 
enables receptors to engage the cell apoptotic machinery.  Caspase activation by the 
death receptor involves the binding of extracellular death ligands, such as Fas ligand 
(FasL) or TNFα to transmembrane death receptors, causing the recruitment and 
oligomerization of the adapter molecule Fas-associating death domain-containing 
protein (FADD) within the death-inducing signaling complex.  Oligomerized FADD, 
in turn, binds the procaspase-8 and -10, causing their dimerization and activation 
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(Debatin and Krammer, 2004).  Cytosolic and active caspase-8 and -10 then mediate 
the activation of the effector caspases-3, -6 and -7, causing further caspase activation 
events, and finally substrate proteolysis and cell death (Debatin and Krammer, 2004; 
Mattson, 2006).  
 
1.1.1.2. Intrinsic pathway  
Mitochondria play a key role in the regulation of apoptosis, collecting and 
integrating both pro- and anti-apoptotic signals, such as pro- and anti-apoptotic B-
cell lymphoma-2 (Bcl-2) family proteins, p53, kinases, phosphatases, reactive 
oxygen species (ROS), calcium overload, viral proteins or toxins.  Unlike in 
extrinsic apoptosis, caspase activation is not always a requirement for 
mitochondrial-induced apoptosis, although caspases accelerate the process.  The 
mitochondrial pathway of apoptosis begins with mitochondrial outer membrane 
permeabilization (MOMP), and subsequent release of apoptotic factors from the 
mitochondria, including cytochrome c (cyt c), second mitochondria-derived 
activator of caspase/direct inhibitor of apoptosis protein (IAP) binding protein 
with a low pI (Smac/DIABLO) and Omi stress-regulated endoprotease/high 
temperature requirement protein A2 (Omi/HtrA2), which act through caspase 
activation; and the caspase independent apoptosis-inducing factor (AIF) and 
endonuclease G (EndoG) (reviewed in (Kroemer et al., 2007)).   
This process is strongly regulated by Bcl-2 family proteins.  The anti-
apoptotic members of this family have four Bcl-2 homology (Oda et al.) regions 
that mediate protein-protein interactions (Youle and Strasser, 2008) and contain 
transmembrane domains that mediate their insertion into the outer membranes of 
mitochondria as well as into the endoplasmic reticulum (Kelly and Strasser, 
2011).  This group includes Bcl-2, Bcl-w, Mcl-1, A1, BOO/DIVA, NR-13 and 
Bcl-xL, which are responsible for inhibition of both MOMP and release of 
apoptotic factors from the mitochondria.  The pro-apoptotic Bcl-2 proteins Bax, 
Bak, Bok, Bcl-xS, Bcl-gL and Bfk are multi-domain proteins with up to four BH 
domains, while Bid, Bad, Bik, Hrk, Puma, Noxa, Bmf and Bim have only the 
BH3 domain, hence called BH3-only proteins.  The pro-apoptotic Bcl-2 family 
members reside in the cytosol but following death signaling, they are translocated 
to mitochondria to promote MOMP.  Bad translocates to mitochondria and forms 
a pro-apoptotic complex with Bcl-xL.  This translocation may also be inhibited by 
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survival factors that induce the phosphorylation of Bad, leading to its cytosolic 
sequestration (Pradelli et al., 2010).  Bax and Bim, in turn, translocate to 
mitochondria in response to death stimuli or survival factor withdrawal.  
Upon release from mitochondria, cyt c, together with dATP and the 
apoptotic protease-activating factor-1 (Apaf-1), form an activation complex with 
caspase-9, the apoptosome.  Another level of regulation is provided by the IAP 
family members that promote survival signaling pathways and interfere with the 
activation of caspases (Fulda and Vucic, 2012).  Smac/DIABLO and Omi/HtrA2, in 
turn, can sequester and/or degrade IAPs, thereby facilitating caspase activation.  AIF 
and EndoG do not interact with caspases and instead translocate to the nucleus to 
promote DNA fragmentation and chromatin condensation. 
Although apparently independent, in some instances, extrinsic death signals 
can crosstalk with the intrinsic pathway through caspase-8-mediated proteolysis of the 
BH3-only protein Bid.  Truncated Bid (tBid) can promote mitochondrial cyt c release 
and assembly of the apoptosome, comprising ATP, seven molecules of Apaf-1 and 
the same number of caspase-9 homodimers (reviewed in (Kroemer et al., 2007)). 
 
1.1.2. p53 family of proteins 
The p53 family includes the products encoded by the p53 gene and its 
homologues, p63 and p73.  The three members of the family share a high level of 
similarity, which allows p63 and p73 to transactivate p53-responsive genes 
causing cell cycle arrest and apoptosis (Dötsch et al., 2010; Murray-Zmijewski et 
al., 2006).  The complexity of the family has been enriched by the use of 
alternative promoters, splicing and translational sites (Moll and Slade, 2004; 
Murray-Zmijewski et al., 2006).  Consequently, several protein isoforms with 
distinct N- and C- termini are encoded.  Transcribing from P1 promoter 
principally gives rise to full-length isoforms with the transactivation domain 
(TAD), including p53, TAp63 and TAp73, whereas using the alternative P2 
promoter produces N-terminal truncated isoforms without TAD, such as ΔNp53, 
ΔNp63 and ΔNp73 (Bourdon, 2007) (Fig. 1.1). 
Combining the alternative splicing with different promoter usage, 
additional protein isoforms of p53, p63 and p73 arise.  The p73 gene expresses at 
least 7 alternatively spliced C-terminal isoforms (α, β, γ, δ, ε, ζ, η) and at least 4 
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alternatively spliced N-terminal isoforms, which contain different parts of the 
transactivation domain. 
 
 
Figure 1.1.  p53 family gene and protein structure.  The main p53 family protein domains 
include the transactivation domain (TAD), DNA binding domain (DBD), oligomerization 
domain (OD), and sterile alpha motif (SAM).  All p53 family proteins produce two groups of 
mRNAs controlled by different promoters.  The isoforms generated may or may not contain 
the transactivation domain, depending on whether they are generated by the activity of the 
promoter P1 (TA forms) or from the promoter P2 (∆N forms).  Adapted from Allocati et al., 
2012. 
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  Similarly to p73, the human and mouse p63 gives rise to three different 
splice variants that differ in their C-termini: a full-length α form; a β form that is 
truncated after exon 12; and a γ form that lacks exons 12-14 and uses an 
additional exon 15.  Each of these isoforms may or may not contain the TAD, 
depending on whether they are generated by the activity of the promoter upstream 
of exon 1 (P1) (TA forms) or from the alternative promoter in intron 3 (∆N 
forms).  Although ∆N isoforms of p63 do not activate transcription, they can act 
dominant negatively and inhibit transactivation by TAp63, TAp73 and p53 
proteins, through a different transactivation domain present in their distinct N-
terminal end (Helton et al., 2006).  
 
1.1.2.1. p53 
p53 functions mainly as a DNA-binding, sequence-specific transcription 
factor, which has well-established roles in promoting neuronal cell death during 
development (Tedeschi and Di Giovanni, 2009), and in adult individuals after 
exposure to stress and/or DNA damage.  Indeed, the p53 protein is a downstream 
target of the DNA damage signaling network that is expressed at low levels under 
physiological conditions and whose activity is promoted by a wide range of stress 
signals; once activated, and depending on cell type and cell environment, p53 
stimulates the expression of multiple pro-apoptotic genes involved in either 
reversible cell cycle arrest or apoptosis, including p21, GADD45, Bax, and many 
other, as well as targets of p63 and p73 (Irwin and Kaelin, 2001; Melino et al., 
2002; Mills, 2006; Vousden and Lu, 2002). 
The pro-apoptotic activity of p53 is often evident after irreversible damage 
in circumstances of exposure to genotoxic stress, oxidative stress or NGF 
withdrawal in developing or mature cortical and sympathetic neurons (Aloyz et 
al., 1998; Anderson and Tolkovsky, 1999; Bonaguidi et al., 2011; Cregan et al., 
2004; Song and Xu, 2007).  In addition, p53 regulates the expression of proteins 
that modulate its own activation and stability, such as the E3 ligase Mdm-2, 
forming multiple positive and negative feedback loops (Harris and Levine, 2005).  
In fact, in response to DNA damage, the p53 protein accumulates upon a number 
of post-translational modiﬁcations (Sims and Reinberg), which reduce its afﬁnity 
for Mdm-2 and hence favor its stabilization (Kruse and Gu, 2009).  Alternatively, 
Mdm-2-repressing mechanisms such as those mediated by the onco-suppressor 
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protein ADP ribosylation factor (ARF), which acts by sequestering Mdm-2 and 
preventing the Mdm-2-p53 interaction in response to oncogenic stress, can 
stabilize p53 (Iwakuma and Lozano, 2003). 
Lethal proteins whose promoter contains a functional p53 responsive 
element of the activator type include pro-apoptotic members of the Bcl-2 protein 
family such as Bad, Bak, Bax, Bid, Bok, Noxa, and PUMA, as well as other 
components of the mitochondrial apoptotic pathway like the cytosolic adaptor 
Apaf-1, AIF, AIF-homologous mitochondria-associated inducer of death, p53-
regulated apoptosis-inducing protein 1, oxidative stress-induced growth inhibitor 
1, which has recently been discovered to contribute to p53-dependent MOMP in 
response to DNA damage, and caspase-6 (Galluzzi et al., 2011).  Moreover, a 
number of genes are transcriptionally repressed by p53.  These genes code for 
negative regulators of MOMP, such as Bcl-2, Bcl-xL, and Mcl-1, as well as for 
anti-apoptotic proteins that operate downstream of mitochondria (Galluzzi et al., 
2011). 
Curiously, until recently, p53 was believed to promote MOMP only by 
transactivating pro-apoptotic genes and/or by repressing genes that exert anti-
apoptotic effects.  Recently, it has become clear that the cytoplasmic pool of p53 
mediates a direct apoptogenic effect at mitochondria by physically interacting and 
inhibiting anti-apoptotic Bcl-2 family members (Chipuk et al., 2005; Chipuk et 
al., 2004; Moll et al., 2005; Morselli et al., 2008; Vaseva et al., 2009), and 
directly stimulating pro-apoptotic proteins, including mitochondria Bak (Pietsch 
et al., 2008), cytosolic Bax (Chipuk et al., 2004), Bad (Jiang et al., 2006), and Bid 
(Song et al., 2009).  Finally, caspase-dependent proteolysis of p53 may also 
generate fragments that translocate to mitochondria and induce MOMP, thereby 
activating a feedforward loop for the ampliﬁcation of the apoptotic signal (Robles 
et al., 2001). 
 
1.1.2.2. p63 and p73 
Much like p53, both p63 and p73 are clearly implicated in apoptosis 
regulation (Rocco and Ellisen, 2006).  The TAp63 isoforms are pro-apoptotic, 
while the ΔNp63 isoforms are anti-apoptotic, similarly to the TA and ΔN 
isoforms of p73 (Flores et al., 2002; Wu et al., 2003). 
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Several studies have highlighted an essential role of endogenous TAp73 in 
regulating apoptosis in response to DNA damage (Jost et al., 1997; Lin et al., 
2004).  Upon this stress, not only ∆Np73 but also ∆Np63α (Chatterjee et al., 
2008; Müller et al., 2006; Westfall et al., 2005) are rapidly degraded.  Thus, they 
do not exert their dominant negative effect on p53, TAp63 and TAp73, allowing 
cell cycle arrest and apoptosis to proceed.  Moreover, previous studies have 
already shown that treatment of cells with various DNA-damaging agents resulted 
in increased expression of TAp63 and TAp73 isoforms (Hershkovitz Rokah et al., 
2010; Sayan et al., 2007b; Yao et al., 2010c).  
p73 is a target of the tyrosine kinase c-Abl in response to DNA damage 
induced by cisplatin or ionizing radiation, thereby resulting in apoptosis (Agami and 
Bernards, 2000; Gong et al., 1999; Yuan et al., 1999).  In turn, the role of p63 in 
apoptosis pathways is still under debated.  Gressner et al. (Gressner et al., 2005) 
described the role of TAp63α in activating apoptosis through death receptor signaling 
and mitochondria by activating transcription of p53 targets (Testoni et al., 2006).  In 
fact, it was shown that TAp63 can induce the expression of death receptors including 
Fas, TNF-R, and TRAIL-R, as well as pro-apoptotic Bcl-2 family members, such as 
Bax (Gressner et al., 2005).  Furthermore, inhibition of TAp63 function results in 
chemoresistance.  Sayan et al. (Sayan et al., 2007b) have also demonstrated that after 
induction of apoptosis, the transactivation-inhibitory domain of the ∆Np63α isoforms 
is cleaved by activated caspases.  Cleavage of ∆Np63α relieves its inhibitory effect on 
transcriptionally active p63 proteins, and the cleavage of TAp63α results in 
production of a TAp63 protein with enhanced transcriptional activity, promoting 
apoptosis.   
Nevertheless, the involvement of p63 and p73 in neural p53-mediated 
apoptosis is still controversial (Benchimol, 2004).  In fact, there is intense debate on 
whether and how p63 and p73 interact with p53 in apoptosis context.  During 
development, the p53 family has been considered pivotal in determining the life 
versus death of developing peripheral sympathetic neurons (Jacobs et al., 2005; 
Pozniak et al., 2000; Walsh et al., 2004).  p53 has a partial but essential role for 
efficient neuronal apoptosis in vivo (Aloyz et al., 1998; Jacobs et al., 2005; Slack 
et al., 1996).  TAp63 can induce neuronal apoptosis on its own, but p53 requires 
TAp63, indicating that p63 is dominant to p53 during developmental sympathetic 
neuronal death (Jacobs et al., 2006).  In addition, analysis of the embryonic 
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superior cervical ganglion shows that TAp63 is also essential for naturally 
occurring sympathetic neuronal death in vivo.  Sympathetic neuron survival is 
largely regulated by pro-apoptotic signals deriving from p75
NTR
 and pro-survival 
signals deriving from the NGF/TrkA receptor (Kaplan and Miller, 2000).  In 
addition, NGF withdrawal and p75
NTR
 activation converge on TAp63 and p53, 
which then activate Bax gene and protein expression to induce mitochondrial 
apoptosis (Jacobs et al., 2005).  Interestingly, Dugani et al. (Dugani et al., 2009) 
have also demonstrated that the ∆Np63 isoform is crucial for the survival of 
neural precursors, namely embryonic cortical precursors, and newly born neurons, 
antagonizing the pro-apoptotic actions of p53.  NGF induced anti-apoptotic 
∆Np73 protein functions, at least in part, by antagonizing the pro-apoptotic 
actions of p53 (Pozniak et al., 2000), and potentially TAp63.  Thus, p73 acts as an 
essential pro-survival protein (Lee et al., 2004; Pozniak et al., 2000).  Thus, 
coordinated regulation of the abundance of p53 family proteins appears to be 
critical in influencing the outcome of neural apoptosis. 
 
1.1.3. JNK/c-Jun signaling pathway 
Several stimuli including growth factors, proinflammatory cytokines, 
neurotransmitters, cell-matrix interactions, physical and chemical stresses activate 
MAPK signaling pathways (Chang and Karin, 2001; Ip and Davis, 1998; Karin et al., 
1997; Whitmarsh and Davis, 1996).  In mammalian cells, the MAPK family is 
comprised of 3 groups: c-Jun N-terminal kinase (JNK), extracellular signal-regulated 
kinase, and p38.  The JNK pathway is a central stress signaling pathway implicated in 
neuronal plasticity, regeneration and death (Herdegen et al., 1997).  Signaling 
cascades activate the activator protein-1 (AP-1) through the phosphorylation of 
distinct substrates.  AP-1 is linked to various cellular responses, including 
proliferation, differentiation, oncogenic transformation and apoptosis (Angel and 
Karin, 1991; Shaulian and Karin, 2002).  The AP-1 capacity to control several 
biological processes is primarily due to its structural and regulatory complexity.  In 
fact, AP-1 is a collective term referring to dimeric basic/leucine zipper transcription 
factors that belong to several subfamilies, including the Jun (Estus et al., 1997) 
subfamily.  These DNA binding proteins may form homodimers or heterodimers with 
each other (Chinenov and Kerppola, 2001).  c-Jun is an essential regulator of both cell 
survival and death, with its levels being increased upon exposure to a variety of stress 
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signals and chemotherapeutic agents as well as growth factors (Eferl and Wagner, 
2003).  Its activity is regulated by phosphorylation at serines 63 and/or 73 through 
JNKs (Dérijard et al., 1994; Ham et al., 1995; Kyriakis et al., 1994).  
The detailed mechanisms by which c-Jun regulates apoptosis is not fully 
understood.  The role of c-jun in apoptosis may be stimulus- and cell type-specific.  
JNK increases the ability of c-Jun to activate the transcription of target genes (Estus et 
al., 1994; Ham et al., 1995) that are more proximal to promote caspase activation and 
neuron apoptosis (Edwards and Tolkovsky, 1994; Putcha et al., 2000).  Indeed, 
induction of pro-apoptotic Bcl-2 family members Bim (Whitfield et al., 2001) and 
death protein 5/harakiri were shown to be JNK/c-Jun-dependent in neurons (Harris 
and Johnson, 2001).  In addition, some studies have reported that after NGF 
withdrawal in sympathetic neurons, c-Jun protein levels increased and the N-terminal 
c-Jun transcriptional activation domain became more phosphorylated (Eilers et al., 
1998; Eilers et al., 2001), in correlation with an increase in JNK activity (Bruckner et 
al., 2001; Eilers et al., 1998).  Moreover, microinjection of an expression vector for a 
c-Jun dominant negative mutant, which inhibited AP-1 activity, resulted in protection 
of neurons against NGF withdrawal-induced death, whereas overexpression of wild-
type c-Jun was sufficient to induce apoptosis in the presence of NGF (Estus et al., 
1994; Ham et al., 1995).  The role for c-Jun in CNS neurons has also been reported, 
namely in cerebellar granule neurons (Watson et al., 1998).  In addition, the c-Jun 
pathway has also been implicated in the induction of apoptosis in differentiated PC12 
cells deprived of NGF (Xia et al., 1995), in striatal neurons treated with neurotoxic 
concentrations of dopamine (Luo et al., 1998), or in a hippocampal neuron cell line 
transfected with an expression vector for polyglutamine-expanded Huntingtin (Liu, 
1998). 
Curiously, JNK may also phosphorylate p53 (Fuchs et al., 1998), and 
subsequently up-regulate Bax (Miyashita and Reed, 1995).  However, the interplay 
between p53 and c-Jun in regulating neuronal survival and death genes remains to be 
determined.  Regarding p73, it was already demonstrated that JNK and c-Jun is 
required for the stabilization of TAp73 (Jones et al., 2007; Toh et al., 2004) and 
degradation of ∆Np73 under stress stimulation (Dulloo et al., 2010).  Importantly, c-
Jun has also been shown to regulate the abundance of p63.  Yao et al. (Yao et al., 
2010b) showed that the transcriptional activity of the TAp63 promoter and TAp63 
 13 
protein levels were both up-regulated by an increased c-Jun activity in the Hep3B 
human hepatocellular carcinoma cell line.   
However, since c-Jun null mice die during embryonic development at 
embryonic day 12.5 (E12.5) due to hepatic failure (Hilberg et al., 1993), in vivo 
studies focused on the role of c-Jun in the nervous system were only possible due to 
knockout (KO) mice models for the three mammalian JNK genes, Jnk1, Jnk2, and 
Jnk3.  JNK3 is mainly expressed in the CNS (Junyent et al., 2011), whereas JNK1 and 
JNK2 are expressed in many other tissues (Ip and Davis, 1998).  In fact, c-Jun 
phosphorylation and neuronal cell death was inhibited in neurons from JNK3 null 
mice (Bruckner et al., 2001).  Finally, JNK1/JNK2 double KO mice, but not single, 
showed that both JNKs are required for developmental cell death in the neural tube, 
whereas in the developing cortex they promote neuronal survival (Kuan et al., 1999; 
Sabapathy et al., 1999).  Thus, although JNKs and c-Jun may be pro-apoptotic in 
many neuronal cell types, they can have other cellular roles.   
 
1.1.4. Role of apoptosis in Alzheimer’s disease 
AD is the most common human age-related, sporadic neurodegenerative 
disorder, characterized by a global, progressive and irreversible cognitive decline 
that is strongly correlated with synaptic dysfunction and death of neurons from 
hippocampus and associated regions of the cerebral cortex.  The affected brain 
shows extracellular deposits of Aβ peptides, known as amyloid or senile plaques 
(Mattson, 2004), and intracellular accumulation of paired helical filaments that form 
NFTs (McKee et al., 1990), consisting of polymerized hyperphosphorylated tau 
protein (Spillantini and Goedert, 1998). Although activation of apoptotic signaling 
has been reported in AD brains (Raynaud and Marcilhac, 2006), the precise 
intracellular signaling pathways by which Aβ peptides trigger cell death are not fully 
understood.   
The study of apoptosis in neurodegenerative diseases has become a 
challenging task and a controversial area of research, especially because synaptic loss 
and electrophysiological abnormalities typically precede cell loss.  In addition, given 
the slow progression of most neurodegenerative diseases, in contrast with the rapid 
progression of a cell through apoptosis, the detection of representative apoptotic 
neurons in AD patients could be difficult.  Further, apoptotic processes may be 
terminated or not yet initiated by the time of tissue examination.  In fact, the collected 
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tissue is usually representative of the end-stage disease, being removed much later 
than it would be ideal to treat patients and prevent neuronal cell death.  Finally, the 
criteria used to classify the type of cell death as apoptosis has often been based on 
morphological assessment and biochemical assays, which may also account for other 
forms of programmed cell death. 
Although many AD mouse models have been reported, there is no single 
model that exactly mimics human AD (Elder et al., 2010).  Thus, it is important to 
keep in mind the limitations when research data generated from using these AD 
animal models are interpreted.   
Knowledge of the production and degradation pathways acting on the toxic 
proteins that cause AD, and various other proteinopathies, could help in the design 
and improvement of therapeutic strategies.  Specifically, the reduction of Aβ load has 
given many insights into drug development strategies for potential therapies in AD 
aimed at preventing Aβ formation or accelerating its degradation.   β- and γ-secretases 
have been considered as possible drug targets.  Targeting secretases may, however, 
have unforeseen effects because a physiological role for Aβ has also been proposed 
(Atwood et al., 2003; Chen and Dong, 2009; Pearson and Peers, 2006).  
 
1.1.4.1. Aβ production and accumulation 
The amyloid precursor protein (APP) in mammals belongs to a family of 
conserved type I membrane proteins that include APP, APP-like protein 1 (Aydin et 
al.) and 2 (APLP2) (Aydin et al., 2012).  Although the APP family is abundantly 
expressed in the brain and APLP1 expression is restricted to neurons (Lorent et al., 
1995), APP and APLP2 can also be found in the majority of other tissues.  The human 
APP gene encodes a single transmembrane polypeptide, whose primary structure 
contains a signal peptide for secretion, a large extracellular N-terminal domain, a 
transmembrane domain, and a cytoplasmic C-terminal tail.   
During normal development, APP can undergo amyloidogenic or non-
amyloidogenic processing via cleavage by three different secretases, α-, β-, and y-
secretases (Ling et al., 2003).  In the non-amyloidogenic pathway, cleavage of APP 
occurs via presenilin-containing α-secretase complex, which cleaves within Aβ 
sequence and consequently abrogates Aβ formation, leading to the release of a large 
soluble extracellular fragment (Mattson), which can be neuroprotective, and retention 
of an 83-residue membrane-bound fragment (C83).  Alternatively, APP can be 
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cleaved by β-secretase, which cuts at the N-terminus of Aβ, generating a smaller 
extracellular fragment (Mattson) and a 99-residue membrane-bound fragment (C99).  
Peptide fragments C83 and C99 may then undergo conformational alterations and 
become targets for the presenilin (PS1/PS2)-dependent γ-secretase, which cleaves 
within the plasma membrane domain.  C99 proteolysis generates Aβ1-40 and Aβ1-42 
(Selkoe and Wolfe, 2007).  The cleavage of either C83 or C99 by γ-secretase may 
also generate an amyloid intracellular domain (AICD), which moves to the nucleus 
where it may modulate transcription of target genes. 
Aβ is produced as a monomer, but readily aggregates to form multimeric 
complexes.  Therefore, the term “soluble Aβ” is generally applied either to newly 
generated, cell-secreted Aβ or to that fraction of tissue or synthetic Aβ that is taken 
into the aqueous phase of a non-detergent containing extraction buffer.  In contrast, 
“misfolded” and “aggregated” Aβ are terms used to describe very early, nonspecific 
changes in Aβ folding states or solubility states, respectively.  In addition,  
“oligomeric” Aβ refers to peptide assemblies with limited stoichiometry, such as 
dimmers and trimers, while protofibrils are structures of intermediate order between 
aggregates and fibrils (Gandy, 2005). 
Aβ peptide is detected in human cerebrospinal fluid (CSF) as a range of 
isoforms between 38 and 43 amino acids in length.  The predominant isoforms 
secreted are Aβ1-40 (90%) whereas Aβ1-42 isoform represents less than 10% 
(Thinakaran and Koo, 2008).  In patients with AD, the relative proportions of Aβ1-40 
and Aβ1-42 change to approximately 50% each (Mehta et al., 2001).  The accumulation 
of Aβ is progressive and strongly accepted as an important contributor to the neuronal 
dysfunction and loss (Hardy and Selkoe, 2002).  The pattern and distribution of the 
different Aβ species varies among the different topographical lesions.  
 
1.1.4.2. Cytotoxicity of Aβ  
Several studies suggest that Aβ-induced oxidative stress leads to apoptotic 
neuronal cell death that can be inhibited by antioxidants (Behl et al., 1994; Mattson 
and Goodman, 1995; Pillot et al., 1999).  In fact, many lines of evidence suggest that 
mitochondria dysfunction and oxidative damage have a central role in aging-related 
neurodegenerative diseases, being key regulators of cell survival and death (Danial 
and Korsmeyer, 2004).   
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The involvement of apoptosis in AD has been corroborated by studies 
showing that Aβ alters the expression of the Bcl-2 family of apoptosis-related genes 
(Yao et al., 2005) and that survival pathways play a pivotal role in preventing Aβ-
mediated apoptosis (Watson and Fan, 2005).  On the other hand, studies in an anti-
NGF transgenic mouse model and PC12 cells suggest that discontinued or limited 
NGF supply induces an overproduction of Aβ peptides, triggering downstream 
apoptotic cell death (Capsoni et al., 2000; Matrone et al., 2008).  Furthermore, p75
NTR
 
has been consistently linked to changes occurring in AD (Schliebs, 2005; 
Sotthibundhu et al., 2009), including cell death of basal forebrain cholinergic neurons, 
where this receptor is highly expressed (Dechant and Barde, 2002).  Both in vitro and 
in vivo evidence suggests that the JNK/c-Jun cascade is a critical event during 
neuronal death in AD (Anderson et al., 1994; Kihiko et al., 1999; Viana et al., 2010), 
where JNK mediates the activation of several molecules, including caspase-2 (Viana 
et al., 2010), p53 (She et al., 2002), and Bcl-2 family members (Sorenson, 2004) and 
potentiate inflammatory responses via AP-1 activation (Manning and Davis, 2003).  
Viana et al. (Viana et al., 2010) showed that Aβ exposure in PC12 cells resulted in 
activation and nuclear translocation of JNK, and caspase-2 activation.  Caspase-2 
triggers apoptosis through activation of the mitochondrial apoptosis pathway.  The 
induction of c-Jun was shown to occur in vitro after Aβ treatment (Estus et al., 1997; 
Iwasaki et al., 1996; Kihiko et al., 1999) and in AD brains (Anderson et al., 1994; 
Anderson et al., 1996), suggesting a possible requirement for this transcription factor 
in Aβ toxicity. 
Curiously, p53 family members have also been associated with Aβ-
induced neuronal apoptosis.  The first indication that the p53 family may play a 
role in AD came in 1996 with the demonstration that intracellular Aβ up-regulates 
p53 in the brains of transgenic mice overexpressing the Aβ fragment of APP 
(LaFerla et al., 1996).  The use of pifithrin-α, an inhibitor of p53-dependent gene 
transcription, was shown to protect neurons against Aβ-induced apoptosis 
(Culmsee et al., 2001; Hooper et al., 2007).  p53 was also found to be up-
regulated in the brain of AD patients [43, 44].  In 2004, Caricasole et al. 
(Caricasole et al., 2004) showed that Aβ activates the expression of the soluble 
Wnt antagonist Dickkopf-1 (Caricasole et al.), a p53 target gene.  Knockdown of 
Dkk1 in primary neurons, in turn, almost completely blocked Aβ-induced tau 
phosphorylation, implicating the p53 family in the “amyloid cascade” pathway.  
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More recently, it has been demonstrated that p53 participates in Aβ-induced 
apoptosis of PC12 neuronal cells through modulation of Bax expression 
(Ramalho et al., 2004).  Furthermore, Aβ-induced apoptosis in rat primary 
cortical neurons was associated with translocation of Bax to the mitochondria, 
followed by cyt c release, caspase activation, and DNA and nuclear fragmentation 
(Solá et al., 2003).  Interestingly, a novel biological function of intracellular Aβ1-
42 has been suggested, where it acts as a transcription factor for the p53 promoter, 
enhancing p53-dependent neuronal apoptosis in AD (Ohyagi et al., 2005).  
Several reports have also demonstrated p73 involvement in apoptosis 
triggered by Aβ25-35, being probably vital for mediating the process of AD (Zhang 
et al., 2011).  It has been shown that in primary cortical neurons generated from 
p73 KO mice, the activity of JNK increased, while JNK inhibition decreased tau 
phosphorylation in these neurons (Wetzel et al., 2008).  Since ΔNp73, and not 
TAp73, can bind and inhibit JNK, the loss of ΔNp73 forms may result in tau 
phosphorylation and neurodegeneration.  As mentioned before, Aβ peptide 
activates c-Abl and increases p73 levels (Alvarez et al., 2004; Vázquez et al., 
2009), while the Swedish mutant form of APP increases expression from both the 
TA and ΔN promoters of the p73 gene, only inducing an overall increase in the 
TA forms (Vázquez et al., 2009).  Surprisingly, the mechanisms regulating p63 
levels under Aβ-mediated apoptosis have yet to be elucidated. 
Aβ peptides accumulate within mitochondria, strongly affecting their function 
and morphology, particularly in the synaptic compartment (Balietti et al., 2012).  
Increasing evidence indicates that the mitochondrial dysfunction is an important early 
factor in the development of AD-like pathology (Blass and Gibson, 2006; Yao et al., 
2009).  Accumulation of Aβ in mitochondria appears to be also associated with 
diminished enzymatic activity of respiratory chain complexes III and IV, and 
reduction of oxygen consumption (Caspersen et al., 2005).  
Finally, several studies have demonstrated that Aβ triggers the formation of 
tau pathology.  Inflammatory processes are strongly correlated with AD onset and 
progression in humans, and could have a pivotal role in disease etiology (Kitazawa et 
al., 2005; Krstic and Knuesel, 2013).  Interestingly, it has been suggested that 
different forms of Aβ may be responsible for inducing tau hyperphosphorylation in 
different settings (Blurton-Jones and Laferla, 2006; LaFerla, 2010).  
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1.1.5. Regulation of apoptosis by autophagy 
Autophagy is a cellular process in which isolated membrane sequesters part of 
the cytoplasm to form a double-membrane vesicle, called autophagosome (AP) that 
fuses with lysosomes for the degradation of its contents, long-lived cytoplasmic 
proteins or damaged organelles, by acidic lysosomal hydrolases, maintaining normal 
cell homeostasis (Nixon and Yang, 2011).  There are at least three types of 
autophagy; macroautophagy (delivery of cytosolic contents to the lysosome by 
autophagosomes), microautophagy (inward invagination of the lysosomal 
membrane) and chaperone-mediated autophagy (direct translocation across the 
lysosomal membrane).  Among these, macroautophagy referred to as autophagy 
has been the most studied.  Autophagy-related (Atg) proteins are a set of 
evolutionarily conserved gene products, originally identified in yeast and 
followed by the identification of homologs in higher eukaryotes (Huang and 
Klionsky, 2002), which are required for autophagy. 
Among Atg proteins, one subset is essential for AP formation, and is 
referred to as the “core” molecular machinery (Xie and Klionsky, 2007).  In 
mammalian cells, most of the Atg proteins are observed in isolated membranes 
but not in complete APs (Longatti and Tooze, 2009; Tooze and Razi, 2009).  
Only microtubule-associated protein light chain 3 (LC3), a mammalian homolog 
of yeast Atg8, is known to exist in APs, and therefore, this protein serves as 
marker for APs and is widely used to monitor autophagy (Kabeya et al., 2000).  
Since autophagy can block apoptosis, one might expect that their regulation 
would be tightly coordinated.  Curiously, the same proteins can regulate both 
processes.  Some molecular connections occur upstream of the autophagic and 
apoptotic machinery itself, where signaling pathways regulate both processes 
(Thorburn, 2008).  p53, which is a potent inducer of apoptosis, can also induce 
autophagy through increased expression of a direct p53 target gene called DRAM 
(Crighton et al., 2006).  Similarly, activation of the phosphatidylinositide 3 kinase 
(PI3K)/Akt pathway, which is well-known to inhibit apoptosis, also inhibits 
autophagy (Arico et al., 2001).  Thus, important signaling pathways simultaneously 
increase or decrease both autophagy and apoptosis.  In addition, proteins that are 
themselves central components of the apoptosis machinery, including Bcl-2 family 
proteins and FADD regulate both processes directly.  In addition, in normal 
cytoprotective autophagy, activation of JNK can up-regulate Beclin-1 (Li et al., 
 19 
2009), a marker for autophagy activation that was originally identified as an 
interaction partner of the anti-apoptotic protein Bcl-2 (Kang et al., 2011).  When Bcl-
2 and Bcl-xL proteins form Beclin-1-Bcl-2/Bcl-xL complexes, the pro-autophagic 
function of Beclin-1 is inhibited (Maiuri et al., 2007). 
Although autophagy is crucial in survival and suppression of apoptosis, it can 
also lead to cell death (Lum et al., 2005; Mizushima, 2005; Yu et al., 2004b), either in 
collaboration with apoptosis or as a backup mechanism when apoptotic machinery is 
disabled (Eisenberg-Lerner et al., 2009; Shimizu et al., 2004; Yu et al., 2004a).  One 
example of autophagic cell death is caused by increased ROS resulting from 
autophagic degradation of catalase (Yu et al., 2006).  Interestingly, neurons presenting 
accumulation of autophagic vacuoles (AVs) seem to have dysfunction of this 
degradation pathway (Nixon et al., 2005; Yu et al., 2005; Yu et al., 2004c).  
Autophagy is normally efficient in the brain as reflected by the low number of AVs at 
any given moment (Boland et al., 2008).  Interestingly, it has been reported an 
elevated number of AVs in brains of AD patients and in transgenic mouse models, 
associated with dystrophic neuritis and deformed synaptic membranes (Nixon et al., 
2005; Yu et al., 2005).  This suggests impairment of clearance mechanisms, thus 
indicating that autophagy is involved in AD pathogenesis.  In addition, Lipinski et al. 
(Lipinski et al., 2010) has shown that ROS play an essential role in mediating 
autophagy upstream of PI3K in brains of AD patients.  This pathway is critical for the 
initiation of autophagy by Aβ.  Zheng et al. (Zheng et al., 2006b) have also 
demonstrated that ROS induce intralysosomal Aβ accumulation in cultured 
differentiated neuroblastoma cells through the activation of autophagy.  However, it 
remains to be elucidated whether intralysosomal Aβ corresponds to autophagocytosed 
cytoplasmic Aβ, or a derivative of autophagocytosed APP, or both.   
Interestingly, autophagy has also been reported as a mechanism of neuronal 
protection from Aβ-induced cytotoxicity (Cheung et al., 2011; Hung et al., 2009; 
Wang et al., 2010), and serves as a mechanism that mediates clearance of 
ubiquitinated Aβ to eliminate molecular debris and restore neurotransmitter balance 
(Khandelwal et al., 2011) (Fig. 1.2).  In fact, Hung et al. (Hung et al., 2009) have 
demonstrated in SH-SY5Y/pEGFP-LC3 cells that Aβ treatment activates autophagy, 
and inhibition of this process increases neuronal death, indicating that the clearance of 
Aβ plays a neuroprotective role.  Furthermore, the decreased activity of the 
proteasomal system and consequent accumulation of Aβ induced autophagy (Iwata et 
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al., 2005; Khandelwal et al., 2011), concurrent with ubiquitination (Nedelsky et al., 
2008; Ravikumar and Rubinsztein, 2004; Wong and Cuervo, 2010).  When proteins 
are aggregate-prone and poor proteasome substrates, autophagy becomes a major 
clearance route by default. 
 
 
 
Figure 1.2.  Autophagy is crucial for intracellular clearance of neurons.  Normal proteins 
are routinely turned over by different protein degradation systems, including the ubiquitin-
proteasome system (UPS), chaperone-mediated autophagy (CMA), and autophagy.  In 
autophagy-deficient neurons, there is an accumulation of ubiquitinated protein aggregates 
that is associated with neurodegeneration.  Proteins altered by mutations, posttranslational 
modifications, or stress undergo a conformational change, are recognized by molecular 
chaperones, and are either refolded and repaired or delivered to protein degradation 
systems, usually UPS or CMA.  If these protein degradation systems are impaired or if the 
altered proteins form oligomeric complexes that cannot be recognized by the UPS or CMA, 
autophagy may be the primary route for the removal of these abnormal and potentially toxic 
proteins.  Impaired autophagy is associated with the formation of protein aggregates and 
increased neurodegeneration.  Adapted from Levine and Kroemer, 2008. 
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In 3xTg-AD mice, the E3-ubiquitin ligase parkin clears vesicle-containing 
defective mitochondria, suggesting that the clearance of intraneural Aβ reduces 
oxidative stress (Geisler et al., 2010; Khandelwal et al., 2011), and may modulate 
autophagy.  These issues deserve further investigation since autophagy might be 
one of the key checkpoints responsible for neural differentiation, as an alternative to 
cell death. 
 
1.1.6. Modulation of neural apoptosis by bile acids 
Bile acids are the major component of bile, produced in the liver and 
secreted via the bile ducts and gallbladder into the intestine (Setchell et al., 1992), 
where they act as detergents being crucial in the solubilization of lipids in the 
human intestinal lumen.  Ursodeoxycholic acid (UDCA) is an endogenous bile 
acid used during the past several decades for the treatment of certain liver 
diseases (Lazaridis et al., 2001; Paumgartner and Beuers, 2002).  It is normally 
present in human bile in low concentrations.  The anti-apoptotic effects of UDCA 
have been demonstrated both in vivo and in vitro in the rat liver [48, 68], and in 
human hepatocytes [69].  Furthermore, it has been shown that both UDCA and its 
taurine conjugated form, tauroursodeoxycholic acid (TUDCA), play a unique role 
in modulating cell death in response to a variety of agents, by interrupting classic 
pathways of apoptosis in both hepatic and non-hepatic cells, including neurons 
(Rodrigues et al., 1998; Rodrigues et al., 2002a; Rodrigues et al., 2000b; Solá et 
al., 2003) (Fig. 1.3).  A possible explanation for this ubiquitous anti-apoptotic 
effect appears to involve the mitochondrial membrane stabilization (Rodrigues et 
al., 2003b).  Indeed, both UDCA and TUDCA are antioxidant molecules (Oveson et 
al., 2011; Phillips et al., 2008), modulating mitochondrial apoptosis in a number of 
animal models (Rodrigues et al., 1998; Rodrigues et al., 2002a; Rodrigues et al., 
2000b).  In fact, UDCA and, more efficiently, TUDCA inhibited bilirubin- and 
Aβ-induced MOMP and consequent cyt c release in isolated mitochondria of 
neural and glial cells (Rodrigues et al., 2000a).  Moreover, using electron 
paramagnetic resonance spectroscopy analysis, it has been demonstrated that 
TUDCA prevents Aβ-driven modifications in mitochondrial membrane redox 
status, lipid polarity and protein order (Rodrigues et al., 2001).  The effects of 
TUDCA on the Aβ-affected mitochondria were further confirmed by the 
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observation of decreased Bax translocation in the presence of this bile acid (Solá 
et al., 2003). 
 
 
 
Figure 1.3.  Tauroursodeoxycholic acid modulates amyloid β-induced toxicity by inhibiting 
organelle-driven apoptosis.  Soluble Aβ is a hydrophobic peptide that is prone to 
aggregation.  Equilibrium is produced between several extracellular and intracellular Aβ 
species, including monomeric, oligomeric, and fibrillar forms.  Cell death by toxic Aβ 
appears to involve a complex signaling network of inter-organellar cross-talk that involves 
mitochondria, ER, Golgi and nucleus.  TUDCA effectively abrogates this signaling network.  
Intracellular calcium (Ca
2+
) free levels are tightly regulated by the ER to avoid cell death 
induced by Ca
2+
 deregulation.  Inside the ER, Ca
2+
 is maintained elevated by Ca
2+
-binding 
buffering proteins, such as GRP94, promoting cellular Ca
2+
 homoeostasis.  Caspase-12 can 
be activated via Ca
2+
-activated protease calpain during ER stress-induced apoptosis.  Aβ-
induced cell death requires the activation of caspase-2, which is localized at the Golgi 
complex and has been described as a target of the JNK pathway that triggers apoptosis 
through activation of the mitochondrial pathway.  In fact, Aβ, p53 and activated JNK trigger 
Bax translocation to the mitochondria, formation of pore complex, cytochrome c release, and 
subsequent mitochondrial apoptosis.  In addition, JNK activates the pro-apoptotic 
transcription factor c-Jun, enhancing the expression of apoptosis proteins.  Adapted from 
Viana et al., 2012. 
 
  In addition, UDCA and TUDCA interfere with upstream targets of 
mitochondria, in a caspase-independent manner (Solá et al., 2003b).  The anti-
apoptotic effects of these bile acids appear to be dependent on other molecular 
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targets upstream of the E2F-1/p53 apoptotic pathway (Solá et al., 2003b), namely the 
nuclear steroid receptors.  In fact, as cholesterol-derived molecules, UDCA and 
TUDCA interact with specific regions of glucocorticoid (GR) and the 
mineralocorticoid (MR) receptors (Solá et al., 2006; Solá et al., 2005; Solá et al., 
2004).  A incubation reduces MR nuclear translocation while increasing nuclear GR 
levels.  Notably, pretreatment with TUDCA markedly altered A-induced changes in 
nuclear steroid receptors.   
The protective role of TUDCA has been extended to several mouse models of 
neurological disorders, including Huntington’s disease (Keene et al., 2002), 
Parkinson’s disease (Duan et al., 2002), and acute ischemic (Rodrigues et al., 2002b) 
and hemorrhagic stroke (Rodrigues et al., 2003a).  Notably, in an in vitro AD 
pathologic model, TUDCA prevented the reduction of dendritic spine number and 
the decrease in the frequency of spontaneous excitatory synaptic activity (Ramalho 
et al., 2013; Shankar et al., 2007), supporting the idea that the protective role of 
this bile acid goes beyond its capacity to modulate neuronal death.  
It is becoming increasingly evident that activation of survival pathways may 
also represent an important additional mechanism by which TUDCA inhibits 
apoptosis.  In primary rat hepatocytes, TUDCA was shown to protect mitochondria-
controlled apoptosis by activating the PI3K and the MAPK survival pathways 
(Bradham et al., 1998; Schoemaker et al., 2004).  PI3K signaling is also activated by 
TUDCA in Aβ-induced neuronal apoptosis (Solá et al., 2003).  In fact, incubation 
with wortmannin, an inhibitor of the PI3K pathway, significantly reduced the ability 
of TUDCA to modulate p53-induced apoptosis (Ramalho et al., 2006).  Moreover, by 
interfering with apoptotic pathways, TUDCA not only increases the survival of 
neurons but also prevents downstream abnormal conformations of tau (Ramalho et 
al., 2008).  Finally, TUDCA was shown to abrogate Aβ-induced apoptosis of 
neuronal PC12 cells by inhibiting the E2F-1/p53 apoptotic pathway, hence 
modulating the expression of Bcl-2 family members (Ramalho et al., 2004).  Similar 
results were seen in vitro models of familial AD that consist of mouse 
neuroblastoma cells expressing APP with the Swedish mutation or double-
mutated human APP and PS1 (Ramalho et al., 2006), as well as in primary rat 
neurons incubated with Aβ (Solá et al., 2003).  A recent study in primary rat 
cortical and hippocampal cultures exposed to Aβ, and brain tissue of APP/PS1 
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transgenic mice also showed that TUDCA suppresses Aβ-induced decrease of the 
neuronal marker postsynaptic density-95 protein (PSD-95).  Of note, TUDCA 
was capable of reducing Aβ deposits, glial activation (Itagaki et al., 1989) and 
neuronal integrity loss in the APP/PS1 double transgenic mouse model of AD, 
rescuing memory and learning deficits (Nunes et al., 2012).  This effect may be 
partially explained by the effect of TUDCA in regulating lipid-metabolism 
mediators that influence Aβ production and intracellular accumulation (Nunes et 
al., 2012). 
 
1.2. Neural Differentiation 
The defining hallmark of metazoan multicell life forms is cell 
specialization and adaptation that results from the process commonly referred to 
as differentiation.  In fact, during differentiation, stem cells give rise to committed 
and specialized cells.  Stem cells are unspecialized precursor cells, capable of 
generating identical progeny (self-renewal), thereby sustaining a stem cell pool, 
with the ability to develop into other cell types (differentiation) carrying out 
particular tissue functions.  In vivo, stem cells are thought to reside in specific 
cellular niches that constitute privileged sites for support of self-renewal 
(Doetsch, 2003; Spradling et al., 2001; Watt and Hogan, 2000).  They can be 
found both in the embryo and adult organisms, and may also differ in their 
differentiation potential.  Stem cells can be somatic (fetal or adult) or embryonic.  
Embryonic stem cells (ECSs) have attracted a lot of attention because of their 
origin and plasticity, being currently used to create transgenic animals, and 
proposed for use in a wide variety of commercial and clinical applications (Gage, 
2000; Thomson et al., 1998).  These cells are derived from the inner mass cell of 
developing blastocysts (Evans and Kaufman, 1981; Martin, 1981) and are 
considered pluripotent, capable of transforming into cells from all three somatic 
germ layers as well into germ cells.  In contrast, adult stem cells are considered 
multipotent because they only originate different cell types of a particular lineage. 
Neural stem cells (NSC) are defined as clonogenic cells, having some 
capacity of self-renewal, and also as multipotent cells, being able to differentiate 
into neuronal and glial precursor cells (Brüstle et al., 1997) (Fig. 1.4).  Neuronal 
precursor cells (NPCs) can further generate motor, sensory, or dopaminergic 
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neurons, while glial precursor cells generate astrocytes or oligodendrocytes 
(Reynolds and Weiss, 1996).  
 
 
Figure 1.4.  Monolayer culture system of neural stem cells.  Monolayer NSC lines can be 
derived from fetal and adult brains and display multipotency, generating neurons, astrocytes 
and oligodendrocytes under appropriate culturing conditions.  The cellular composition of 
the monolayer NSC culture system is highly homogeneous.  This property of monolayer NSC 
lines results in higher reproducibility of differentiation protocols and higher neurogenic 
potential.  Adapted from Conti and Cattaneo, 2010. 
 
Neurogenesis, the process of generating integrated neurons from 
progenitor cells, was traditionally believed to occur only during embryonic stages 
in the mammalian CNS.  Only recently neurogenesis was shown to also occur in 
the adult mammalian brain (Alvarez-Buylla and Garcia-Verdugo, 2002; Christie 
and Cameron, 2006; Gage, 2000; Pignatelli et al., 2009).   
Neurogenesis in mammals begins with thickening of the ectoderm, leading to 
the induction of neuroectoderm, which forms the neural plate, at E7.5 in mice, and 
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then folds to give rise to the neural tube.  These structures are made up by a layer of 
neuroepithelial cells (Götz and Huttner, 2005), which contact both apical (ventricular) 
and basal (pial) surfaces.  Initially, neuroepithelial cells divide symmetrically at the 
ventricular surface to increase the pool of stem cells.  However, at a certain point, 
they start dividing asymmetrically, generating stem cells that remain in the ventricular 
zone, and other cells that migrate radially outward (Haubensak et al., 2004).  These 
cells are responsible for the first wave of neurogenesis in the neural tube, after which 
they give rise to radial glia (RG) (Conti and Cattaneo, 2010). 
The name of RG was attributed due to several characteristics shared with 
astrocytes, including the presence of glycogen granules and the expression of glial 
fibrillary acidic protein (GFAP) (Choi and Lapham, 1978; Levitt and Rakic, 1980), 
astrocyte-specific glutamate transporter (Shibata et al., 1997) and brain lipid binding 
protein (Feng et al., 1994).  RG cells act as guide wires for the migration of neurons 
(Malatesta et al., 2008).  It is now clear that in many regions of the CNS, RG also 
represents the main population of neural progenitors and that their progeny includes 
neurons, astrocytes, oligodendrocytes, ependymocytes and adult NSCs (Conti and 
Cattaneo, 2010; Malatesta et al., 2003; Merkle et al., 2004; Spassky et al., 2005).  
While in many species RG persists into adulthood, in the mammalian brain RG 
disappears soon after birth, giving rise to the adult astrocyte-like NSCs (Merkle 
and Alvarez-Buylla, 2006). 
 
1.2.1. Adult NSCs 
The existence of adult NSCs, capable of self-renewing and generating both 
neuronal and glial derivatives has been an area of great controversy.  Adult NSCs 
were first isolated from the adult CNS of rodents (Reynolds and Weiss, 1992), 
and later from humans (Kukekov et al., 1999).  Full acceptance of postembryonic 
mammalian neurogenesis was not immediate until Luskins et al. (Luskin, 1993) 
described neurogenesis in the anterior portion of the subventricular zone (SVZ) in 
postnatal mice, Lois and Alvarez-Buylla (Lois and Alvarez-Buylla, 1993) 
demonstrated neurogenesis in the adult mouse SVZ, and several groups showed 
neurogenesis in the subgranular layer of the hippocampus (Altman and Das, 1965; 
Cameron et al., 1993; Kaplan and Bell, 1984; Kuhn et al., 1996).  The discovery 
of the “no new neuron” dogma suggested that ongoing adult neurogenesis might 
be supported by a population of multipotent NSCs.  This idea was based on the 
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following observations: (1) primary precursors within CNS germinal zones 
continue to produce neurons and glia throughout an organism life; and (2) cells 
from the adult brain with properties of NSCs can be grown in vitro with growth 
factors.   
Along the lateral walls of the lateral ventricles lies the largest germinal 
zone of the adult mammalian brain, the SVZ.  NSCs in the SVZ give rise 
predominantly to committed progenitor cells that migrate interiorly into the olfactory 
bulb (OB) via the rostral migratory stream (Kornack and Rakic), where they 
differentiate into two kinds of local olfactory interneurons, granule and 
periglomerular cells (Altman, 1969; Kornack and Rakic, 2001; Luskin, 1993).  SVZ 
NSCs can be dissociated and grown in culture as free-floating spheres, or 
neurospheres, in the presence of epidermal growth factor (EGF), fibroblast growth 
factor (FGF), or combination of both growth factors (Gage, 2000; Temple and 
Alvarez-Buylla, 1999; Weiss et al., 1996).  Some of these primary spheres are capable 
of generating other spheres upon dissociation and can be renewed through many 
passages.  
The hippocampus is other major site of neurogenesis in adult mammals.  
Granule neurons in the dentate gyrus (DG) are born locally in the sugranular zone 
(SGZ).  The progenitors in the SGZ migrate into the granular cell layer (Kuhn et al.) 
and also differentiate into neurons (Eriksson et al., 1998). 
In the SVZ, the NSC pool is larger than in the SGZ (Yao et al., 2012), and 
three types of progenitors can be found, defined by their morphology, ultrastructure, 
and molecular markers:  SVZ neuroblasts (type A cells) migrate in homotypic chains 
(Lois et al., 1996) into to OB through the RMS, where they differentiate into several 
types of neurons, depending on their place of origin within the SVZ (Lois and 
Alvarez-Buylla, 1994; Merkle et al., 2007).  These chains are unsheathed by slowly 
proliferative type B cells (Lois et al., 1996).  B cells have properties of astrocytes, 
including light cytoplasm, thick bundles of GFAP-positive intermediate filaments, 
gap junctions, glycogen granules, and dense bodies (Doetsch et al., 1999), which have 
been hypothesized to represent the primary neuronal precursors in vivo (Mu et al., 
2010).  Scattered along the chains of type A cells are clusters of spherical and rapidly 
dividing C cells.  The SVZ is largely separated from the ventricle cavity by a layer of 
ependymal cells.  In contrast to the SVZ, the sugranular layer is deep within the brain 
at the interface of the GCL of the DG and the hilus of the hippocampus and, opposite 
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to the extensive tangential migration undertaken by OB neurons, hippocampal granule 
neurons move only a short distance into the GCL (Seri et al., 2001).  The NSCs from 
this region are radial astrocytes, also known as RG-like cells or type 1 progenitors.  
Although expressing the astrocyte marker GFAP, these cells are morphologically and 
functionally different from mature astrocytes.   
Recently, type 1 cells were also shown to be indeed multipotent NSCs, as they 
are capable of undergoing self-renewing symmetric and asymmetric divisions and can 
differentiate into both neurons and astrocytes (Bonaguidi et al., 2011).  Radial 
astrocytes have long radial processes that penetrate the GCL.  Dividing radial 
astrocytes generate immature, non-radial intermediate progenitors termed type 2 or 
type D cells.  These D cells can differentiate into neuroblasts, which migrate into the 
nearby granule layer and differentiate into glutamatergic neurons (Kuhn et al., 1996).  
D cells developed a branched apical process that becomes the dendrites of the new 
granule neuron, and later an axon that projects to area CA3 (Stanfield and Trice, 
1988).  Approximately half of these cells survive and integrate the pre-existing 
neuronal circuits (Toni et al., 2007; van Praag et al., 2002).  The demonstration of 
neurogenesis in adult human brains not only proves the unforeseen regenerative 
capacity of CNS, but also gives hope for strategies to repair damaged adult CNS after 
injury of neurodegenerative diseases. 
 
1.2.3. Apoptosis-associated factors in neural differentiation 
The mechanisms controlling the neural differentiation process remain poorly 
understood, and many molecules and their specific functions are yet unknown.  
Emerging evidence suggests that apoptosis players and inducers may also control cell 
fate, without involving cell death per se (Fernando et al., 2002; Fernando and 
Megeney, 2007; Galluzzi et al., 2012).  In fact, essential players of apoptotic 
executioner pathways cannot be totally blocked to assure differentiation efficiency 
but, at the same time, must be carefully regulated to avoid cell loss (Chasis and 
Schrier, 1989; Solá et al., 2012).  Specifically, apoptosis-related microRNAs 
(miRNAs), such as miRNA-34a, -16 and let-7a, and proteins, including caspases, 
calpains, and Bcl-2 and p53 family members are involved in mouse NSC 
differentiation by mechanisms independent of cell death (Aranha et al., 2011; Aranha 
et al., 2010; Aranha et al., 2009; Solá et al., 2011a). 
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1.2.3.1. Proteases 
Caspases are cysteinyl aspartate-specific proteases with a number of properties 
that make them highly effective as cellular remodeling enzymes.  Although their 
critical function in apoptosis is firmly established, caspase activation is also essential 
for dynamic, non-apoptotic cell processes, such as innate immune response, neural 
regeneration, NSC fate determination, and neural activation.  Indeed, caspases have 
recently been implicated in the differentiation process for a variety of model systems, 
including neural cells (Santos et al., 2012b; Schwerk and Schulze-Osthoff, 2003).  It 
has been demonstrated that NSC differentiation depends on endogenous caspase-3 
activity that may influence kinase activities associated with changes in phenotype 
(Fernando et al., 2005).  In addition, caspases modulate FOXO3A/inhibitor of 
differentiation 1 (Id1) signaling during mouse NSC differentiation (Aranha et al., 
2009).  In fact, caspase inhibition and silencing of p53 synergistically delayed neural 
differentiation, with no evidence of apoptosis.  Recently, the role of caspases in neural 
differentiation has been further elucidated and suggested to be required for neuronal 
growth cones (Campbell and Holt, 2003), learning and memory (Lu et al., 2002), axon 
routing, synaptic connections (Ohsawa et al., 2010), among others.  Several 
mechanisms for regulating non-apoptotic caspase function in neural differentiation 
have been proposed, including transient caspase activation, local caspase activation and 
regulation of endogenous caspase inhibitors (Solá et al., 2012). 
Although the available literature on calpain activity in NSCs is scarce, recent 
data has also elucidated the role of calpain 1 and 2 during NSC self-renewal and 
differentiation.  Santos et al. (Santos et al., 2012b) showed that calpain 1 maintains 
stemness and represses neural differentiation, while calpain 2 acts as potential 
modulator of gliogenesis.  These results underscored the distinct regulatory functions 
of calpain 1 and 2 in NSC fate decision. 
 
1.2.3.2. Bcl-2 family 
Bcl-2 family proteins suffer developmental regulation in the nervous system, 
being highly expressed in neuroepithelial cells of the SVZ, and in post-mitotic 
neurons before adulthood (Merry et al., 1994).  Bcl-2 acquired immunoreactivity 
signal in the brain of squirrel monkeys, specifically in areas involved in neurogenesis 
and morphogenesis (Bernier and Parent, 1998).  Therefore, it has been suggested that 
Bcl-2 might be important, but not crucial, during neuronal cell differentiation. 
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In vitro, Bcl-2 expression was associated with both neural differentiation of 
human neural-crest-derived tumor cell line, Paju (Zhang et al., 1996), and RA (Sarkar 
and Sharma)-mediated differentiation of CNS neurons (Wang et al., 2001).  In PC12 
cells, in turn, Bcl-2 was shown to trigger differentiation as a result of prevention of 
cell death induced by serum free medium (Sato et al., 1994).  In addition, other 
studies indicate that Bcl-2 may act as an intercellular factor that controls neurite 
extension and axonal regeneration (Eom et al., 2004; Suzuki and Tsutomi, 1998).  It 
was recently reported that Bcl-xL and Bax play an instructive role in determining the 
fate of embryonic cortical precursor cells (Chang et al., 2007).  Bcl-xL and Bax appear 
to mediate neurogenesis and astrogliogenesis, respectively, independently from their 
roles in cell survival and apoptosis (Solá et al., 2012).  These findings support the 
possibility that determination of neuronal versus astroglial lineages is actively 
regulated by balanced levels of anti- and pro-apoptotic Bcl-2 family proteins in NPCs 
(Chang et al., 2007).  Finally, pro-apoptotic Bim was associated with the neurogenesis 
of adult-born NPCs (Bunk et al., 2010).   
 
1.2.3.3. p53 family 
p53 family members, p53, p63 and p73 play crucial roles as regulators of 
NSC proliferation and differentiation (Murray-Zmijewski et al., 2006). 
 
p53 
In the past several years, a specific novel function for p53 in neuronal 
biology has emerged.  In fact, increased evidence points to a role for p53 in neural 
progenitor proliferation and differentiation, independent of its apoptotic role (Solá 
et al., 2013; Tedeschi and Di Giovanni, 2009).  p53 was shown to be required to 
the differentiation of mouse embryonic stem cells (ESCs) by suppressing 
expression of Nanog, a transcription factor essential to the maintenance of 
pluripotency of ESCs (Chen et al., 2008; Mitsui et al., 2003) (Fig. 1.5).  In 
addition, it was also reported that in neurons from a p53
-/- 
mouse, p53 plays an 
important role in neuronal differentiation (Ferreira and Kosik, 1996).  Curiously, 
high levels of p53 mRNA have also been detected in the developing brain in areas 
showing little or no apoptosis.  Some p53-null embryos die during development, 
and a percentage of the surviving mice exhibit neuronal abnormalities, namely 
defects in neural tube closure (Armstrong et al., 1995), resulting in exencephaly 
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(Sah et al., 1995).  Curiously, this exencephalic phenotype is identical to that 
observed in animals with mutations in other members of the intrinsic death 
pathway, including Apaf-1, caspase 3 (Kuida et al., 1996), and caspase 9 (Kuida 
et al., 1998).  p53 was already shown to promote neurogenesis through 
downregulation of the Akt/p-FOXO3A/Id1 pathway (Aranha et al., 2009) (Fig. 
1.5).  Furthermore, the role of p53 during mouse NSC differentiation has been 
further dissected by other studies (Solá et al., 2012). 
p53 might also play a key role in neural differentiation as a limiting factor of 
stem cell proliferative competence (Armesilla-Diaz et al., 2009; Krizhanovsky and 
Lowe, 2009).  Recent experiments of NSCs extracted from the OB of wild-type 
and p53-null mouse embryos showed that p53 controls proliferation, 
chromosomal stability, and differentiation pattern of mouse OB stem cells 
(Armesilla-Diaz et al., 2009).  In fact, p53-null NSCs have increased proliferation 
with tendency to a neuronal phenotype, with concomitant reduction of astrocytes.  
This effect had been previously reported in SVZ-derived stem cells from adult 
mice (Gil-Perotin et al., 2006).  Studies in neuronal-like PC12 and neuroblastoma 
cells have also suggested that p53 plays a role in cell survival following NGF 
administration (Hughes et al., 2000; Zhang et al., 2006a), and that the interaction 
of p53 with neuronal-specific transcription factors, such as Brn-3a, may 
determine a shift from cell death to neuronal survival (Hudson et al., 2005; 
Hudson et al., 2004).  In fact, when forming a complex with Brn-3a, p53 cannot 
activate pro-apoptotic genes, such as Bax and Noxa, but rather shows increased 
affinity for the pro-differentiation gene p21.  p53 was also reported to bind to the 
NGF receptor TrkA, which is required for PC12 neuronal differentiation (Browes 
et al., 2001), and to activate TrkA expression and consequent MAPK pathways 
(Zhang et al., 2006a) (Fig. 1.5).  Also in PC12 cells, p53 regulates the expression 
of both actin-binding protein Coronin 1b and the GTPase Rab13, which are 
needed for correct neurite outgrowth and maturation of cortical neurons in vitro 
(Di Giovanni et al., 2006; Tedeschi and Di Giovanni, 2009) (Fig. 1.5).  Integrated 
transcriptomic profiling, in silico promoter analysis, and functional studies of 
murine NSCs established that inactivation of both p53 and phosphatase and tensin 
homolog (PTEN) promotes an undifferentiated state, with high self-renewal 
potential, and increased Myc protein levels (Zheng et al., 2008).  In agreement, 
increased Myc activity was validated as a potent contributor to impaired 
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differentiation and enhanced self-renewal of NSCs in murine double-null mice for 
p53 and PTEN.  Thus, due its dual actions on cell cycle and cell death, p53 plays 
a versatile role in the regulation of cellular growth and differentiation, being 
considered a gatekeeper of self-renewal in NSCs that may function either as a 
pro-apoptotic or differentiation factor in neural precursors.  
 
 
Figure 1.5.  p53 in neurogenesis.  p53 is involved in non-apoptotic processes such as cell-
fate determination and actin-cytoskeleton reorganization.  p53 plays a critical role in 
neuronal differentiation, in part via regulation of TrkA and MAPK pathways in PC12 cells.  
Moreover, Wnt7b is a new putative p53 target during NGF-mediated PC12 neuronal 
differentiation, involved in dendritic extension.  p53 also regulates the expression of actin-
binding protein Coronin 1b and the GTPase Rab13 in primary cultured neurons, both of 
which associate with the cytoskeleton and regulate neurite outgrowth, as well as the 
expression of the axonal growth-associated protein GAP-43, which is involved in pro-axon 
outgrowth and regeneration protein.  In mouse NSC, p53 promotes neurogenesis by 
downregulating the Akt/p-FOXO3A/Id1 proliferation pathway.  Interestingly, p53 and the 
desmethylase JMJD3, a key regulator of neurogenesis, are coordinately regulated during 
adult neural differentiation.  JMJD3 directly interacts with p53 to induce demethylation of 
p53 and subsequent p53 nuclear accumulation during specific stages of neural 
differentiation.  Adapted from Solá et al. 2012. 
 
Epigenetic mechanisms have an important role in control maintenance of stem 
cell state and in the differentiation process (Li and Zhao, 2008; Wu and Sun, 2006).  
In this regard, during the past decades, covalent modifications have been 
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discovered to play fundamental roles in either homeostatic maintenance or stress-
induced activation of p53.   
Specific targets and cofactors of p53 during neuronal differentiation may 
be unique and different from those regulated in genotoxic stress and apoptosis.  
This is possible by the multiple PTMs that target p53 on its N- and C-termini, 
which are not limited to phosphorylation, but may also include acetylation, 
sumoylation, neddylation, ubiquitination, or methylation (Collavin et al., 2010; 
Lavin and Gueven, 2006; Solá et al., 2011).  In fact, specific combination of PTMs 
differentially regulates the interaction of p53 with co-activators and co-repressors and 
produces distinct gene expression profiles, which may also dictate cell fate. 
p53 PTMs directly affect the transcriptional activity of p53 and regulate its 
affinity to several cofactors, which in turn regulate the occupancy of p53 specific 
promoters (Sims and Reinberg, 2008).  Phosphorylation at Ser 15, Ser 20, Ser 33, 
Ser 46 and Thr 18 promotes p53 stabilization by preventing either its nuclear 
export or its recruitment to specific promoters.  Early in the differentiation of 
ESCs, phosphorylation of p53 at Ser 15, Ser 315 and Ser 392 is significantly 
increased, which is thought to activate p53 (Xu, 2003).  p53 phosphorylation at 
Ser 315 was also shown to be important for p53-dependent suppression of Nanog 
during differentiation of ESCs (Lin et al., 2005).  The acetylation of p53 in 
neurons is mediated by the activity of at least these two histone acetyltransferases, 
CREB-binding protein (CBP)/p300 and p300/CBP-associated protein (P/CAF).  
CBP/p300 acetylates Lys370, Lys372, Lys373 and Lys382, and P/CAF acetylates 
only Lys320 (Brooks and Gu, 2003).  These kinase and acetyltransferase 
pathways are activated downstream from NGF and BDNF signaling during 
neuronal differentiation and axon outgrowth.  Interestingly, the acetylation of p53 
at Lys 320 leads to increased transcriptional activation of the p21 promoter, 
which triggers G1/S arrest and promotes neuronal differentiation in PC12 cells 
(Wong et al., 2004).  Interestingly, p53 acetylation in the same residue was reported 
to be involved in promotion of neurite outgrowth (Di Giovanni et al., 2006).  
Additionally, acetylated p53 at Lys372, Lys373 and Lys382 was shown to drive 
axon outgrowth and GAP43 expression, and to bind to specific elements on the 
neuronal GAP43 promoter (Tedeschi and Di Giovanni, 2009) (Fig. 1.5).  
p53-induced control of cell fate may also be associated with p53 subcellular 
distribution.  In fact, it has been reported that p53 translocates to the nucleus 
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following induction of differentiation (Brynczka and Merrick, 2007; Solá et al., 
2011).  SIRT1, a p53 deacetylase, inhibits p53 nuclear translocation in mouse ESCs 
and inhibits p53-mediated suppression of Nanog expression (Han et al., 2008).  
Moreover, p53 demethylation appears to be also essential in p53 nuclear distribution 
in mouse NSC differentiation, associated with an increase in neuronal markers (Solá 
et al., 2011b).  In fact, recent studies have already established protein methylation as a 
novel mechanism of p53 regulation (Scoumanne and Chen, 2008).  Recently, it has 
been shown that this proapoptotic protein cross-talks with key regulators of 
neurogenesis, such as the histone H3 lysine 27-specific demethylase JMJD3.  In fact, 
Solá et al. have demonstrated that JMJD3 increases total levels of p53 by a 
mechanism dependent, at least in part, of ARF, a mechanism that is not associated 
with cell death. Importantly, they have also shown that JMJD3 directly interacts with 
p53 to modulate p53 methylation levels and regulate p53 cellular distribution during 
mouse neural differentiation (Solá et al., 2011) (Fig. 1.5).  The molecular crosstalk 
between the transcription factor p53 and the histone lysine specific demethylase 1 has 
been previously demonstrated by Huang et al. (Huang et al., 2007). 
While p53 is ubiquitously expressed, p63 exhibits a tissue-specific distribution 
that it is most detectable in embryonic ectoderm and in basal regenerative layers of 
stratified epithelial tissues in the adult (Yang et al., 1998).  However, both TA and 
∆Np63, as well as TA and ∆Np73 proteins are also expressed in the cortex of 
embryonic, postnatal, and adult brains (Jacobs et al., 2005).   
 
p73 
p73 is known to play an important role in controlling neuronal 
development, being an essential regulator of NSC maintenance and differentiation 
in both embryonic and adult neurogenesis (Fujitani et al., 2010; Talos et al., 
2010).  The first evidence for the role of p73 in neural differentiation of a normal 
mammalian cell came from studies showing that both p53 and p73, but not p63, are 
involved in thyroid hormone-induced oligodendrocyte precursor cells differentiation, 
and that p73 also plays a crucial role in platelet-derived growth factor withdrawal-
induced differentiation (Billon et al., 2004). 
p73 developmental role is supported by the phenotype of total p73 KO mice.  
Unlike p53 null mice, total p73 KO mice do not develop tumors; however, they show 
developmental defects in the CNS with 100% penetrance (Yang et al., 2000), 
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including congenital hydrocephalus and hippocampal dysgenesis, with loss or 
truncation of the lower blade of the neurogenic DG (Talos et al., 2010), thinning of 
the SVZ in the forebrain and loss of the Cajal-Retzius neurons (Hernández-Acosta et 
al., 2011).  The total p73
 
KO mice also have defects in both embryonic and adult 
neurogenesis, suggesting that p73 isoforms may be important factors for the 
maintenance of NSCs (Fujitani et al., 2010; Holembowski et al., 2011; Talos et al., 
2010).  p73
-/- 
 mice also have a reduction in cortical thickness as a consequence of loss 
of mature cortical neurons (Pozniak et al., 2002).  Curiously, ∆Np73 variants are the 
predominant expression product of the p73 gene in developing and adult tissues.  
ΔNp73 isoforms are expressed in postmitotic neurons and act as survival factors of 
differentiated mature postmitotic neurons in discrete regions of the brain (Tissir et al., 
2009; Wilhelm et al., 2010).  Their loss explains this neurological phenotype (Pozniak 
et al., 2000).  In addition selective TAp73 null mice also show hippocampal 
dysgenesis with loss of the lower blade of the DG, a phenotype intermediate between 
the phenotypes of p73
-/- 
and p53
-/- 
mice (Tomasini et al., 2008), reflecting a reduction 
in neurogenesis in the SGZ of the DG, and suggesting that TAp73 may be required 
for NSC proliferation (Michalak et al., 2008).  Therefore, these studies suggest a role 
for p73 in neurogenesis and a cooperation or redundancy between the isoforms during 
this process.  p73 also maintains an adequate neurogenic pool by promoting self-
renewal and proliferation and inhibiting premature senescence of NSC and early 
progenitor cells in both embryonic and adult neurogenesis (Talos et al., 2010).  
Curiously, TAp73 appears to act via the basic helix-loop-helix Hey2 to promote long-
term maintenance of neural precursors (Fujitani et al., 2010).  Further, p73 deficiency 
results in impaired self-renewal and premature neuronal differentiation of mouse 
NPCs independently of p53 [103].   
Neuroblastoma cell differentiation in vitro requires activation of a molecular 
pathway by p73, which is not shared by p53.  p73 protein increases in cells induced to 
differentiate by RA (De Laurenzi et al., 2000),.  Exogenously expressed p73, in turn, 
is sufficient to induce neurite outgrowth, expression of neurofilaments and neural 
adhesion molecule, (N-CAM), downregulation of N-Myc and upregulation of pRb, all 
markers of neural differentiation (De Laurenzi et al., 2000).  An in vitro neurosphere 
assay from p73 KO mice and their wild-type counterparts, demonstrated that p73 KO 
results in decreased capacity to form neurospheres, and smaller neurosphere sizes 
with fewer cells per neurosphere, indicating an impairment in the proliferation of 
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progenitors (Talos et al., 2010).  Together, these results indicate that p73-deﬁcient 
NSCs are not only deﬁcient in self-renewal but also in proliferation and generation of 
progeny.  Finally, p73 drives the expression of miRNA-34a in mouse cortical 
neurons, which then modulates the expression of synaptic targets, including 
synaptotagmin-1 and syntaxin-1A (Agostini et al., 2011b).  In fact, p73 was shown 
increased during postnatal development of the brain, when synaptogenesis occurs 
(Agostini et al., 2011a). 
 
p63 
The p63 protein, in turn, has been extensively described as a key regulator of 
development and maintenance of stratified epithelial tissues, having a tissue-specific 
distribution, mostly detectable in the basal layer of epithelia, including epidermis 
(Yang et al., 1998).  In fact, the phenotype of p63-deficient mice presents several 
developmental defects, suggesting that the primary biological function of p63 proteins 
is to regulate development.  However, brain malformations have not been reported in 
humans with p63 mutations.  This phenotype contrasts with mice lacking p73 gene, 
which have immunological, neurological, and pheromone defects (Yang et al., 2000).  
This raises the question whether p63 has a similar important role in neural 
differentiation as p53 and p73.  Thus far, it is not clear whether p63 contributes to 
brain development.  Dugani et al. (Dugani et al., 2009) have reported that p63 is a 
crucial pro-survival regulator of NPCs.  Jacobs et al. (Jacobs et al., 2005) have also 
investigated the role of p63 in developing sympathetic neurons of the autonomous 
nervous system, concluding that the TAp63 isoforms play pro-apoptotic functions in 
these neurons.  Furthermore, during embryonic stages, p73 and p63 are co-expressed 
in Cajal Retzius cells derived from a marginal zone of developing cortex, the cortical 
hem, which is a putative signaling center and the main place for the generation of CR 
cells.  However, in contrast with the previous studies, the analysis of p63
-/- 
and p73
-/-
 
mice shows that only p73 is essential for brain development and CR cell formation 
(Tissir et al., 2009), indicating that p63 expression and signaling in the cortical hem 
seems to be an accessory feature of these cells, and not essential for brain 
development in general (Hernández-Acosta et al., 2011). 
Despite these divergences, it has been reported that p63 expression during 
development of the CNS is scant.  Indeed, TAp63 and ∆Np63 mRNA levels are very 
low in murine embryonic cortex (Holembowski et al.; Jacobs et al., 2005), which is in 
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contrast to the essential role of p73 in neurogenesis (Agostini et al., 2010; Fujitani et 
al., 2010; Holembowski et al., 2001; Talos et al., 2010).  In the SVZ of the lateral 
ventricle of postnatal mice, the three members of the p53 family are detected and may 
influence cell fate in this region of the adult brain.  However, in contrast to p73, the 
detection levels of p63 and p53 were weak.  In fact, immunohistochemistry revealed 
co-expression of p73 and a marker of proliferating cells, the proliferating cell nuclear 
antigen (Uberti et al.) in the SVZ, where the same double staining was not possible 
with either p63 or p53 (Hernández-Acosta et al., 2011; Lois and Alvarez-Buylla, 
1993).  Nevertheless, in contrast to p63-restricted expression observed during brain 
development, high levels of p63 were visualized in adult human cerebral cortex and 
hippocampus (Hernández-Acosta et al., 2011), suggesting a role for p63 in the adult 
brain.  Furthermore, in postnatal mice, p63 is expressed in neurogenic niches, such as 
the SVZ of the lateral ventricle (Hernández-Acosta et al., 2011).  This suggests that 
p63 may have a role during adult neurogenesis that remains to be explored. 
 
1.2.4. Role of Aβ peptides in neural differentiation  
Aβ peptides are highly multifunctional identities, which may display 
significant non-pathological activities (Fig. 1.6).  Indeed, proposed functions of Aβ 
peptides include trophic and neuronal survival, neural differentiation, control of 
synaptic activity and memory consolidation, cholesterol transport and antioxidant 
functions (Parihar and Brewer, 2010; Pearson and Peers, 2006; Plant et al., 2003).  
The Aβ cellular functions are evident only when the peptides are present at 
physiological concentrations, before they aggregate and form amyloid fibrils (Parihar 
and Brewer, 2010; Pearson and Peers, 2006; Plant et al., 2003; Ramsden et al., 2002).  
In fact, Plant et al. (Plant et al., 2003) showed that, in rodent and human neuronal 
cells, in vitro inhibition of γ- or β-secretase culminates with toxicity.  Recovery of cell 
viability using physiologically concentrations of exogenous Aβ suggests that this 
peptide may have a role in the normal function of neuronal cells as suggested 
previously by Ramsden and co-workers (Ramsden et al., 2001).  Recent studies 
indicate that Aβ plays an important role at the synapse as well as in synaptic structure 
and functional plasticity, critical to learning and memory (Parihar and Brewer, 2010).  
A necessary role of Aβ in synaptic plasticity and memory in normal brain is also 
supported by the observation that APP KO mice show impaired LTP and memory 
(Dawson et al., 1999).  The impaired synaptic plasticity and memory found in beta-
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site APP-cleaving enzyme 1 KO mice also suggest a crucial role of Aβ (Laird et al., 
2005). 
 
Figure 1.6.  Pathological versus proneurogenic effects of amyloid β peptides.  A summary of 
suggested function of β- and γ-secretases-generated APP fragments, including Aβ peptides, in 
AD neuropathology and in neurogenesis.  sAPPα, soluble amyloid precursor protein α.  
Adapted from Lazarov and Marr, 2010. 
 
The evidence that Aβ is present in the CSF of healthy individuals and in media 
from neuronal cell cultures (Blennow and Zetterberg, 2009; Tamaoka et al., 1997) 
indicates that Aβ may also play a role in the normal physiology of the CNS.  
Importantly, it was already reported that non-aggregated peptide at low doses exhibits 
neurotrophic effects including enhancement of neuronal survival and neurite-
promoting effects (Luo et al., 1996; Pike et al., 1991; Whitson et al., 1990; Yankner et 
al., 1990).  Indeed, Aβ1-42 monomers were shown to promote the survival of 
developing neurons under conditions of trophic deprivation, and protect mature 
neurons against excitotoxic death (Giuffrida et al., 2009).  In addition, Aβ1-42 
increased the number of newborn neurons in cultured NSCs (Chen and Dong, 2009; 
López-Toledano and Shelanski, 2004).  Neurotrophic function of Aβ1-40 was obtained 
in a cell culture treated with picomolar and micromolar levels of Aβ1-40 (Chen and 
Dong, 2009; Plant et al., 2003; Yankner et al., 1990).  These findings provide 
compelling evidence for a role for Aβ in neuronal survival. 
Recently, in vitro and in vivo studies revealed that Aβ is also able to drive the 
differentiation of NPCs toward neurons (Calafiore et al., 2006; Chen and Dong, 2009; 
Heo et al., 2007; López-Toledano and Shelanski, 2004; Sotthibundhu et al., 2009).  
However, the precise role of different forms of monomer, oligomer, and fibrillar Aβ 
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on the neurogenesis are still poorly understood.  Indeed, there is a lot of variance in 
the literature regarding the experimental conditions used to address the neurogenic 
effects of Aβ.  The experiments differ, not only in the form of Aβ used, but also in the 
type of NSC culture used, and in the concentrations of Aβ incubated (Calafiore et al., 
2012; Haughey et al., 2002a; Haughey et al., 2002b; Heo et al., 2007; Kim et al., 
2007; López-Toledano and Shelanski, 2004; Sotthibundhu et al., 2009).  In cultures of 
NSCs derived from striatum and hippocampus it was demonstrated that Aβ has a role 
on the survival and neuronal differentiation (López-Toledano and Shelanski, 2004).  
The authors showed that this peptide increases the total number of neurons in vitro in 
a dose-dependent manner.  In addition, they have shown that neurogenesis is induced 
by Aβ1-42 but not by Aβ1-40 or Aβ25–35, and that the pro-neurogenic activity appears to 
be a property of Aβ oligomers and not fibrils.  In concordance, other studies showed 
that low micromolar concentrations of oligomeric Aβ1-42 enhance neuronal 
differentiation of adult NSCs and their ability to migrate (Heo et al., 2007).  An in 
vivo study also demonstrated that Aβ1-42 promotes amyloid deposition while Aβ1-40 
inhibits it.  Chen et al. (Chen and Dong, 2009) have reported notable neurogenic and 
survival effects of soluble Aβ1-40 in primary NPCs; Aβ1-42 treatment both in vitro and 
in vivo, as well as endogenous generation of Aβ in transgenic models of AD, 
stimulated neurogenesis of young adult SVZ precursors (Sotthibundhu et al., 2009).  
The neurogenic effect of Aβ1-42 was found to require expression of the p75
NTR
 by the 
precursor cells, and activation of p75
NTR
 by metalloprotease cleavage.  In 
neurospheres incubated with oligomers of synthetic Aβ1-42, the expression levels of 
DNA polymerase-β, an enzyme that represses proliferation and promotes 
differentiation, were rapidly increased (Calafiore et al., 2012). 
On the other hand, studies using animal models of AD have proposed the 
opposite effect of Aβ peptides in neurogenesis (Haughey et al., 2002a; Haughey et al., 
2002b).  In fact, it has been reported that Aβ compromises the survival and 
differentiation processes (Haughey et al., 2002b; Mazur-Kolecka et al., 2006; Millet 
et al., 2005).  However, these results appear to be correlated with the decreased levels 
of soluble Aβ peptide observed in AD.  Consistent with this, others have 
demonstrated that higher levels of Aβ monomers, oligomers, and ﬁbrils in the brain of 
individuals with amyloidosis-β induce oxidative stress and do not promote adult 
endogenous neurogenesis (Mazur-Kolecka et al., 2006).  AD is a dynamic disease 
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process, and it is plausible that an increase in neuronal differentiation is followed by 
an overall decline as Aβ aggregates and loses its neurogenic functions.  
 
1.2.5. Autophagy during neural differentiation 
Autophagy acts as a quality control mechanism in differentiated cells by 
promoting basal turnover of long-lived proteins and organelles, and selectively 
degrading damaged cellular components (Wirawan et al., 2012).  In addition, 
autophagy promotes morphological and structural remodeling (Singh et al., 2009).  
In fact, as a dynamic and highly inducible catabolic process, it can drive the rapid 
cellular changes necessary for proper differentiation and/or development. 
In mammals, autophagy plays key roles in pre-implantation embryonic 
development (Levine and Ranganathan, 2010; Tsukamoto et al., 2008), survival 
during neonatal starvation (Aburto et al., 2012; Mizushima and Levine, 2010), 
cancer (Chen and Karantza, 2011; Edinger and Thompson, 2003), neuronal 
degeneration (Hara et al., 2006; Komatsu et al., 2006; Wong and Cuervo, 2010), 
and cell differentiation during erythropoiesis, lymphopoeisis, adipogenesis 
(Asanuma et al., 2003; Mizushima and Levine, 2010; Pua et al., 2007; Vessoni et 
al., 2012), and neurogenesis (Aburto et al., 2012; Zeng and Zhou, 2008; Zhao et 
al., 2010) (Fig. 1.7)  Targeted mutagenesis of a few Atg genes in mice 
substantiated these hypotheses.  Severe neural tube defects and embryonic 
lethality were associated with impaired autophagy in mice lacking the autophagy 
regulator Ambra1 (Cecconi et al., 2007; Fimia et al., 2007).  In embryos 
homozygous for the gene-trapped (gt) allele Ambra1
gt/gt
,
 
it was observed reduced 
expression of neurogenic genes, accumulation of ubiquitinated proteins, 
unbalanced cell proliferation and excessive apoptotic cell death (Fimia et al., 
2007).  These interesting results suggest that autophagy may also be involved in 
the proliferative state or in the maintenance of pluripotency of NPCs.  Activation 
of autophagy was also shown to be required for differentiation of glioma 
progenitor cells (Zhang et al., 2006b).  It was shown that the autophagy inhibitors 
bafilomycin and 3-methyladenine could inhibit differentiation, while the 
autophagy activator and mTOR inhibitor, rapamycin, could promote it (Zhao et 
al., 2010).  The basal low autophagic activity in glioma progenitor cells appears to 
be correlated with the inhibition of differentiation. 
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Figure 1.7.  Autophagy is involved in neural differentiation.  Autophagy is involved in 
multiple aspects of neuronal physiology, including axonal differentiation and maintenance, 
UPS-independent removal of unfolded cytosolic proteins and elimination of aggregosomes.  
HDAC6, histone deacetylase 6.  Adapted from Tooze and Schiavo 2008. 
 
Zhuang et al. (Zhuang et al., 2011) have also reported the relevance of 
autophagy in glioma-initiating cell differentiation and radiosensitization in vitro 
by rapamycin.  The authors propose that autophagy deficiency in these cells 
contributes to the differentiation impairment and glioma radioresistance.  NPCs 
from the mouse embryo olfactory bulb are also a well-characterized tool for the 
study of neuronal differentiation.  Vazquez et al. (Vázquez et al., 2012) have 
recently investigated whether basal autophagy occurs in these cells using this in 
vivo model during development.  In fact, in wild-type mouse OB, they observed a 
progressive increase in the expression of the autophagy genes Atg7, Beclin1 (the 
orthologue of yeast Atg6), LC3 and Ambra1, during the differentiation of mitral 
neurons in vivo, associated with upregulation of Ngn1, NeuroD and βIII-tubulin 
neurogenic markers.  In addition, an increase of autophagic activity in NPCs from 
mouse embryo OB undergoing differentiation was also observed in vitro 
(Vázquez et al., 2012). 
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The requirement of autophagy for neural differentiation was further 
confirmed in Ambra1 haploinsufficient mice, where it was shown the generation 
of smaller neurospheres and fewer differentiated neurons (Vázquez et al., 2012).  
Importantly, these changes were reversed, to a large extent, by the metabolic 
substrate methylpyruvate, suggesting that in the context of neural differentiation, 
autophagy is crucial to energy supply, maintaining the ATP levels necessary for 
correct transition from proliferative precursor to postmitotic neuron. This 
hypothesis is indeed supported by previous studies in the developing retina, where 
autophagy was shown crucial for cell corpse clearance during naturally occurring 
cell death associated with neurogenesis (Mellén et al., 2008). 
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Objectives 
 
The studies presented in this thesis were driven by the ambition to further 
understand the role of apoptosis in AD, and the function that AD-related apoptosis 
effectors may play in neural differentiation.  Three main objectives were designed.  
First, our goal was to elucidate the precise role of p63 during Aβ-induced apoptosis 
and TUDCA protection.  Second, we sought to investigate the potential involvement 
of p63 in regulating neural differentiation.  Finally, we aimed to further explore the 
effect of soluble Aβ fragments in modulating neural proliferation and differentiation. 
 
The specific questions addressed in this thesis are: 
 
1. Does p63 play a role in Aβ-mediated cell death and/or TUDCA 
protection? Which molecular pathways does p63 modulate?  
2. Does p63 modulate mouse NSC differentiation?  
3. Can soluble Aβ peptides enhance neuronal-specific lineage of NSCs? 
How does Aβ regulate NSC fate determination? 
 
The overarching goal of the research presented in this thesis is to increase our 
understanding on the pathogenic mechanisms of Aβ in AD as well as the role of 
apoptosis-regulatory players in NSC fate decision.  The results may have broad 
implications in advancing our knowledge of neural degeneration and differentiation, 
and their interplay with the apoptosis machinery.  Ultimately, our findings may prove 
useful in the comprehension of the key checkpoints responsible for neural 
degeneration versus differentiation, as an alternative to cell death, thus contributing to 
a better therapeutic management of apoptosis-associated AD and to a more efficient 
use of stem cells in neural-replacement therapy. 
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2.1. Abstract 
p63, the structural and functional homologue of p53, is expressed either as a 
full-length isoform, containing a transactivation (TA) domain (TAp63), or as a 
truncated isoform, which lacks TA (ΔNp63).  Amyloid β (Aβ) incubation of neuronal 
cells results in stress-induced cell death through poorly understood mechanisms.  We 
investigated the role of p63 in Aβ-induced stress.  Our results show that Aβ-induced 
apoptosis of rat PC12 neuronal-like cells and primary cortical neurons was associated 
with stabilization of pro-apoptotic TAp63 and, most importantly, degradation of anti-
apoptotic ΔNp63 through a MAPK- and proteasome-dependent mechanism.  This was 
associated with increased c-Jun, and partially modulated by tauroursodeoxycholic 
acid.  As expected, classic genotoxic insults resulted in c-Jun upregulation and 
concomitant ΔNp63 reduction.  Endogenous and ectopic ΔNp63 expression was also 
markedly reduced by c-Jun overexpression.  Further, Aβ-mediated ΔNp63 
degradation occurred in a c-Jun-dependent manner.  Downregulation of c-Jun 
expression by specific c-Jun siRNA abrogated the reduction of ΔNp63 levels 
following Aβ insult, whereas overexpression of c-Jun led to its degradation.  c-Jun 
significantly decreased ΔNp63 half-life.  Together, these findings demonstrate that the 
abundance of anti-apoptotic ΔNp63 in response to Aβ-induced cell stress is regulated 
by a c-Jun-dependent mechanism, and highlight the importance of finding novel 
targets for potential therapeutic intervention. 
 
Keywords: Amyloid β peptide; Apoptosis; c-Jun; ∆Np63; Tauroursodeoxycholic acid 
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2.2. Introduction 
Alzheimer’s disease (AD) is the most common human age-related, sporadic 
neurodegenerative disorder, and is characterized by a global cognitive decline.  The 
major histopathological hallmarks of the disease are deposition of amyloid β (Aβ) 
peptide in neuritic plaques, formation of neurofibrillary tangles, and synaptic loss 
(Selkoe, 2001a).  Aβ has been shown to play a critical role in the pathogenesis of AD.  
Among its two predominant forms, Aβ1-42 possesses stronger aggregation and 
deposition propensity than Aβ1-40 (Selkoe, 2001a).  Previous studies have shown that 
Aβ-induced toxicity involves oxidative stress, inflammation, perturbation of calcium 
homeostasis, and most importantly apoptosis (Anderson et al., 1996; Estus et al., 
1997; Loo et al., 1993; Selkoe, 2001a).  In this respect, we have previously 
demonstrated that p53 participates in Aβ-induced apoptosis of PC12 neuronal cells 
through modulation of Bax expression (Ramalho et al., 2004).  Furthermore, Aβ-
induced apoptosis in rat primary cortical neurons was associated with translocation of 
pro-apoptotic Bax to the mitochondria, followed by cytochrome c (cyt c) release, 
caspase activation, and DNA and nuclear fragmentation (Solá et al., 2003a).  
Interestingly, a novel biological function of intracellular Aβ1-42 has been suggested, 
where it acts as a transcription factor for the p53 promoter, enhancing p53-dependent 
neuronal apoptosis in AD (Ohyagi et al., 2005). 
The role of apoptosis in Aβ-induced toxicity suggests that its modulation may 
slow the neurodegenerative process.  Ursodeoxycholic acid (UDCA) and its taurine 
conjugate, tauroursodeoxycholic acid (TUDCA) are well characterized endogenous 
potent inhibitors of apoptosis in different cell types and their effects have expanded to 
several experimental models of neurological disorders, including AD (Ramalho et al., 
2008).  Several lines of evidence suggest that TUDCA modulates Aβ-induced 
neuronal death by inhibiting the mitochondrial machinery and enhancing survival 
signaling (Ramalho et al., 2006; Ramalho et al., 2004; Solá et al., 2006; Solá et al., 
2003a).  TUDCA is also a potent suppressor of Aβ-induced changes of lipid/protein 
fluidity and oxidative status in mitochondrial membranes (Rodrigues et al., 2001).  
Finally, TUDCA prevents an endoplasmic-reticulum-specific apoptotic pathway 
involved in Aβ neurotoxicity (Viana et al., 2011). 
The p63 protein is a member of the p53 family that includes p53, p63 and p73.  
Alternative splicing and promoter usage results in multiple p63 isoforms with 
different biological activities.  The p63 gene contains two promoters, leading to the 
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expression of two groups of proteins.  Full-length proteins contain a transactivation 
(TA) domain (TAp63), whereas truncated proteins lack the TA domain (ΔNp63) 
(Yang et al., 1998).  Additionally, both groups of proteins undergo carboxi-terminal 
alternative splicing giving rise to at least 6 different isoforms.  TA isoforms act 
similarly to p53 and have the ability to transactivate p53 target genes and induce 
apoptosis.  In contrast, ΔN isoforms have little transactivation activity and are thought 
to play a role in blocking transactivation of target genes of both p53 and TA isoforms 
(Yang et al., 2002).  Therefore, ΔN isoforms function, at least in part, as naturally 
occurring dominant-inhibitory p53 family members.  Both TA and ΔNp63 proteins 
are expressed in the cortex of embryonic, postnatal, and adult brains (Jacobs et al., 
2005).  Moreover, TAp63 has been shown to be required for growth factor-
deprivation-mediated apoptosis of developing sympathetic neurons (Jacobs et al., 
2005). 
Given its key biological role, p63 is normally kept under tight regulatory 
control, mainly at the level of protein stability (Galli et al., 2010).  Apoptotic doses of 
UV irradiation or genotoxic drugs promote phosphorylation-induced, proteasome-
mediated degradation of the pro-survival isoform ΔNp63α (Chatterjee et al., 2008; 
Lazzari et al., 2011; Liefer et al., 2000; Papoutsaki et al., 2005; Westfall et al., 2005).  
Surprisingly, the mechanisms regulating p63 levels under cellular insults such as Aβ-
mediated apoptosis have yet to be elucidated. 
The c-Jun transcription factor, a component of the AP-1 family, is a critical 
regulator of both cell survival and death that responds to genotoxic stress.  
Importantly, c-Jun induction has been shown to occur after Aβ treatment in vitro 
(Estus et al., 1997; Iwasaki et al., 1996; Viana et al., 2010) and in AD brains 
(Anderson et al., 1994; Anderson et al., 1996), suggesting a possible requirement of 
this transcription factor for Aβ toxicity.  In this respect, it was also reported that 
sympathetic neurons from c-Jun-deficient mice were resistant to Aβ1-40 toxicity 
(Kihiko et al., 1999) and that extracellular application of aggregated Aβ induces 
neuronal apoptosis with c-Jun activation (Estus et al., 1997; Kihiko et al., 1999).  
Additionally, in AD patients, an increase in c-Jun immunoreactivity was reported in 
the brain (Anderson et al., 1996).  These results suggest that c-Jun activation is a 
predominant feature of AD pathology and extracellular Aβ accumulation is a trigger 
of c-Jun activation.  As c-Jun has been shown to regulate the abundance of TAp63 
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(Yao et al., 2010a), we hypothesized that c-Jun would have a key role in Aβ-mediated 
potential regulation of p63 stability. 
The results presented here demonstrate that Aβ-induced apoptosis is 
associated with increased TAp63 and decreased ∆Np63 levels.  Furthermore, our 
results strongly support the existence of a c-Jun-dependent mechanism regulating the 
abundance of anti-apoptotic ΔNp63 in the context of Aβ-induced stress.  Importantly, 
TUDCA was efficient in partially modulating these effects.  
 
2.3. Material and methods 
2.3.1. Cell culture and treatments 
Rat adrenal pheochromocytoma PC12 cells were grown in RPMI-1640 
medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% heat-
inactivated horse serum (Sigma-Aldrich), 5% fetal bovine serum (Invitrogen Corp., 
Carlsband, CA, USA) and 1% penicillin/streptomycin (Invitrogen Corp.), and 
maintained at 37°C in a humidified atmosphere of 5% CO2.  Cells were plated and 
differentiated in the presence of nerve growth factor (Promega Corp., Madison, WI, 
USA) for 6 days, as previously described (Viana et al., 2010).  Cell density was either 
1 × 10
5
 cells/cm
2
 for morphological assessment of apoptosis, or 4 × 10
5
 cells/cm
2
 for 
protein extraction, and transfection assays.  PC12 neuronal-like cells were then 
preincubated in medium supplemented with 100 μM TUDCA (Sigma-Aldrich), or no 
addition (control), for 12 h, and then exposed to 25 μM of peptide active fragment 
Aβ25–35 (Bachem AG, Bubendorf, Switzerland) for 2, 8, and 24 h.  This was found to 
be the ideal concentration of soluble Aβ to achieve maximum cellular response with 
minimum exacerbated toxic effects in neuronal-like PC12 cells (Viana et al., 2010). In 
parallel experiments, cells were incubated with either 10 μM soluble Aβ1-40 (Bachem 
AG), or 20 μM fibrillar Aβ1-42 (Bachem AG) for 24 h (Viana et al., 2011).  The 
predominant aggregates in these preparations are thought to be low N-oligomers, 
mainly monomeric to tetrameric, as fibrillogenesis usually requires longer incubation 
times and higher concentrations of the peptides [27].  Although high, the 
concentration of Aβ peptides used in this study are below the concentration of Aβ1-42 
found in the cerebrospinal fluid of AD patients [28, 29].  For the experiments with the 
MAPK and proteasome inhibitors, cells were pretreated with the JNK inhibitor 
SP600125 (10 μM), ERK inhibitor U0126 (50 μM), p38 inhibitor SB202190 (50 μM) 
(all from Sigma-Aldrich) or the proteasome inhibitor MG132 (5 μM; Calbiochem, 
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San Diego California, USA) for 1 h, in the presence or absence of Aβ25–35 incubated 
for 24 h.  Differentiated PC12 cells were also incubated for 6 h with genotoxic drugs 
doxorubicin (5 μM; Sigma-Aldrich) and cisplatin (20 μM; Sigma-Aldrich) as 
controls. 
 
2.3.2. Primary culture of cortical neurons  
Primary cultures of cortical neurons were prepared from embryonic 
(gestational day 18) CD1 mice and maintained in MEM Eagle’s HBSS medium 
(Invitrogen).  After dissociation with trypsin 0.25% (Invitrogen Corp.) and 
centrifugation, the cells were ressuspended in Neurobasal medium (Invitrogen Corp.), 
supplemented with 2% B-27 (Invitrogen), 0.5 mM glutamine (Invitrogen Corp.), 25 
μM glutamic acid (Merck, Darmstadt, Germany), and 10 mg/mL gentamycin 
(Invitrogen Corp.).  Neurons were plated onto 35 mm dishes coated with poly-D-
lysine (0.05 mg/ml, Sigma-Aldrich) at a density of 1.0 × 10
6
cells/cm
2
.  The cultures 
were kept at 37ºC in a humidified incubator with a 5% CO2 atmosphere.  The medium 
was replaced half on day 4 with Neurobasal medium without glutamic acid.  TUDCA 
and Aβ25–35 treatment was performed as described before for PC12 cells, starting at 
day 4 in culture. 
 
2.3.3. Measurement of cell death 
Apoptotic nuclei were detected by Hoechst labeling after cell fixation with 4% 
formaldehyde in phosphate buffer saline (PBS), for 10 min at room temperature. 
Following incubation with Hoechst dye 33258 (Sigma-Aldrich) at 5 μg/mL in PBS 
for 5 min, and PBS washes, slides were mounted with Fluoromount-G (Beckman 
Coulter, Inc, Fullerton, CA, USA) and fluorescence visualized with an Axioskop 
fluorescence microscope (Carl Zeiss GmbH, Hamburg, Germany). Fluorescent nuclei 
were scored and categorized according to the condensation and staining 
characteristics of chromatin.  Normal nuclei showed non-condensed chromatin 
dispersed over the entire nucleus. Apoptotic nuclei were independently identified by 
condensed and fragmented chromatin contiguous to the nuclear membrane, as well as 
nuclear fragmentation and presence of apoptotic bodies. Three random microscopic 
fields per sample of ~250 nuclei were counted and mean values expressed as the 
percentage of apoptotic nuclei. 
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2.3.4. Plasmids, siRNAs and transfections 
For the identification of the endogenous p63 isoforms, PC12 cells were 
transfected using Lipofectamine 2000 (Invitrogen Corp.) with 8 µg pcDNA3.1-
ΔNp63α, -ΔNp63γ, TAp63α or TAp63γ expression plasmids (kind gift from Dr. Kurt 
Engeland, University of Leipzig).  In subsequent experiments, 4 µg pSG5-c-Jun 
expression plasmid (kind gift from Dr. Imakawa, University of Tokyo), 2 µg 
pcDNA3.1-ΔNp63γ, or 100 nM c-Jun siRNA (Dharmacon, Waltham, MA, USA) 
were used.  As controls, cells were transfected with the corresponding empty vector 
plasmids, or a control siRNA (Dharmacon) containing a scrambled sequence that does 
not lead to the specific degradation of any known cellular mRNA.  Total amount of 
transfected nucleic acids was equalized with appropriate amounts of empty vector in 
all cases. Cells were collected 48 h after transfection for immunoblot analyses.  In 
experiments with the protein synthesis inhibitor cycloheximide (CHX), cells were 
transfected with pSG5-c-Jun and pcDNA3.1-ΔNp63γ plasmids 48 h prior to addition 
of CHX (50 μg∕mL; Sigma-Aldrich), and maintained for the indicated time points.  In 
addition, c-Jun siRNA was transfected 48 h prior to addition of Aβ25–35 and 
maintained throughout the 24 h of Aβ incubation. Floating and attached cells were 
harvested, and total protein extracts were prepared for Western blot analysis. 
 
3.3.5. Western blot 
Protein levels of TAp63, ΔNp63 and c-Jun in PC12 neuronal-like cells and 
primary cortical neurons were determined by Western blot analysis.  Briefly, 100 μg 
of total proteins were separated by 8% sodium dodecyl-polyacrylamide gel 
electrophoresis.  After electrophoretic transfer onto nitrocellulose membranes, and 
blocking with a 5% milk solution, membranes were incubated overnight at 4ºC with a 
primary mouse monoclonal antibody reactive to p63 (4A4; Santa Cruz Biotechnology, 
Santa Cruz, CA, USA), which detects both TAp63 and ΔNp63 isoforms, and a 
primary rabbit monoclonal antibody reactive to c-Jun (60A8; Cell Signaling 
Technology, Inc., Danvers, MA, USA).  Finally, secondary goat anti-mouse or anti-
rabbit IgG antibody conjugated with horseradish peroxidase (BioRad Laboratories, 
Hercules, CA, USA) was added for 3 h at room temperature.  The membranes were 
processed for protein detection using the SuperSignal substrate (Pierce 
Biotechnology, Rockford, IL, USA).  β-Actin (AC-15; Sigma-Aldrich) was used as 
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loading control.  Protein concentrations were determined using the Bio-Rad protein 
assay kit (Bio-Rad Laboratories), according to the manufacturer’s specifications. 
 
2.3.6. Statistical analysis 
The relative intensities of protein bands were analyzed using the QuantityOne 
Version 4.6 densitometric analysis program (Bio-Rad Laboratories) and normalized to 
the respective loading controls. Statistical analysis was performed using GraphPad 
InStat version 3.00 (Graph-Pad Software) for the analysis of variance and 
Bonferroni’s multiple comparison tests. Values of p < 0.05 were considered 
significant. 
 
2.4. Results 
2.4.1. Aβ-induced cell stress is associated with decreased ΔNp63 and increased 
c-Jun protein levels 
Expression of p63 isoforms was first confirmed in PC12 neuronal-like cells 
after overexpression of either TAp63α, TAp63γ, ΔNp63α, or ΔNp63γ.  Endogenous 
TAp63γ (~ 57 kDa) and ΔNp63γ (~ 54 kDa) were detected from a group of at least six 
different isoforms encoded by p63 (Fig. 2.1A).  In addition, endogenous expression of 
ΔNp63γ was more than 5-fold greater than that of TAp63γ. 
Genotoxic signals are known to regulate p63 (Kirschner et al., 2008; Liefer et 
al., 2000; Papoutsaki et al., 2005; Yao et al., 2010a).  In fact, exposure of PC12 
neuronal-like cells to classic genotoxic insults, such as doxorubicin and cisplatin 
resulted in increased TAp63 levels, concurrent with the reduction of ΔNp63 
abundance (Fig. 2.1B).  To determine whether p63 levels are also controlled by Aβ-
induced stress, we performed a time-course analysis of Aβ25-35 treatment in PC12 
neuronal-like cells.  Our results show that Aβ treatment resulted in stabilization of 
TAp63 and, most importantly, reduction of ΔNp63 (Fig. 2.2A).  These effects were 
more evident after 24 h of Aβ treatment.  c-Jun, a key regulator of stress-mediated 
cell death has been shown to modulate the abundance of TAp63 (Yao et al., 2010a).  
We therefore investigated if c-Jun would have any role in the Aβ-mediated regulation 
of p63 levels.  Time-course analysis of Aβ25-35 treatment revealed that c-Jun protein 
levels increased with time, peaking at 24 h after Aβ treatment (Fig. 2.2A).  Similarly, 
exposure of PC12 neuronal-like cells to classic genotoxic insults resulted in c-Jun 
upregulation (Fig. 2.1B).  Finally, to confirm Aβ role on the regulation of p63 levels, 
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PC12 cells were incubated with the full-length soluble Aβ1-40 and fibrillar Aβ1-42 
peptides.  As predicted, similarly to Aβ25-35, both Aβ1-40 and Aβ1-42 decreased ΔNp63 
levels while increasing TAp63 and c-Jun levels (Fig. 2.2B).  These results suggest the 
existence of an inverse relationship between ΔNp63 and c-Jun levels following Aβ 
treatment. 
To investigate if Aβ-mediated reduction of ΔNp63 protein levels is influenced 
by the mitogen activated protein kinase (MAPK) pathway, PC12 neuronal-like cells 
were treated with MAPK inhibitors for 1 h before Aβ incubation, and p63 levels were 
examined by Western blot analysis.  Treatment with the JNK inhibitor SP600125, 
ERK inhibitor PD98059 and p38 inhibitor SB202190 rescued the reduction of ΔNp63 
levels observed after Aβ treatment (Fig. 2.2C).   
 
 
Figure 2.1.  Expression of endogenous p63 isoforms and genotoxic stress-induced 
regulation of p63 and c-Jun protein levels in PC12 neuronal-like cells.  A) Detection of p63 
isoforms in cells transfected with the overexpression plasmid TAp63α, TAp63γ, ΔNp63α, or 
ΔNp63γ for 48 h, compared with untransfected cells.  Total proteins were extracted from 
transfected and untransfected cells and used for Western blot analysis of 5 and 100 μg, 
respectively.  p63 protein isoforms were identified using the pan-p63 monoclonal antibody 
4A4, as described in Materials and Methods.  B) Protein levels of ∆Np63, TAp63 and c-Jun in 
cells incubated with 5 µM doxorubicin or 20 µM cisplatin for 6 h, or no addition (control).  
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β-actin was used as loading control.  Immunoblots are representative of at least three 
different experiments. 
 
 
Figure 2.2.  Aβ-induced cell stress is associated with decreased ΔNp63 and increased 
TAp63 and c-Jun protein levels in PC12 neuronal-like cells.  Cells were incubated with 25 
μM soluble Aβ25–35 or no addition (control).  Total proteins were extracted for Western blot 
analysis as described in Materials and Methods.  β-actin was used as loading control.  A) 
Protein levels of ∆Np63, TAp63 and c-Jun in cells incubated with Aβ25–35 for 2, 8, and 24 h.  
B) Protein levels of ∆Np63, TAp63 and c-Jun in cells incubated with Aβ25–35, 10 μM soluble 
Aβ1-40, or 20 μM fibrillar Aβ1-42 for 24 h.  C) Protein levels of ∆Np63 in cells incubated with 
the JNK inhibitor (SP600125), ERK inhibitor (U0126), p38 inhibitor (SB202190) or 
proteasome inhibitor MG132 for 1 h, in the presence or absence of Aβ25–35 incubated for 24 h.  
β-actin was used as loading control.  Immunoblots are representative of at least three 
different experiments. 
 
We also investigated the effect of directly inhibiting the proteasome by 
treating cells with the proteasome inhibitor MG132.   
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Treatment with the proteasome inhibitor abolished the Aβ-dependent 
reduction of ΔNp63 levels (Fig. 2.2C), indicating that ΔNp63 degradation occurs via 
the proteasome.  These results suggest that the decrease in ΔNp63 protein levels in 
cells exposed to Aβ is MAPK pathway- and proteasome-dependent. 
 
2.4.2. TUDCA modulates Aβ-induced changes in ΔNp63 and c-Jun protein 
levels 
It has been previously shown that soluble Aβ25-35 fragment induces apoptosis 
in PC12 neuronal-like cells and cortical neurons, which is abrogated by TUDCA 
pretreatment (Ramalho et al., 2004; Solá et al., 2003a; Viana et al., 2010).  In this 
study, rat PC12 neuronal-like cells and primary cortical neurons were incubated with 
Aβ25-35, with or without pre-treatment with the anti-apoptotic bile acid TUDCA, and 
assessed for cell death as well as ΔNp63 and c-Jun protein levels.  Incubation with 
Aβ25-35 for 24 h induced apoptosis in ~ 13 and 40% of PC12 cells and cortical 
neurons, respectively (p < 0.01) (Fig. 2.3A).  Pre-treatment with TUDCA markedly 
reduced Aβ-induced apoptosis (p < 0.05).  Notably, TUDCA prevented Aβ-induced 
ΔNp63 degradation in both PC12 cells and cortical neurons, possibly by restoring c-
Jun protein levels to almost control values (p < 0.01 in PC12 cells, and p < 0.05 in 
cortical neurons).  These results suggest that inhibition of ΔNp63 degradation through 
modulation of c-Jun levels may also account for TUDCA neuroprotective mechanism. 
 
2.4.3. c-Jun is required for ΔNp63 degradation after Aβ treatment 
To clarify whether c-Jun could directly lead to ΔNp63 degradation, c-Jun was 
overexpressed in PC12 cells.  c-Jun overexpression led to a reduction of endogenous 
ΔNp63, compared with cells transfected with the empty vector pSG5 (Fig. 2.4A). 
Additionally, transient co-expression of c-Jun and ΔNp63 caused a marked decrease 
of exogenous ΔNp63 (p < 0.01) (Fig. 2.4B), even with high level expression reached 
after transfection, suggesting that c-Jun may be a potent negative regulator of ΔNp63 
abundance. 
To further investigate the role of c-Jun in regulating ΔNp63 abundance, we 
then examined whether ΔNp63 protein levels were altered by silencing endogenous c-
Jun.  Immunobloting analysis revealed that knockdown of c-Jun by specific c-Jun 
siRNA abrogated the reduction of ΔNp63 levels following Aβ stress, when compared 
with control siRNA-transfected cells (p < 0.05) (Fig. 2.5A). 
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Figure 2.3.  TUDCA modulates Aβ-induced apoptotic changes in ΔNp63 and c-Jun protein 
levels in PC12 neuronal-like cells and cortical neurons.  Cells were incubated for 24 h with 
25 μM soluble Aβ25–35, or no addition (control), in the presence or absence of 100 μM 
TUDCA. In co-incubation experiments, TUDCA was added 12 h prior to incubation with Aβ.  
Cells were fixed and stained for microscopic assessment of apoptosis and total proteins were 
extracted for Western blot analysis as described in Materials and Methods.  A) Percentage of 
apoptosis after Hoechst staining in cells exposed to Aβ with or without TUDCA pretreatment.  
Results are expressed as mean ± SEM for at least three different experiments. *p < 0.01 from 
control and 
†p < 0.05 from Aβ alone.  B) Protein levels of ΔNp63 and c-Jun in cells exposed 
to Aβ with or without TUDCA pre-treatment.  Representative immunoblot of ΔNp63 and c-
Jun (top) and respective protein levels (bottom).  Results were normalized to endogenous β-
Actin protein levels and expressed as mean ± SEM for at least four different experiments. *p 
< 0.01 from control; †p < 0.01 and ‡p < 0.05 from Aβ alone. 
 
These results strongly suggest that Aβ-mediated ΔNp63 degradation occurs in 
a c-Jun-dependent manner.  Furthermore, knockdown of endogenous c-Jun in cells 
transfected with ΔNp63 plasmid resulted in increased expression of exogenous 
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ΔNp63 (p < 0.01) (Fig. 2.5B).  These results further corroborate the hypothesis that c-
Jun plays an important role in regulating ΔNp63 abundance. 
 
 
Figure 2.4.  Overexpression of c-Jun downregulates both endogenous and exogenous levels 
of ∆Np63 in PC12 neuronal-like cells.  Cells were transfected with c-Jun overexpression 
plasmid in the presence or absence of ∆Np63γ overexpression plasmid.  After 48 h of 
transfection, total proteins were extracted for Western blot analysis as described in Materials 
and Methods.  A) Protein levels of ΔNp63 and c-Jun in cells transfected with c-Jun 
overexpression plasmid (pSG5-c-Jun) or its corresponding empty vector (pSG5).  B) Protein 
levels of ΔNp63 and c-Jun in cells co-transfected with c-Jun overexpression plasmid (pSG5-c-
Jun), or its corresponding empty vector (pSG5), and ∆Np63γ overexpression plasmid 
(pcDNA3.1-∆Np63), or its corresponding empty vector (pcDNA3.1).  Representative 
immunoblot of ΔNp63 and c-Jun (top) and respective protein levels (bottom).  Results were 
normalized to endogenous β-Actin protein levels and expressed as mean ± SEM for at least 
four different experiments.  *p < 0.01 from ∆Np63 overexpressing cells.  
 
Finally, to better understand c-Jun contribution to ΔNp63 degradation, we 
investigated ΔNp63 half-life in the presence of c-Jun.  For this purpose, PC12 cells 
transfected with ΔNp63 alone or together with c-Jun were treated with the protein 
synthesis inhibitor CHX.   
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Figure 2.5.  Silencing of endogenous c-Jun abrogates Aβ-induced ∆Np63 degradation and 
increases exogenous ∆Np63 levels in PC12 neuronal-like cells.  Cells were transfected with 
100 nM of either c-Jun siRNA or control siRNA (siRNA C) for 48 h.  A) After 48 h of siRNA 
transfections, cells were challenged with 25 μM soluble Aβ25–35, or no addition (control), for 
24 h.  *p < 0.01 from control cells transfected with siRNA control (siRNA C); †p < 0.05 from 
Aβ-incubated cells transfected with siRNA control.  B) ∆Np63γ overexpression plasmid 
(pcDNA3.1-∆Np63) and its corresponding empty vector (pcDNA3.1) were co-transfected with 
c-Jun and control siRNAs.  Total proteins were extracted for Western blot analysis as 
described in Materials and Methods.  Representative immunoblots of ΔNp63 and c-Jun (top) 
and respective protein levels (bottom).  Results were normalized to endogenous β-Actin 
protein levels and expressed as mean ± SEM for at least three different experiments.  *p < 
0.01 from ∆Np63 overexpressing cells transfected with siRNA control (siRNA C). 
 
Results demonstrate that the highly stable ΔNp63 half-life was reduced to less 
than 8 h in the presence of c-Jun (p < 0.01) (Fig. 2.6), confirming that c-Jun indeed 
regulates the stability of ΔNp63.  
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Figure 2.6.  c-Jun decreases ∆Np63 half-life in PC12 neuronal-like cells.  Cells transfected 
with ∆Np63γ alone (∆Np63) or with c-Jun (∆Np63 + c-Jun) were untreated (0 h) or treated 
with 50 μg/mL CHX for 2, 4, 6, and 8 h.  At the indicated time points, total proteins were 
extracted for immunoblot analysis as described in Materials and Methods.  A) Representative 
immunoblots of ΔNp63 and c-Jun after CHX treatment.  B) Percentage of remaining ∆Np63 
after CHX treatment.  Results were normalized to endogenous β-Actin protein levels and 
expressed as mean ± SEM for at least four different experiments.  *p < 0.01 and 
†
p < 0.05 
from ∆Np63 overexpressing cells. 
 
2.5. Discussion 
Aβ-induced toxicity is a multifactorial process that ultimately leads to 
apoptotic neuronal death.  In the present study, we show that Aβ induces an 
antagonistic effect in the regulation of p63 isoform abundance in PC12 neuronal-like 
cells, with upregulation of the pro-apoptotic isoform TAp63γ and downregulation of 
the anti-apoptotic isoform ΔNp63γ.  A similar effect was observed by incubation of 
PC12 neuronal-like cells with the genotoxic drugs doxorubicin and cisplatin.  
Previous studies have already shown that treatment of cells with various DNA-
damaging agents resulted in increased expression of TAp63 isoforms (Hershkovitz 
Rokah et al., 2010; Kirschner et al., 2008; Sayan et al., 2007a; Yao et al., 2010a).  A 
downregulation of ∆Np63 in response to UV irradiation or genotoxic drugs was only 
reported for the α isoform (Chatterjee et al., 2008; Lazzari et al., 2011; Liefer et al., 
2000; Papoutsaki et al., 2005; Westfall et al., 2005).  Further, we show that Aβ 
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induces apoptosis in rat cortical neurons by regulating the abundance of both 
antagonistic isoforms of p63, TAp63γ and ∆Np63γ. 
The many isoforms generated from the p63 gene provide the molecular 
flexibility to play very different, and even functionally antagonistic roles, depending 
on the cellular context.  Indeed, TAp63 isoforms are often upregulated after exposure 
to cellular insults, contributing to cell death (Hershkovitz Rokah et al., 2010; 
Kirschner et al., 2008; Sayan et al., 2007a; Yao et al., 2010a), as TAp63 can activate 
both death receptor- and mitochondrial-mediated apoptotic pathways (Gressner et al., 
2005).  Similarly, stress signals trigger the reduction of ΔNp63 levels (Chatterjee et 
al., 2008; Lazzari et al., 2011; Liefer et al., 2000; Papoutsaki et al., 2005; Westfall et 
al., 2005), which will allow the manifestation of apoptosis.  The balance between 
these two major p63 isoforms dictates cell fate (Vanbokhoven et al., 2011).  Because 
both isoforms have profoundly distinct biological effects, it is not surprising that they 
are differently regulated by Aβ-induced stress signaling.  As shown here, exposure of 
both PC12 neuronal-like cells and cortical neurons to Aβ active fragment Aβ25–35 
resulted in apoptotic cell death.  In addition, Aβ25–35 and the full-length Aβ peptides, 
Aβ1-40 and Aβ1-42, increased TAp63 and decreased ΔNp63 levels.  Importantly, the 
anti-apoptotic bile acid TUDCA strongly modulated Aβ-induced apoptosis while 
preventing the changes in p63 levels, further suggesting that the reduction of ΔNp63 
levels is important for apoptosis to occur. 
c-Jun transcriptionally activates the TAp63 promotor (Yao et al., 2010a), 
possibly contributing to some forms of c-Jun-mediated cell death.  Furthermore, c-Jun 
is increased after Aβ exposure and in AD brains (Anderson et al., 1994; Anderson et 
al., 1996; Estus et al., 1997) suggesting a role for c-Jun in Aβ-induced toxicity.  We 
have recently shown that JNK is the proximal stress sensor for Aβ-induced toxicity, 
and that it translocates to the nucleus and activates caspase-2 in PC12 neuronal cells 
(Viana et al., 2010). Caspase-2 in turn induces cleavage of golgin-160, suggesting a 
unique transduction mechanism of Aβ apoptotic signaling through the Golgi complex.  
This led us to hypothesize that c-Jun could be responsible for Aβ-dependent decrease 
in ΔNp63 protein levels.  Here, we demonstrate that ΔNp63 reduction was associated 
with increased c-Jun protein levels after Aβ treatment of PC12 neuronal-like cells and 
cortical neurons.  Moreover, TUDCA rescued Aβ-induced decrease of ΔNp63 levels 
and prevented the increase in c-Jun levels.  Importantly, c-Jun overexpression led to 
ΔNp63 degradation, whereas knockdown of c-Jun by specific c-Jun siRNA abrogated 
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the reduction of ΔNp63 following Aβ stress.  Finally, the highly stable ΔNp63 half-
life was reduced in the presence of c-Jun.  These results clearly show that Aβ-
mediated ΔNp63 degradation occurs in a c-Jun-dependent manner, and highlight the 
existence of distinct pathways that have probably evolved for the reciprocal regulation 
of the abundance of functionally different but highly homologous proteins TAp63 and 
ΔNp63 under Aβ stress.  
c-Jun is one of the components of the transcription factor AP-1 and its 
expression is regulated by a variety of signals in different cell types (Hess et al., 
2004).  Despite the extensive knowledge regarding c-Jun activation, downstream cell 
signaling events remain unclear in Aβ-induced cell stress.  Here we demonstrate that 
ΔNp63γ is a downstream target of c-Jun in Aβ-induced apoptosis.  In fact, after 
depleting cells of c-Jun by specific siRNA, Aβ failed to decrease ΔNp63 protein 
levels.  c-Jun is a major target of the MAPK pathway as it contributes to the cellular 
stress response and is believed to mediate neuronal apoptosis (Behrens et al., 1999; 
Suganuma et al., 2010).  We therefore explored whether Aβ-mediated ΔNp63γ 
reduction was influenced by the MAPK pathway.  Our results show that in the 
presence of the JNK, ERK or p38 inhibitors, Aβ no longer resulted in decreased 
ΔNp63.  The same was true for the incubation with the proteasome inhibitor, 
suggesting that the decrease in ΔNp63 protein levels in cells exposed to Aβ was 
MAPK pathway- and proteasome-dependent.  In the past few years, some ΔNp63α-
modifying enzymes have been identified and reported to regulate ΔNp63α stability 
(Bakkers et al., 2005).  These proteins bind to sites in the C-terminal region of 
ΔNp63α, which are absent in the shorter and more stable ΔNp63γ isoform.  Future 
studies are needed to clarify the exact mechanism by which c-Jun targets ΔNp63γ 
isoform to proteasomal-dependent degradation.  Despite the fact that Aβ may inhibit 
the proteasome [39, 40], our results are in accordance with others demonstrating that 
important mediators of AD are degraded in a proteasome-dependent fashion [41, 42], 
thus contributing to AD pathogenesis.   
In conclusion, this study clearly shows that Aβ exposure differently regulates 
TAp63 and ΔNp63 isoforms to allow the manifestation of apoptosis.  This suggests 
that the selective regulation of the two antagonistic isoforms of p63 is crucial in 
maintaining the homeostatic balance between life and death of a cell that is 
undergoing Aβ-induced cell stress.  The present study also convincingly shows that c-
Jun is required for Aβ-mediated degradation of ΔNp63, which occurs via MAPK 
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pathway and proteasome activation.  Thus, c-Jun appears to be a stress sensor for Aβ-
induced apoptosis, which in turn is strongly modulated by TUDCA.  These results 
provide novel insights into the specific cellular mechanism of Aβ-induced neuronal 
apoptosis and suggest novel targets for potential therapeutic intervention. 
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3.1. Abstract 
 p63 is a close relative of the p53 tumor suppressor and transcription factor that 
modulates cell fate.  The full-length isoform of p63, containing a transactivation (TA) 
domain (TAp63) is an essential proapoptotic protein in neural development.  The role 
of p63 in epithelial development is also well established; however, its precise function 
during neural differentiation remains largely controversial.  Recently, it has been 
demonstrated that several conserved elements of apoptosis are also integral 
components of cellular differentiation; p53 directly interacts with key regulators of 
neurogenesis.  The aim of this study was to evaluate the role of p63 during mouse 
neural stem cell (NSC) differentiation and test whether the histone H3 lysine 27-
specific demethylase JMJD3 interacts with p63 to redirect NSCs to neurogenesis.  
Our results showed that JMJD3 and TAp63γ are coordinately regulated to establish 
neural-specific gene expression programs in NSCs undergoing differentiation.  
JMJD3 overexpression increased TAp63γ levels in a demethylase activity-dependent 
manner.  Importantly, overexpression of TAp63γ increased β-III tubulin whereas 
downregulation of TAp63γ by specific p63 siRNA decreased β-III tubulin.  
Immunoprecipitation assays demonstrated direct interaction between TAp63γ and 
JMJD3, and modulation of TAp63γ methylation status by JMJD3-demethylase 
activity.  Importantly, the demethylase activity of JMJD3 influenced TAp63γ protein 
stabilization and cellular distribution, as well as TAp63γ-regulated neurogenesis.  
These findings clarify the role of p63 in adult neural progenitor cells and reveal 
TAp63γ as a direct target for JMJD3-mediated neuronal commitment. 
 
Keywords: Differentiation; JMJD3; Neural stem cells; p63 post-translation 
modifications 
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3.2. Introduction 
The transcription factor p63, member of the p53 family, can be expressed as a 
full-length isoform containing a transactivation (TA) domain, termed TAp63, or as a 
truncated isoform that lacks the TA domain, termed Np63.  This isoform functions, 
at least in part, as naturally occurring dominant-inhibitor of full-length p53 family 
members.  Additionally, both TAp63 and Np63 undergo C-terminal alternative 
splicing giving rise to at least 6 different isoforms, which along with post-translational 
modiﬁcations (PTM), accounts for molecular and regulatory complexity (Fonseca et 
al., 2012; Nicotera and Melino, 2005; Yang et al., 1998).  Full-length p53 family 
members show structural and functional similarities, including a comparable domain 
structure of an N-terminal TA domain, an invariant DNA-binding domain, and an 
oligomerization domain (Courtois et al., 2004).  p63 has been well-established as an 
important regulator of cell survival and cell death in the nervous system, primarily by 
acting through the apoptosis machinery (Fonseca et al., 2012; Jacobs et al., 2005; 
Nicotera and Melino, 2005).  In this respect, we have shown that both TA and Np63 
isoforms are involved in molecular mechanisms associated with Alzheimer’s disease 
(Fonseca et al., 2012).  
Recently, it has been suggested that cell death-relevant proteins, especially 
those involved in the core of the executing apoptosis machinery, may play a dual 
function in differentiation and cell death (Fernando and Megeney, 2007).  Restrictive 
activation and careful regulation will assure differentiation efficiency and thus avoid 
cell loss.  In this regard, we have previously demonstrated the involvement of specific 
apoptosis-related microRNAs and proteins, including p53, caspases and calpains, in 
mouse neural stem cell (NSC) differentiation, by mechanisms that do not result in cell 
death (Aranha et al., 2011; Aranha et al., 2010; Aranha et al., 2009; Santos et al., 
2012b; Solá et al., 2011b).  Several studies have shown that inactivation of p53 
sustains the undifferentiated state of neural precursor cells (Armesilla-Diaz et al., 
2009; Meletis et al., 2006; Zheng et al., 2008), and that p53 is required for both 
neurite outgrowth and axonal regeneration in mice primary neurons (Di Giovanni et 
al., 2006).  We have further dissected the role of p53 during NSC differentiation by 
showing that this proapoptotic protein cross-talks with key regulators of neurogenesis, 
such as the histone H3 lysine 27-specific demethylase JMJD3 (Solá et al., 2011b).  In 
fact, PTM of apoptosis-related proteins may redirect stem cells to differentiation, as 
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an alternative to cell death, and establish tissue-specific programs of gene expression 
throughout differentiation.  A strong interplay between p53, p63 and p73 isoforms has 
been recently demonstrated, which orchestrates cell fate decisions (Jost et al., 1997; 
Marcel et al., 2012).  In addition, similar to p53, TAp63 can oligomerize, bind to 
DNA, transactivate p53 target genes, and induce cell cycle arrest and apoptosis 
(Fonseca et al., 2012; Jost et al., 1997; Yang et al., 1998).  
The pivotal role of p63 during epithelial development has been well 
recognized.  Mice lacking all
 
p63 isoforms die at birth and show severe 
developmental abnormalities,
 
including limb truncation, and defects in the epidermis 
and
 
its appendages (Yang et al., 1999).  However, although TAp63 critical function in 
sympathetic neuronal development is firmly established (Jacobs et al., 2005), two 
independent studies have recently reported that p63 is not essential for central nervous 
system development (Hernández-Acosta et al., 2011; Holembowski et al., 2011).  
Nevertheless, in contrast to p63-restricted expression observed during mice and 
human brain development, high levels of p63 protein and mRNA were observed in 
adult human cerebral cortex and hippocampus (Hernández-Acosta et al., 2011), 
suggesting a role for p63 in the adult brain.  Furthermore, in postnatal mice, p63 was 
shown to be expressed in neurogenic niches, such as the subventricular zone of the 
lateral ventricle (Hernández-Acosta et al., 2011).  Together, this evidence supports the 
idea that p63 may have a key role during adult neurogenesis.  
Here, we investigated p63 involvement during adult mouse NSC 
differentiation and explored the potential cross-talk between p63 and JMJD3 in this 
cellular context.  Our results demonstrated that TAp63γ and JMJD3 are coordinately 
regulated during NSC differentiation to establish a neuronal-specific gene expression 
program.  In addition, TAp63γ subcellular distribution and neurogenic functions may 
be regulated by direct JMJD3-dependent demethylation of TAp63γ. 
 
3.3. Material and methods 
3.3.1. Ethics statement 
The mouse NSC line used in this study was obtained from Dr. Smith’s 
Laboratory, University of Cambridge, Cambridge, UK (Pratt et al., 2000; Silva et al., 
2006; Solá et al., 2011b), and provided by Dr. Henrique, University of Lisbon, 
Lisbon, Portugal.  The Animal Ethical Committee at the Faculty of Pharmacy, 
University of Lisbon, Portugal waived the need for approval.  
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3.3.2. Cell culture and differentiation 
A mouse NSC line was derived from day 14.5 post-coitum mouse fetal 
forebrain (Pratt et al., 2000; Silva et al., 2006; Solá et al., 2011b).  This cell line was 
established using a method that produces pure cultures of adherent NSCs, which 
continuously expand by symmetrical division, and are capable of tripotential 
differentiation (Conti et al., 2005; Glaser et al., 2007; Pollard et al., 2006).  Cells were 
grown in monolayer as previously described (Santos et al., 2012b; Spiliotopoulos et 
al., 2009) and routinely maintained in undifferentiation medium, Euromed-N medium 
(EuroClone S.p.A., Pavia, Italy), supplemented with 1% N-2 supplement (Invitrogen 
Corp., Grand Island, NY), 20 ng/mL epidermal growth factor (EGF; PeproTech EC, 
London, UK), 20 ng/mL basic fibroblast growth factor (bFGF; PeproTech EC) and 
1% penicillin-streptomycin (Invitrogen Corp.), in uncoated tissue culture plastic 
flasks at 37°C in a humidified atmosphere of 5% CO2.  Medium was changed every 3 
days and cells collected with accutase (Sigma-Aldrich Co., St. Louis, MO) when 
confluent.  Differentiation of NSCs was performed by first platting cells in 
undifferentiation medium onto uncoated tissue culture plastic dishes at 1 x 10
6
 
cells/cm
2
 for 24 h, and changing the culture medium to differentiation medium, 
Euromed-N medium supplemented with 10 ng/mL bFGF, 0.5% N-2 supplement, 1% 
B27 supplement and 1% penicillin-streptomycin.  Cells were collected before medium 
change (time 0), or cultured for additional 6, 12, 24 or 48 h, and then fixed for 
immunocytochemistry analysis or collected for protein extraction.  
 
3.3.3. siRNAs and plasmid transfections 
The NSC cell line was transfected with Flag-JMJD3 or Flag-JMJD3 mutant 
overexpression plasmids to amplify JMJD3 expression.  The expression plasmids 
were kindly provided by Dr. Kristen Jepsen (University of California, San Diego, 
USA).  The Flag-JMJD3 construct was cloned by inserting full-length mouse JMJD3 
cDNA in frame into p3xFLAG CMV-10 (Sigma-Aldrich Co.) vector within HindIII 
and BamHI sites.  The Flag-JMJD3 mutant was generated by removing the carboxy-
terminus 410 amino acids, which include the jumonji C domain.  Briefly, NSCs were 
first cultured in uncoated dishes in undifferentiation medium without penicillin-
streptomycin.  Twenty-four hours after plating, cells were transfected using 
Lipofectamine 2000 (Invitrogen Corp.), according to the manufacturer’s instructions, 
the medium was changed to differentiation medium, and cells were cultured for 
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additional 24 h. The cDNAs for TAp63γ were ligated as BamHI/XhoI fragments into 
the pcDNA3.1/His C vector (Invitrogen Corp.).  Mutant TAp63γ carries a R304H 
exchange to yield a mutation in the DNA binding domain, as previously described 
(Dietz et al., 2002).  Briefly, the mutant expression vector includes a His at the 
equivalent Arg position, which is transcriptionally impaired.  As a control (mock), 
cells were incubated with the transfection agent at the same concentration and time, in 
the absence of any plasmid.  Attached cells were either harvested for immunobloting 
or fixed for immunocytochemistry and apoptosis assays using Hoechst staining.  p63 
manipulation was achieved by transfecting cells with the overexpression plasmids 
TAp63γ and TAp63γ mutant that lack p63 transactivation activity (kind gift from Dr. 
Kurt Engeland, University of Leipzig), or 100 nM of siRNA designed to knockdown 
mouse p63 expression (M-040654-01, Dharmacon, Waltham, MA, USA).  As a 
control, cells were transfected with the corresponding empty vector plasmid 
(pcDNA3.1), or control siRNA containing a scrambled sequence that does not lead to 
specific degradation of any known cellular mRNA. Transfection efficiencies were 
assessed by immunoblotting analyses and found to be ~70% for JMJD3 and 80% for 
TAp63γ overexpression plasmids.  p63 protein levels, in turn, decreased by ~ 60% 
after transfection with siRNAs.  In experiments using the protein synthesis inhibitor 
CHX, cells were previously transfected with TAp63γ and either Flag-JMJD3 or Flag-
JMJD3 mutant plasmids 24 h prior to addition of 50 μg∕mL CHX (Sigma-Aldrich 
Co.), and maintained for 4, 6 and 8 h.  
 
3.3.4. Total, cytosolic and nuclear protein extraction 
For total protein extracts, NSCs were lysed in ice-cold buffer (10 mM Tris-
HCl, pH 7.6, 5 mM MgCl2, 1.5 mM potassium acetate, 1% Nonidet P-40, 2 mM 
dithiothreitol) and protease inhibitor cocktail tablets Complete (Roche Applied 
Science, Mannheim, Germany) for 30 min, and then sonicated.  The lysate was 
centrifuged at 3,200 g for 10 minutes at 4ºC, and the supernatant recovered.  For 
nuclear and cytosolic extracts, cells were lysed with hypotonic buffer (10 mM Tris-
HCl, pH 7.6, 5 mM MgCl2, 1.5 mM potassium acetate, 2 mM dithiothreitol) and 
protease inhibitors, homogenized with 40 strokes in a loose fitting Dounce, and 
centrifuged at 500 g for 10 min at 4ºC.  Cytosolic proteins were recovered in the 
supernatant, while the nuclear pellet was washed in buffer containing 10 mM Tris-
HCl, pH 7.6, 5 mM MgCl2, 0.25 M sucrose, 0.5% Triton X-100 and protease 
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inhibitors, then resuspended and sonicated in buffer containing 10 mM Tris-HCl, pH 
7.6, 0.25 M sucrose with protease inhibitors.  Finally, the suspension was centrifuged 
through 0.88 M sucrose at 2,000 g for 20 min at 4ºC, and nuclear proteins were 
recovered in the supernatant. 
 
3.3.5. Immunoblotting 
Protein levels of p63, JMJD3, Flag, β-III tubulin, NeuN, MAP2 and 
H3K27me3 were determined by Western blot analysis in 8 or 12% sodium dodecyl 
sulphate polyacrylamide gel electrophoresis, using either primary mouse monoclonal 
antibodies reactive to p63 (4A4; Santa Cruz Biotechnology, Santa Cruz, CA), NeuN 
(MAB377; Chemicon International, Temecula, CA), Flag (M2; Sigma-Aldrich Co.), 
and β-III tubulin (Tuj1; Covance, Princeton, New Jersey), or primary polyclonal 
antibodies reactive to MAP2 (AB5622, Chemicon International) H3K27me3 (Abcam 
plc, Cambridge, UK) and JMJD3 (RB10082; Abgent Inc, San Diego, CA), as well as 
corresponding secondary antibodies conjugated with horseradish peroxidase (Bio-Rad 
Laboratories, Hercules, CA, USA).  Membranes were processed for protein detection 
using Super Signal
TM
 substrate (Pierce, Rockford, IL, USA).  -Actin (AC-15; Sigma-
Aldrich Co.) was used as loading control.  GAPDH (6C5; Santa Cruz Biotechnology) 
and total histone H3 (Millipore Corporation, Temecula, CA, USA) were used as 
markers for cytoplasmic and nuclear protein extraction, respectively.  Protein 
concentrations were determined using the Bio-Rad protein assay kit (Bio-Rad 
Laboratories), according to the manufacturer’s specification. 
 
3.3.6. Immunocytochemistry 
NSCs undergoing differentiation were fixed with 4% paraformaldehyde in 
phosphate-buffered saline (PBS) for 30 min.  Cells were then blocked for 1 h at room 
temperature in PBS containing 0.1% Triton-X-100, 1% fetal bovine serum and 10% 
normal donkey serum (Jackson Immuno Research Laboratories, Inc., West Grove, 
PA).  Subsequently, cells were incubated with either primary monoclonal antibody 
reactive to p63 (4A4; 1:50) or primary polyclonal antibody reactive to JMJD3 
(KDM6B; 1:50) in blocking solution, overnight at 4ºC.  After three washes with PBS, 
cells were incubated with anti-rabbit Alexa Fluor 594- or anti-mouse Alexa Fluor 
568-conjugated secondary antibodies (Invitrogen Corp.; 1:200) for 2 h at room 
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temperature.  In control samples, the primary antibody was replaced by blocking 
buffer.  Cells were incubated with Hoechst dye for nuclear staining.  Images were 
acquired with an Axioskop fluorescence microscope (Carl Zeiss GmbH, Hamburg, 
Germany). 
 
3.3.7. Immnunoprecipitation assay 
The physical association between p63 and JMJD3 was evaluated by 
immunoprecipitation analysis.  In brief, whole-cell extracts were prepared by lysing 
cells by means of sonication in lysis buffer (50 mM Tris-HCl pH 7.4, 180 mM NaCl, 
1 mM EDTA, 0,5% Triton X-100) and protease inhibitors (Roche Applied Science).  
Immunoprecipitation experiments were carried out using the monoclonal antibody 
reactive to p63 (4A4) and the Ezview Red Protein G Affinity Gel (Sigma-Aldrich 
Co.).  Typically, 500 μg of lysate was incubated with 1 μg of p63-specific antibody 
overnight at 4ºC.  Immunoblots were then probed with the rabbit polyclonal antibody 
reactive to JMJD3 (KDM6B).  p63 protein levels were determined in the same 
membrane after stripping off the immune complex for the detection of JMJD3.  
Immunoprecipitation assays using mouse monoclonal antibodies reactive to IgG 
showed neglectable binding with either JMJD3 or p63.  Methylated levels of p63 
were detected by immunoprecipitation analysis in denaturing conditions.  In brief, 
whole-cell extracts were prepared by lysing cells by means of sonication in lysis 
buffer (50 mM Tris-HCl pH 7.4, 180 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 
mM dithiothreitol) and protease inhibitors (Roche Applied Science).  
Immunoprecipitation experiments were carried out using the monoclonal antibody 
reactive to p63 and the Ezview Red Protein G Affinity Gel (Sigma-Aldrich Co.).  
Typically, 500 μg of lysate was incubated with 1 μg of p63-specific antibody 
overnight at 4ºC.  Immunoblots were then probed with the rabbit polyclonal 
methylated lysine (MeK) (Abcam plc) antibody.  p63 expression was determined in 
the same membrane after stripping off the immune complex for the detection of MeK.  
Finally, the results of MeK after p63 immunoprecipitation were normalized with 
those obtained using mouse monoclonal antibodies reactive to IgG 
immunoprecipitation assays as well as with p63 total levels.  
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3.3.8. Evaluation of apoptosis 
Hoechst labeling of NSCs were used to detect apoptotic nuclei.  In brief, for 
morphologic evaluation of apoptosis, medium was gently removed to minimize 
detachment of cells.  Attached cells were fixed with 4% paraformaldehyde in PBS, 
pH 7.4, for 10 minutes at room temperature, incubated with Hoechst dye 33258 
(Sigma-Aldrich Co.) at 5 g/ml in PBS for 5 minutes, washed with PBS and mounted 
using Fluoromount.  Fluorescent nuclei were scored blindly and categorized 
according to the condensation and staining characteristics of chromatin.  Normal 
nuclei showed noncondensed chromatin dispersed over the entire nucleus.  Apoptotic 
nuclei were identified by condensed chromatin, contiguous to the nuclear membrane, 
as well as nuclear fragmentation of condensed chromatin.  
 
3.3.9. Densitometry and statistical analysis 
The relative intensities of protein bands were analyzed using the QuantityOne 
Version 4.6 densitometric analysis program (Bio-Rad Laboratories) and normalized to 
the respective loading controls.  Statistical analysis was performed using GraphPad 
InStat version 3.00 (Graph-Pad Software, San Diego, CA, USA) for the analysis of 
variance and Bonferroni’s multiple comparison tests.  Values of p < 0.05 were 
considered significant. 
 
3.4. Results 
3.4.1. TAp63γ and JMJD3 levels increase throughout mouse NSC 
differentiation 
Several lines of evidence point toward the involvement of classical apoptotic 
molecules in neural differentiation, including p53, caspases and Bcl-2 family 
members.  To investigate p63 involvement in neurogenesis, we first evaluated 
endogenous p63 levels throughout neural differentiation of NSCs.  Comparing with 
the exogenous overexpression of several p63 isoforms (Fonseca et al., 2012), TAp63γ 
(57 kDa) was the only endogenous isoform detected by Western blot analysis in 
NSCs.  Importantly, TAp63γ levels increased by 7-fold at 24 h of NSC differentiation 
(Fig. 3.1A).  JMJD3 upregulation was observed as early as at 6 h of differentiation, 
peaking at 24 h (Fig. 3.1A), in agreement with previous studies (Fernando et al., 
2005).  Accordingly, JMJD3 activity was also increased during differentiation, as 
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demonstrated by the reduced levels of H3K27 trimethylation throughout time (Fig. 
3.1A).  The neuronal marker β-III tubulin increased throughout differentiation, 
peaking at 24 h (Fig. 3.1A), as previously described (Santos et al., 2012b).  
 
 
Figure 3.1.  Endogenous TAp63γ protein levels increase at early stages of neural 
differentiation.  Undifferentiated (0 h) and differentiated mouse NSCs were collected for 
Western blot analysis or fixed for immunostaining at indicated time-points, as described in 
Materials and Methods.  (A) Protein levels of TAp63γ, JMJD3, β-III tubulin, and H3K27me3 
throughout NSC differentiation.  Representative immunoblots (top), and TAp63γ and JMJD3 
protein levels (bottom).  β-Actin and H3 were used as loading controls.  Immunoblots are 
representative of at least three different experiments.  TAp63γ and JMJD3 protein levels were 
normalized to endogenous β-Actin protein levels and expressed as mean ± SEM for at least 
three different experiments.  *p < 0.01 from control, undifferentiated.  (B) Fluorescence 
staining of TAp63γ and JMJD3 throughout NSC differentiation.  Hoechst dye was used for 
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nuclear staining.  Images are representative of at least 3 different experiments.  Scale bar = 
10 µm 
 
Other markers, including mouse achaete scute homolog-1 (Mash1) and 
neuronal differentiation 1 (NeuroD1) were also markedly increased (data not shown).  
Immunocytochemistry analysis corroborated Western blot data by showing 
upregulation and nuclear distribution of TAp63γ and JMJD3 at 24 h of differentiation 
(Fig. 3.1B). These results suggest that JMJD3 and TAp63γ are coordinately regulated 
to influence neural-specific gene expression programs. 
 
3.4.2. JMJD3 regulates TAp63γ protein in a demethylase activity-dependent 
manner 
To clarify whether JMJD3 regulates TAp63γ during neurogenesis, we 
overexpressed JMJD3 by transfecting NSCs with a Flag-JMJD3 plasmid and 
evaluated TAp63γ protein levels 24 h after transfection.  In control experiments, cells 
were transfected with either a Flag-JMJD3 mutant plasmid that does not contain the 
C-terminal region associated with JMJD3 demethylase activity, or no plasmid (mock).  
Overexpression of JMJD3 markedly increased TAp63γ protein levels when compared 
with control (mock) cells (p < 0.01) (Fig. 3.2). 
To better distinguish endogenous JMJD3 protein from the transfected 
versions, we have also detected Flag using a Flag antibody.  Of note, overexpressing 
the mutant form of JMJD3 had no effect on TAp63γ protein levels, indicating that 
JMJD3-induced increase of TAp63γ is dependent on its demethylase activity.  
Consistent with a role for JMJD3 as H3K27 demethylase, JMJD3 overexpression 
resulted in ~ 50% decreased levels of trimethylated H3K27 when compared with 
mock or cells transfected with JMJD3 mutant plasmid (p < 0.05) (Fig. 3.2).  As 
expected, JMJD3 overexpression significantly enhanced the neuronal marker β-III 
tubulin by ~2-fold when compared with mock- and JMJD3 mutant plasmid-
transfected cells (p < 0.05) (Fig. 3.2).  These results are consistent with a role for 
JMJD3-dependent demethylation in neurogenesis progression.  Moreover, the data 
here presented suggest that JMJD3-demethylase activity modulates TAp63γ protein 
levels and this may account, at least in part, for the neuronal commitment of NSCs. 
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Figure 3.2.  JMJD3 modulates TAp63γ levels during neural differentiation.  Mouse NSCs 
undergoing differentiation were transfected with JMJD3 or JMJD3 mutant (JMJD3mut), 
overexpression plasmids or no plasmid (mock), and collected for Western blot analysis as 
described in Material and Methods.  Representative immunoblots of TAp63γ, β-III tubulin, 
Flag, JMJD3 and H3K27me3, in control (mock), JMJD3mut- and JMJD3-overexpressing 
cells (top) and respective protein levels (bottom).  β-Actin and H3 were used as loading 
controls.  Immunoblots are representative of at least three different experiments.  TAp63γ and 
β-III tubulin protein levels were normalized to endogenous β-Actin whereas H3K27me3 
protein levels were normalized to endogenous total H3, when compared with mock cells.  
Results were expressed as mean ± SEM for at least three different experiments.  §p < 0.05 
and *p < 0.01 from control. 
 
3.4.3. TAp63γ manipulation influences neuronal differentiation 
To substantiate a role for TAp63γ in non-embryonic neuronal differentiation, 
we tested the functional relevance of TAp63γ in regulating β-III tubulin abundance in 
NSCs undergoing differentiation by short-interference RNA (siRNA)-mediated gene 
knockdown of p63.  Immunoblot analysis revealed that knockdown of TAp63γ by 
specific p63 siRNA resulted in a ~ 50% reduction in β-III tubulin levels when 
compared with control siRNA-transfected cells (Fig. 3.3A and B).  Other neural 
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markers, including the neuronal nuclei (NeuN) and microtubule-associated protein 2 
(MAP2) were also markedly reduced (Fig. 3.3A).   
 
 
Figure 3.3.  Modulation of TAp63γ levels in mouse NSCs affects neuronal differentiation.  
Mouse NSCs undergoing differentiation were transfected with p63 siRNA or TAp63γ 
overexpression plasmids and collected for Western blot analysis as described in Material and 
Methods.  (A) Representative immunoblot of β-III tubulin, NeuN, MAP2 and TAp63γ in cells 
transfected with 100 nM of either p63 siRNA or control siRNA (siRNA C) for 24 h.  (B) 
Respective β-III tubulin protein levels.  (C) Protein levels of β-III tubulin and TAp63γ in cells 
transfected with overexpression plasmids TAp63γ, TAp63γ mutant (TAp63γmut) or its 
corresponding empty vector (pcDNA3.1).  Representative immunoblot of β-III tubulin and 
TAp63γ (top) and respective β-III tubulin protein levels (bottom).  Results were normalized to 
endogenous β-Actin protein levels and expressed as mean ± SEM for at least three different 
experiments.  §p < 0.05 from control. 
 
These results were corroborated by immunofluorescence analysis (data not 
shown) and indicate that the increase in TAp63γ throughout NSC differentiation is 
important for neuronal fate specification.  In addition, overexpression of TAp63γ 
significantly increased β-III tubulin protein levels by ~2-fold when compared with 
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cells transfected with the corresponding empty vector (p < 0.01) (Fig. 3.3C).  
Importantly, overexpression with the mutant form of TAp63γ that lacks p63 
transactivation activity had no effect on β-III tubulin protein levels (Fig. 3.3C), 
indicating that TAp63γ-mediated increase of β-III tubulin is dependent on its 
transactivation activity. 
 
3.4.4. TAp63γ is directly demethylated by JMJD3 during neural differentiation 
Since JMJD3 also demethylates non-histone proteins, including p53 (Solá et 
al., 2011b), we hypothesized that JMJD3 may possibly demethylate TAp63γ during 
neurogenesis.  Thus, the interaction between JMJD3 and TAp63γ, as well as JMJD3-
mediated TAp63γ demethylation were investigated by immunoprecipitation assays.  
Specifically, to evaluate TAp63γ and JMJD3 endogenous association during 
differentiation of NSCs, we immunoprecipitated TAp63γ from total protein extracts 
with p63 antibody, and immunoblots were probed with JMJD3 antibody.  As depicted 
in Fig. 3.4A, JMJD3 directly binds to TAp63γ during NSC differentiation (p < 0.01). 
To investigate whether TAp63γ/JMJD3 association is dependent on JMJD3-
demethylase activity, TAp63γ immunoprecipitation was performed in NSCs 
overexpressing either JMJD3 wild-type or JMJD3 mutant plasmids.  Western blot 
analysis revealed a significant increase in TAp63γ/JMJD3 association in cells 
overexpressing JMJD3 wild-type when compared with mock (p < 0.05) (Fig. 3.4B).  
Importantly, the association between TAp63γ and JMJD3 was not increased in cells 
transfected with mutant JMJD3, suggesting that the interaction between TAp63γ and 
JMJD3 is dependent on the catalytic JmjC domain of JMJD3.  To investigate whether 
TAp63γ/JMJD3 association results in modification of TAp63γ methylation status, 
TAp63γ immunoprecipitation under denaturating conditions was performed in NSCs 
transfected with JMJD3 wild-type or JMJD3 mutant overexpression plasmids.  
Subsequent detection of methylated TAp63γ was performed by probing immunoblots 
with a pan-methylated lysine antibody.  Notably, TAp63γ was significantly less 
methylated in cells overexpressing JMJD3 wild-type, as compared to cells transfected 
with the C-terminal mutant form of JMJD3 or control (mock) cells (p < 0.01) (Fig. 
3.4C).  These results suggest that the proneuronal effects of TAp63γ during 
differentiation of NSCs might involve direct JMJD3-dependent demethylation. 
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Figure 3.4.  TAp63γ and JMJD3 directly associate during neural differentiation.  Mouse 
NSCs undergoing differentiation were collected and processed for immunoprecipitation 
assays with either p63 antibody or mouse IgG as control, as described in Material and 
Methods.  (A) Representative immunoblot of JMJD3 and TAp63γ (top) and histogram of 
TAp63γ/JMJD3 endogenous association (bottom).  (B) Representative immunoblot of JMJD3 
and TAp63γ (top) and histogram of TAp63γ/JMJD3 association (bottom) in cells transfected 
with JMJD3 or JMJD3 mutant (JMJD3mut) overexpression plasmids, or no plasmid (mock).  
(C) Representative immunoblot of methylated lysine (MeK) and TAp63γ (top), and histogram 
of TAp63γ methylated levels (bottom).  All densitometry values for JMJD3 and methylated 
lysines were normalized to the respective p63 expression, and the results expressed as mean ± 
SEM for at least three different experiments.  §p < 0.05 and *p < 0.01 from controls.  IP, 
Immunoprecipitation; WB, Western blot; MeK, Methyl K pan. 
 
3.4.5. TAp63γ is stabilized by JMJD3-demethylase activity and accumulates in 
the nucleus 
p63 activity is controlled by an intricate network of PTM that targets and 
modulates its transcriptional activity, stability or subcellular trafﬁcking (Stehmeier 
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and Muller, 2009).  These PTM are catalyzed by a large number of enzymes that 
contribute to the activation of p63 through a variety of mechanisms.  To investigate 
the effect of JMJD3-mediated TAp63γ demethylation on TAp63γ protein stability, we 
evaluated TAp63γ half-life in the presence and absence of JMJD3-demethylase 
activity.  For this purpose, NSCs co-transfected with TAp63γ and either Flag-JMJD3, 
Flag-JMJD3 mutant or no plasmid (mock) were treated with the protein synthesis 
inhibitor CHX (Fig. 3.5). 
 
 
Figure 3.5.  TAp63γ is stabilized by JMJD3 during mouse NSC differentiation.  Cells co-
transfected with TAp63γ and with the overexpression plasmids JMJD3 (TAp63 + JMJD3), 
JMJD3 mutant (TAp63 + JMJD3mut), or no plasmid (TAp63 + mock) were untreated (0 h) or 
treated with 50 μg/mL CHX for 2, 4, 6, and 8 h.  At the indicated time-points, total proteins 
were extracted for immunoblot analysis as described in Materials and Methods.  
Representative immunoblots of TAp63γ after CHX treatment (top) and percentage of 
remaining TAp63γ after CHX treatment (bottom).  Results were normalized to endogenous β-
Actin protein levels and expressed as mean ± SEM for at least three different experiments. §p 
< 0.05 from control. 
 
Our results demonstrate that TAp63γ half-life was reduced to less than 8 and 4 
h, respectively in control (mock)- and mutant JMJD3-transfected cells (p < 0.05).  In 
contrast, TAp63γ protein levels only slightly decreased in the presence of JMJD3 
wild-type, showing that JMJD3-demethylase activity indeed regulates the stability of 
TAp63γ.  
We next investigated the effect of JMJD3-mediated TAp63γ demethylation on 
TAp63γ subcellular distribution (Fig. 3.6).  
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Figure 3.6.  TAp63γ is translocated to the nucleus in a demethylase activity-dependent 
manner.  Mouse NSCs undergoing differentiation were transfected with JMJD3 or JMJD3 
mutant (JMJD3mut) overexpression plasmids, or no plasmid (mock), and collected for 
Western blot analysis, immunocytochemistry and apoptosis assays as described in Material 
and Methods.  (A) Representative immunoblots of nuclear and cytosolic TAp63γ (top) and 
respective protein levels (bottom).  GAPDH and H3 were used as loading controls for 
cytosolic and nuclear fractions, respectively.  Results were normalized to the respective 
endogenous controls and expressed as mean ± SEM for at least three different experiments.  
§p < 0.05 from control.  (B) Subcellular localization of TAp63γ in transfected mouse NSCs.  
Hoechst dye was used for nuclear staining and morphologic evaluation of apoptosis.  Images 
are representative of at least 3 different experiments.  Scale bar = 10 µm. 
 
Increased nuclear localization of TAp63γ was observed in NSCs 
overexpressing wild-type JMJD3 compared with control (mock)- and mutant JMJD3-
transfected cells (p < 0.05) (Fig. 3.6A).  Immunocytochemistry analysis confirmed 
Western blot data by showing TAp63γ accumulation in the nucleus of JMJD3-
 83 
transfected cells compared to cells overexpressing either the mutant form of JMJD3 
or control (mock) cells (Fig. 3.6B). 
Together, these results suggest that TAp63γ demethylation by JMJD3 is 
crucial for its stabilization and accumulation in the nucleus.  Moreover, these data 
support the hypothesis that JMJD3-induced TAp63γ nuclear translocation might 
direct NSCs to a neuronal fate specification, through the transcriptional activation of 
proneuronal genes.  Importantly, TAp63γ nuclear accumulation was not associated 
with an increase in apoptotic cell death, as confirmed by Hoechst staining (Fig. 3.6B). 
 
3.5. Discussion 
This study demonstrates for the first time a role for p63 in adult neural 
progenitors, directing NSCs to a neuronal phenotype.  Our findings are in accordance 
with postnatal p63 expression in the subventricular zone of the lateral ventricle 
(Hernández-Acosta et al., 2011), a region for continued adult neurogenesis.  In 
contrast with the lack of p63 effect on central nervous system development 
(Hernández-Acosta et al., 2011; Holembowski et al., 2011), our results point toward 
an age-dependent p63 involvement in the regulation of neural differentiation.  
Furthermore, we demonstrate that, during neural differentiation, p63 interacts with 
JMJD3, a key regulator of neurogenesis (Burgold et al., 2008), which results in the 
modulation of p63 methylation status.  Finally, our results demonstrate that JMJD3-
demethylase activity regulates p63 half-life and nuclear accumulation during mouse 
NSC differentiation.  
Much attention has been centered on p63 regulatory pathways in epidermal 
differentiation, due to the severe epithelial phenotype of p63 null mice (Yang et al., 
1999).  Recently, a role for p63 on cardiac differentiation of embryonic stem cells has 
also been reported (Paris et al., 2012).  However, the precise function for p63 during 
neural differentiation remains largely unknown, when compared with other members 
of the p53 family.  In fact, p53 and p73 are well-established key regulators of both 
embryonic and adult neurogenesis.  Mice lacking p53 display elevated proliferation 
rate in the neurogenic niche of the adult lateral ventricle wall, as well as increased 
self-renewal of in vitro propagated p53 –/– NSCs (Meletis et al., 2006).  Moreover, a 
relevant role for p53 in the biology of NSCs derived from the embryo olfactory bulb 
has been identified, where lack of p53 increases neurosphere-forming potential of 
precursor cells by favoring self-renewal capacity (Armesilla-Diaz et al., 2009).  
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TAp73, in turn, is an essential regulator of stemness in NSCs, which maintains an 
adequate neurogenic pool by promoting self-renewal and proliferation and inhibiting 
premature senescence of NSC and early progenitor cells, in both embryonic and adult 
neurogenesis (Talos et al., 2010).  In addition, the width of neurogenic areas appears 
to be significantly reduced in brains of embryonic and adult p73 knockout mice 
(Agostini et al., 2010).  Curiously, TAp73 acts via the basic helix-loop-helix Hey2 to 
promote long-term maintenance of neural precursors (Fujitani et al., 2010).  p73 
deficiency results in impaired self-renewal and premature neuronal differentiation of 
mouse neural progenitors independently of p53 (Gonzalez-Cano et al., 2010).   
In contrast with p53 and p73, there is still a breach in the literature regarding 
p63 potential involvement in adult neurogenesis by cell death-independent 
mechanisms.  Further, emerging knowledge suggests that a number of apoptosis-
associated factors, including p53, regulate neural differentiation (Paris et al., 2012; 
Yang et al., 1999).  This led us to explore p63 involvement in adult mouse NSC 
differentiation, which are capable of tripotential differentiation in neurons, glial cells 
and oligodendrocytes (Glaser et al., 2007), resembling adult neurogenesis.  Several 
studies have claimed that p63 is dispensable for embryonic neurogenesis.  However, 
since p63 knockout mice do not survive into postnatal life, a role for p63 in the adult 
brain cannot be excluded.  
In this study, a detailed characterization of p63 isoform expression (Fonseca et 
al., 2012) revealed that only one isoform with ~57 kDa was detected and subsequently 
confirmed as TAp63γ by comparison with exogenous p63 isoform overexpression 
(Jacobs et al., 2005).  Time-course analysis of TAp63γ protein levels throughout NSC 
differentiation demonstrated an increase of TAp63γ at early stages of neural 
differentiation, when JMJD3 protein levels and activity were already significantly 
increased.  Accordingly, we have previously demonstrated that JMJD3 expression and 
activity at the Hoxc8 promoter increased early in mouse NSC differentiation (Solá et 
al., 2011b).  Importantly, overexpression of JMJD3 in NSCs undergoing 
differentiation resulted in increased levels of TAp63γ protein, accompanied by 
increased neuronal marker β-III tubulin.  We have previously reported a similar effect 
of JMJD3 on the neural precursor Pax6 in JMJD3-transfected mouse NSCs (Solá et 
al., 2011b).  All together, these results suggest that JMJD3 modulates TAp63γ levels 
during neural differentiation, which might contribute to the neuronal fate specification 
of NSCs.  In accordance with this hypothesis, overexpression of TAp63γ during early 
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differentiation of NSCs resulted in increased β-III tubulin levels, whereas 
downregulation of TAp63γ expression by specific p63 siRNA abrogated the increase 
in β-III tubulin. 
Interestingly, in NSCs undergoing differentiation, both TAp63γ and β-III 
tubulin were modulated by JMJD3 in a demethylase activity-dependent manner.  
While not excluding an effect of H3K27 demethylation on NSC neuronal 
differentiation, our results also suggest that TAp63γ-mediated neuronal differentiation 
essentially relies on TAp63γ direct demethylation by JMJD3.  In this respect, JMJD3 
was reported to bind non-histone proteins, including p53 (Solá et al., 2011b), much 
like other demethylases (Tsai et al., 2008).  Our results demonstrate a direct 
interaction between TAp63γ and JMJD3, dependent of the C-terminal region of 
JMJD3, and modulation of TAp63γ methylation levels by JMJD3.  Importantly, 
JMJD3-demethylase activity appears to be relevant in regulating TAp63γ protein half-
life.  Cycloheximide experiments demonstrated that modulation of TAp63γ levels by 
JMJD3 during differentiation of NSCs occurs through protein stabilization and not by 
transcriptional regulatory mechanisms.  Supporting this idea, it has recently been 
shown that among several genes involved in neurogenesis and neuronal 
differentiation that are up-regulated by H3K27 demethylation, p63 is not included 
(Pereira et al.).  This suggests that JMJD3-mediated regulation of TAp63γ in NSCs 
does not occur at the transcriptional level.  In addition to TAp63γ stabilization, we 
here show that JMJD3-demethylase activity increases TAp63γ nuclear accumulation 
during NSC differentiation.  These results are in agreement with those previously 
obtained for JMJD3 and p53 in mouse NSCs (Solá et al., 2011b), reinforcing the 
similarities in structural and function properties of p53 family members.  Noteworthy, 
TAp63γ cellular distribution concurs with a role for this protein as a transcriptional 
activator of pro-neuronal gene expression.  Accordingly, NSCs cells transfected with 
the mutant form of TAp63γ that lacks p63 transactivation activity failed to 
differentiate in β-III tubulin-positive cells, indicating that TAp63γ-mediated neuronal 
differentiation might be dependent on its transactivation activity.  This study 
constitutes the first to show that TAp63γ demethylation affects its stability and 
subcellular localization.  Similar effects were already described for p63 
phosphorylation and acetylation, the best characterized p63 PTM (Collavin et al., 
2010) resulting in different cellular outcomes.  A deepest knowledge of these 
regulatory modifications of p63 protein will improve our understanding of p63 
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function during adult neural differentiation.  In this respect, future studies are 
warranted to determine the specific residues demethylated by JMJD3 and to address 
the importance of TAp63γ demethylation in neurogenesis by modification of the 
identified residues.  Since most mutated p63 proteins found in patients suffering from 
ectodermal dysplasia syndromes (Ying et al., 2005) are more stable than wild-type 
peptides, it would be interesting to clarify whether the mutated residues are sites of 
methylation.  We also anticipate TAp63γ protein demethylation to be highlighted as a 
PTM crucial for the neurogenic process.  
In conclusion, our results clearly demonstrate that TAp63γ and JMJD3 directly 
interact during NSC differentiation, in a JMJD3 C-terminal region-dependent manner.  
In addition, both TAp63γ protein stability and nuclear accumulation appear to be 
modulated by JMJD3-demethylase activity during neural differentiation.  These 
findings suggest that JMJD3 is a regulator of TAp63γ during NSC differentiation, and 
JMJD3-mediated TAp63γ demethylation plays a role in proneural gene expression. 
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4.1. Abstract 
Although regarded as neurotoxic, amyloid β (Aβ) peptides may also mediate a 
wide range of non-pathogenic processes.  Autophagy has been implicated in Aβ-
mediated effects, although its precise function in neural differentiation remains 
unknown.  Here, we addressed the role of different Aβ fragments in neural stem cell 
(NSC) proliferation and differentiation, and investigated whether autophagy is involved 
in Aβ-induced alterations of neural fate.  Our results demonstrate that neuronal and 
glial-specific protein markers are significantly induced by both Aβ1-40 and Aβ1-42.   
However, Aβ1-40 preferentially enhances neurogenesis of NSCs, as determined by βIII-
tubulin, NeuN and MAP2 neuronal marker immunoreactivity, while Aβ1-42 appears to 
favor gliogenesis.  In contrast, Aβ25-35 does not influence NSC fate.  The effect of Aβ1-40 
on neurogenesis is partially dependent on its role in NSC self-renewal as both S-phase 
of the cell cycle and BrdU labeling were markedly increased.  Nevertheless, Aβ1-40 
resulted also in increased Tuj1 promoter activity.  Autophagy, assessed by conversion 
of endogenous LC3-I/-II, fluorescence of pGFP-LC3 transfected cells, and Atg9 protein 
levels was evident in both Aβ1-40- and Aβ1-42-treated NSCs, independently of reactive 
oxygen species production and apoptosis.  Finally, inhibition of autophagy by 
pharmacologic means abrogated Aβ-induced lineage-specific protein markers.  These 
results support distinct roles for different Aβ peptides in NSC fate decision and 
underline the importance of autophagy control of this process.  
 
Keywords: Alzheimer’s disease; Gliogenesis; Neural stem cell fate; Neurogenesis; 
Proliferation 
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4.2. Introduction 
Over the past years, neural differentiation in mammalians has significantly 
impacted on our understanding of brain physiology, holding great promise for neuro-
replacement therapies (Alvarez-Buylla and Garcia-Verdugo, 2002; Bernal and Peterson, 
2004; Gage, 2000; Kempermann and Gage, 2000).  Neural stem cells (NSCs) are self-
renewing, multipotent cells that have the ability to differentiate into the three major cell 
types of the central nervous system (CNS) including, neurons, astrocytes and 
oligodendrocytes (Reynolds and Weiss, 1996).  The dimension of the NSC pool and its 
ability to restore damaged neural tissue in the brain results from tightly regulated 
cellular processes, including self-renewal, differentiation and cell death.  Thus, a better 
understanding of the molecular mechanisms responsible for neural differentiation, as an 
alternative to cell death will surely advance neuronal repair strategies. 
Amyloid-β (Aβ) peptide is the main component of deposits found in the brains 
of patients with Alzheimer's disease (AD) (Selkoe, 2001b).  It is processed from the 
amyloid precursor protein (APP), through β- and γ-secretases, originating Aβ1-40, the 
major species under physiological conditions, and a number of minor and more toxic 
species, such as Aβ1-42 (Steiner and Haass, 2000).  While best known as components 
responsible for neuronal death in AD, evidence has suggested that Aβ species are highly 
multifunctional peptides with significant non-pathological activities.  In fact, under 
deprived conditions, Aβ exhibits neurotrophic and neuroprotective properties at 
physiological concentrations in neonatal cells (Kontush et al., 2001; Whitson et al., 
1989; Yankner et al., 1990).  Aβ1-40 might have a beneficial role in reducing the amyloid 
burden, while Aβ1-42 is the major component of amyloid deposits, responsible for many 
neurodegenerative phenotypes and learning deficits (McGowan et al., 2005).  Indeed, 
studies in human brain, cerebrospinal fluid and plasma, as well as in transgenic animals 
and cellular systems modeling familial AD mutations have demonstrated that the 
Aβ42/Aβ40 ratio is consistently elevated (Bentahir et al., 2006; Kumar-Singh et al., 
2006).  Recently, it has been demonstrated that Aβ1-40 may also have neurogenic 
properties (Chen and Dong, 2009).  However, the precise molecular pathways 
underlying the regulation of NSC proliferation and differentiation by different Aβ 
peptides species are still not fully defined, and may implicate survival among other 
processes. 
Autophagy as a dynamic process of protein degradation fulfills multiple 
functions in mammalian cells, and is essential for cellular survival and differentiation, 
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development and homeostasis (Asanuma et al., 2003; Levine and Klionsky, 2004; Pua 
et al., 2007; Zeng and Zhou, 2008; Zhao et al., 2010; Zhuang et al., 2011).  It is 
regulated by a complex signal transduction machinery involving autophagy-related 
(Atg) gene products and other proteins that sense the intracellular energy status.  As 
most neurons survive for the lifetime of the organism, maintenance of organelle 
function and clearance of aberrant or damaged proteins are critical processes regulated 
by autophagy.  In fact, a growing number of studies support the idea that autophagy is 
highly active during differentiation and development (Asanuma et al., 2003; Vessoni et 
al., 2012), including neural differentiation (Zhao et al., 2010).  In addition, autophagy 
has recently been reported as a mechanism of neuronal protection from Aβ-induced 
cytotoxicity (Cheung et al., 2011; Hung et al., 2009; Moreira et al., 2010; Wang et al., 
2010).  Although Aβ-induced cell death via an autophagic degradation pathway has also 
been reported, the correlation between pro-neurogenic effects of Aβ peptides and 
autophagic activity has not been explored before. 
Reactive oxygen species (ROS) may be generated by Aβ species.  Further, ROS 
are important signaling molecules for autophagy (He et al., 2011), during periods of 
nutrient deprivation, hypoxia, ischemia, reperfusion injury, and general cell stress (Chen 
et al., 2009; Gurusamy and Das, 2009), and have been implicated in differentiation in 
certain developmental programs such as neurogenesis (Essick and Sam, 2010).  In fact, 
the correct balance of ROS production and utilization is critical to the regulation of self-
renewal and differentiation in pluripotent cells (Ray et al., 2012; Santos et al., 2012a).  
In the present study, we elucidated the role of different Aβ peptides during NSC 
fate decision.  Our results demonstrate that, in contrast with their conventional effects in 
cell death, lower levels of Aβ1-40 and Aβ1-42 mediate neural differentiation.  Aβ1-40 
strongly promotes NSC proliferation and neurogenesis, while Aβ1-42 facilitates glial fate 
decision.  Moreover, Aβ active fragments increase neural-lineage markers possibly by 
enhancing the autophagy survival response in differentiating NSC, independently of 
ROS production and apoptosis.  
 
4.3. Material and methods 
4.3.1. Cell culture 
A mouse NSC line was derived from day 14.5 post-coitum mouse fetal 
forebrain.  This cell line was established using a method that produces pure cultures of 
adherent NSCs, which continuously expand by symmetrical division and are capable of 
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tripotential differentiation (Ezashi et al., 2005; Smith et al., 2000).  NSCs were grown in 
monolayer as previously described (Conti et al., 2005; Glaser et al., 2007; Pollard et al., 
2006), and routinely maintained in undifferentiation medium, Euromed-N medium 
(EuroClone S.p.A., Pavia, Italy), supplemented with 1% N-2 supplement (Invitrogen 
Corp., Grand Island, NY, USA), 20 ng/mL epidermal growth factor (EGF; PeproTech 
EC, London, UK), 20 ng/mL basic fibroblast growth factor (bFGF; PeproTech EC) and 
1% penicillin-streptomycin (Invitrogen Corp.), in uncoated tissue culture plastic flasks 
at 37°C, in a humidified atmosphere of 5% CO2.  Medium was changed every 3 days 
and cells collected with accutase (Sigma-Aldrich Co., St. Louis, MO) when confluent.  
Differentiation of NSCs was performed by first platting cells in undifferentiation 
medium onto uncoated tissue culture plastic dishes at 1x10
6
 cells/cm
2
 for 24 h, and 
changing the culture medium to differentiation medium, Euromed-N medium 
supplemented with 10 ng/mL bFGF, 0.5% N-2 supplement, 1% B27 supplement and 
1% penicillin-streptomycin. 
 
4.3.2. Cell treatments 
Twenty-four hours after induction of differentiation, 1.5 µM of peptide active 
fragments Aβ25-35, Aβ1-40, or Aβ1-42 (American Peptide Company, Sunnyvale, CA, USA) 
were added to the culture medium for 48 h.  In selected experiments, undifferentiated 
cells were also incubated with Aβ peptide fragments for different time periods, up to 24 
h.  Aβ-treated cells were then collected for luciferase and lactate dehydrogenase (LDH) 
assays, immunoblotting, flow cytometry, and immunocytochemistry analysis.  To 
inhibit autophagy, 10 mM of 3-methyladenine (3-MA) (Sigma-Aldrich Co.) was added 
to the culture medium for 48 h. 
 
4.3.3. Plasmid transfections 
For the luciferase reporter assay, cells were transfected 24 h after plating into 35 
mm dishes with the murine Tuj1-promoter plasmid (1 g per dish) and the Renilla 
luciferase reporter as internal control for transfection efficiency (1 ng per dish) (CMV-
PRL; Promega, Fitchburg, WI, USA) using lipofectamine 2000 (Invitrogen Corp.).  The 
Tuj1-promoter, kindly provided by Fred Gage, was cloned by PCR from genomic DNA 
and inserted into pNeoLuci (Spiliotopoulos et al., 2009).  To analyze the intracellular 
localization and processing of the microtubule-associated protein 1 light chain 3 (LC3), 
a reliable autophagy marker, cells were transfected with a pGFP-LC3 plasmid for 24 h.  
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The pGFP-LC3 construct was kindly provided by Dr. Tamotsu Yoshimori and 
generated by inserting LC3 cDNA into the BglII and EcoRI sites of pEGFP-C1, a GFP 
fusion protein expression vector (Clontech Laboratories Inc., Mountain View, CA, 
USA) (Kuwabara et al., 2004).  GFP intensity was evaluated by immunocytochemistry. 
 
4.3.4. Dual luciferase assay 
Twenty-four hours after transfection with the murine Tuj1-promoter plasmid, 
cells were treated with A peptides in fresh culture medium for 48 h before harvest.  
Firefly and Renilla luciferase activities were measured using the Dual-Luciferase® 
Reporter Assay System (Promega) according to the manufacturer’s recommendation.  
The luminescence signal of the specific luciferase reporter plasmid was normalized to 
the internal control Renilla luciferase reporter intensity. 
 
4.3.5. Immunoblotting 
Steady-state levels of βIII-tubulin, GFAP, NeuN, MAP2, Atg9 and LC3 in NSCs 
were determined by Western blot analysis.  Cells were collected and lysed for isolation 
of total protein extracts using ice-cold lysis buffer (10 mM Tris-HCl, pH 7.6, 5 mM 
MgCl2, 1.5 mM potassium acetate, 1% Nonidet P-40, 2 mM dithiothreitol) and protease 
inhibitor cocktail tablets Complete (Roche Applied Science, Mannheim, Germany) for 
30 min.  Samples were then sonicated and centrifuged at 3,200g at 4ºC for 10 min. 
Protein content was measured by the Bio-Rad protein assay kit (Bio-Rad Laboratories, 
Hercules, CA, USA) according to the manufacturer’s specifications.  One hundred μg of 
protein extracts were separated on 8 and 12% sodium dodecyl sulphate polyacrylamide 
electrophoresis gels.  After electrophoretic transfer onto nitrocellulose membranes, and 
blocking with a 5% milk solution, membranes were incubated overnight at 4ºC with 
either primary mouse monoclonal antibodies reactive to βIII-tubulin (Tuj1 clone; 
Covance, Princeton, New Jersey), GFAP and NeuN (MAB360 and MAB377, 
respectively; Chemicon International, Temecula, CA, USA), primary rabbit polyclonal 
antibodies reactive to MAP2 (AB5622; Chemicon International) and LC3 (PA1-16931; 
Affinity Bioreagents, Golden, Colorado, USA), or primary goat polyclonal antibody 
reactive to Atg9a (sc-70141; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).  
Blots were subsequently incubated with secondary antibodies conjugated with 
horseradish peroxidase (Bio-Rad Laboratories) for 3 h at room temperature.  
Membranes were processed for protein detection using Super Signal
TM
 substrate 
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(Pierce, Rockford, IL, USA).  -Actin (AC-15; Sigma-Aldrich Co.) was used as loading 
control. 
 
4.3.6. Immunocytochemistry 
For detection of proliferating cells, S-phase nuclei were stained in 
undifferentiated cells using the bromodeoxyuridine (BrdU) in-situ detection kit (BD 
Biosciences Pharmingen, San Diego, CA, USA).  BrdU was added to the culture 
medium 18 h after A treatments, and cells were re-incubated for additional 6 h and 
processed according to manufacturer’s instructions.  For fluorescence microscopy, 
NSCs cells were maintain in differentiation medium for 6 days, fixed with 4% 
paraformaldehyde (w/v) in phosphate buffer saline (PBS) and blocked for 1 h at room 
temperature in PBS, containing 0.1% Triton X-100, 1% fetal bovine serum (FBS), and 
10% normal donkey serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, 
PA, USA).  Cells were then incubated with either anti-βIII-tubulin antibody at a dilution 
of 1:500 in blocking solution, with anti-MAP2 (AB5622, Millipore Corporation, 
Darmstadt, Germany), anti-Nestin (MAB353; Chemicon International), anti-NG2 
(neuronal/glial 2 AB5320; Millipore) and anti-GFAP antibodies at a dilution of 1:200 in 
blocking solution, or with anti-GFP (B-2) antibody (sc-9998; Santa Cruz 
Biotechnology, Inc.) at a dilution of 1:50 in blocking solution, overnight at 4°C.  At the 
end of the incubation with primary antibodies and after washing in PBS, cells were 
incubated with appropriate secondary antibodies, mouse antibodies conjugated to either 
Alexa 568 (Life Technologies Ltd., Carlsbad, CA, USA) at a dilution of 1:200 or 
Dylight 488 (Jackson ImmunoResearch Laboratories, Inc.) at a dilution 1: 100, and 
Alexa 594-conjugated anti-rabbit antibody (Life Technologies Ltd) at a dilution of 
1:200, for 2 h at room temperature.  Finally, nuclei were counterstained with Hoechst 
33258 (Sigma-Aldrich Co.) at 50 µg/ml in PBS, for 5 min at room temperature.  
Samples were mounted using Fluoromount-G™ (Beckman Coulter, Inc., Brea, CA, 
USA).  Fluorescence microscopy assessments were performed with a Zeiss AX10 
microscope (Carl Zeiss, Jena, Germany) equipped with a Leica DFC490 camera (Leica 
Wetzlar, Germany) or with a Zeiss LSM 510 META confocal microscope (Carl Zeiss).  
 
4.3.7. Flow cytometry analysis 
For detection of βIII-tubulin and GFAP expression levels, cells were fixed with 
4% paraformaldehyde in PBS for 20 min at 4
o
C, washed twice with washing solution 
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0.1% saponin (Fluka, Biochemika, Switzerland) in PBS, and blocked for 20 min in 
blocking solution 0.25% saponin and 5% FBS in PBS.  Subsequently, cells were 
washed and incubated with antibodies reactive to βIII-tubulin or GFAP at a dilution of 
1:500 and 1:200, respectively, in antibody blocking solution 0.1% saponin and 5% FBS 
in PBS, for 30 min.  Cells were then washed twice and incubated with anti-mouse 
antibody conjugated to Dylight 488, at a dilution of 1:100 for 30 min.  Cells were 
washed twice, resuspended in PBS with 2% FBS and analyzed using the Guava 
EasyCyte 5HT® Cytometry system (Millipore).  For ROS quantification, 10 μM 2′,7′-
dichlorodihydrofluorescein diacetate (H2DCFDA; Molecular Probes, Invitrogen, 
Eugene, OR, USA) was added to the culture medium 30 min prior to cell collection. 
Then, cells were ressuspended in PBS with 2% FBS, and emission of green 
fluorescence was analyzed in the Guava EasyCyte 5HT® Cytometry system after 20 
min.  Proliferation levels were determined by BrdU incorporation analysis using the 
APC BrdU Flow Kit (BD Biosciences Pharmingen).  BrdU was added to the culture 
medium 18 h after cell treatments, and cells were re-incubated for additional 6 h and 
later analyzed by flow cytometry using the LSR Fortessa
TM
 system (Becton Dickinson, 
Mountain View, CA).  The percentage of cells in the S-phase of the cell cycle was also 
evaluated by the LSR Fortessa
TM
 system.  First, cells were synchronized by double-
thymidine block.  Twelve hours after plating, 2 mM thymidine (Sigma-Aldrich Co.) was 
added to the culture media for additional 12 h.  Cells were then released from first 
thymidine block by removing culture media, washing 3 times with PBS and by adding 
fresh undifferentiation medium, without thymidine.  Twelve hours later, cells were 
submitted to a second thymidine block.  Aβs were added to the medium without 
thymidine at the end of second block.  Cells were grown for additional 48 h, prior to cell 
collection with accutase.  Subsequently, cells were washed with PBS, fixed in 80% 
ethanol at 4ºC overnight, and then stained with 5 µg/mL propidium iodide (PI) (Sigma-
Aldrich Co.) for DNA contents.  Data were statistically evaluated using FlowJo 
software (Tree Star, Inc, Ashland, OR, USA).  
 
4.3.8. Evaluation of cell death 
Hoechst labeling of NSC was used to detect apoptotic nuclei.  In brief, for 
morphologic evaluation of apoptosis, medium was gently removed to minimize 
detachment of cells.  Attached cells were fixed with 4% paraformaldehyde in PBS, pH 
7.4, for 10 min at room temperature, incubated with Hoechst dye 33258 (Sigma-Aldrich 
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Co.) at 5 g/ml in PBS for 5 min, washed with PBS and mounted using Fluoromount.  
Fluorescent nuclei were scored blindly and categorized according to the condensation 
and staining characteristics of chromatin.  Normal nuclei showed noncondensed 
chromatin dispersed over the entire nucleus.  Apoptotic nuclei were identified by 
condensed chromatin, contiguous to the nuclear membrane, as well as nuclear 
fragmentation of condensed chromatin.  Cell viability was quantified by the LDH assay 
(Sigma-Aldrich Co.).  The absorbance was measured spectrophotometrically at 490 nm 
wavelength, using a 96-well plate reader (Bio-Rad Laboratories). 
 
4.3.9. Densitometry and statistical analysis 
The relative intensities of protein bands were analyzed using the QuantityOne 
Version 4.6 densitometric analysis program (Bio-Rad Laboratories) and normalized to 
the respective loading controls.  Statistical analysis was performed using GraphPad 
InStat version 3.00 (Graph-Pad Software, San Diego, CA, USA) for the analysis of 
variance and Bonferroni’s multiple comparison tests.  Values of p < 0.05 were 
considered significant. 
 
4.4. Results 
4.4.1. Characterization of NSCs isolated from mouse fetal forebrain under 
differentiating conditions 
Monolayer culturing systems of NSCs can be generated from embryonic stem cells, 
induced pluripotent stem cells (derived from reprogrammed somatic cells), as well as 
from fetal and adult brain (Kabeya et al., 2000).  These systems have the potential to 
give rise to neurons, astrocytes and oligodendrocytes.  The different cellular 
compositions of the monolayer cultures, with homogeneous composition, result in high 
neurogenic potential.  In this study, we used NSCs derived from 14.5-days post coitum 
mouse fetal forebrain.  This cell line was established using a method that produces pure 
cultures of adherent NSCs, which continuously expand by symmetrical division and are 
capable of tripotential differentiation (Conti and Cattaneo, 2010).  NSCs were grown in 
monolayer as previously described (Conti et al., 2005; Glaser et al., 2007; Pollard et al., 
2006) and routinely maintained in undifferentiating medium (Fig. 4.1A).  Under these 
conditions, ~ 90% of the cells were positive for proliferative marker Nestin. 
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Figure 4.1.  Monolayer culture system of NSCs and differentiation into major CNS cell types.  
Mouse NSCs were expanded and induced to differentiate as described in Materials and 
Methods.  Undifferentiated (A) and differentiated (B) NSCs.  Fluorescence staining of βIII-
tubulin (C), MAP2 (D), GFAP (E), NG2 (F) and Nestin (G) throughout NSC differentiation.  
Nuclei were stained with Hoechst.  Scale bar, 10 µm. 
 
Following incubation in differentiation medium, cells displayed a sharp increase 
in markers for neurons and neural precursors.  In fact, at 3 days of differentiation, 15-
20% of cells were positive for βIII-tubulin or GFAP, and ~ 50% were positive for 
Nestin.  After 3 days in differentiating conditions, cells were gently dissociated, replated 
on a laminine-coated surface, and exposed to a FGF-2 and BDNF containing medium 
for terminal differentiation for additional 3 days (Spiliotopoulos et al., 2009).  When 
exposed to these conditions, NSCs gradually adhered and progressively developed a 
neuronal morphology as indicated by the appearance of neurites outgrowth, and 
establishment of complex branched morphology and cell-cell contacts (Fig. 4.1B).  A 
significant fraction of cells in culture showed increased immunoreactivity for the 
immature neuronal marker βIII-tubulin, in addition to acquiring immunoreactive signal 
for the mature neuronal marker MAP2, and showing a more complex and branched 
neuronal morphology (Fig. 4.1C and D).  Finally, only a small portion of the total cell 
population became GFAP-positive astrocytes and NG2-positive oligodendrocytes (Fig. 
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4.1E and F), indicating that the culture conditions do not favor conversion into the 
astroglial and oligodendroglial lineages.  Differentiated cells also appear to have cell 
type-specific morphologies.  Consistent with induction of differentiation, Nestin 
immunoreactivity in NSC cultures showed a few number of cells expressing this 
immature marker (Fig. 4.1G). 
 
4.4.2. Distinct roles of Aβ1-40 and Aβ1-42 in modulating lineage-specific markers of 
NSCs 
Several lines of evidence point toward the involvement of Aβ in neurogenesis 
(Spiliotopoulos et al., 2009).  However, the effects of Aβ in neural differentiation have 
not reached a consensual agreement.  To address the role of Aβ during neural 
differentiation in vitro, the expression levels of βIII-tubulin, MAP2, NeuN and GFAP 
were investigated in NSCs incubated with Aβ1-40, Aβ1-42 or Aβ25-35 for 48 h.  Flow 
cytometry analysis showed that Aβ1-40 and Aβ1-42 induced a marked increase of both 
βIII-tubulin- and GFAP-positive cells (p < 0.01).  However, while Aβ1-40 appeared to 
preferentially increase neuronal markers, Aβ1-42 exhibited a stronger effect on astrocytic 
differentiation (Fig. 4.2A).  In addition, Aβ25-35 elicited no significant alterations in 
neuronal and astrocytic-specific protein markers.  Accordingly, Western blot data 
revealed that, although increasing GFAP levels (p < 0.05), Aβ1-40 markedly augmented 
βIII-tubulin, MAP2 and NeuN (p < 0.01) throughout differentiation (Fig. 4.2B).  
Aβ1-42, in turn, induced βIII-tubulin levels (p < 0.05); however, the strongest 
effect was observed in GFAP protein levels, which doubled in Aβ1-42-treated cells (p < 
0.01).  Finally, immunocytochemistry analysis of the βIII-tubulin and MAP2 markers 
corroborated the effects of Aβ1-40 and Aβ1-42 in regulating neuronal lineage of NSCs 
(Fig. 4.2C).  While Aβ1-42 slightly increased the expression of βIII-tubulin and did not 
alter MAP2, Aβ1-40 significantly increased both markers, when compared with untreated 
cells.  These results reinforce a stronger effect of Aβ1-40 in enhancing the neuronal 
lineage of NSCs when compared with Aβ1-42, and demonstrate distinct effects for 
different Aβ active fragments in NSC-fate determination. 
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Figure 4.2.  Aβ1-40 preferentially promotes neuronal differentiation of NSCs.  Cells were 
induced to differentiate, treated with either Aβ25-35, Aβ1-40 or Aβ1-42 for 48 h, and labeled for 
neural marker detection by flow cytometry as described in Materials and Methods.  (A) 
Representative histograms of βIII-tubulin-positive cells (left) and GFAP-positive cells (right).  
(B) Representative immunoblot of βIII-tubulin and MAP2 (top), and NeuN and GFAP (bottom), 
and respective protein levels.  Results were normalized to endogenous β-Actin protein levels 
and expressed as mean ± SEM for at least three different experiments.  (C) Immunostaining of 
neuronal markers βIII-tubulin and MAP2 in control untreated cells (a and d), and in cells 
treated with Aβ1-40 (b and e) and Aβ1-42 (c and f).  Nuclei were stained with Hoescht.  Scale bar, 
10 µm.  *p < 0.01  and §p < 0.05 from controls. 
 
 
4.4.3. Aβ1-40 increases proliferation and neuronal-promoter activity of NSCs 
It has been suggested that Aβ peptides may also alter NSC proliferation 
depending on the time and type of animal models used (Chen and Dong, 2009).  We 
next investigated whether the effects of Aβ1-40 and Aβ1-42 in enhancing lineage-specific 
markers were due to proliferative effects.  Undifferentiated cells were preincubated with 
Aβ1-40 and Aβ1-42 for 24 h and pulse-labeled for 6 h with BrdU to mark S-phase cells.  
Immunocytochemistry analysis revealed that treatment with Aβ1-40 significantly 
increased BrdU incorporation, when compared with untreated cells (Fig. 4.3A).  
Surprisingly, no significant changes were observed in the percentage of BrdU-positive 
cells upon Aβ1-42 treatment.  The percentage of BrdU incorporated in Aβ-treated NSCs 
was also determined by flow cytometry analysis.  Our results confirmed that ~ 80% of 
the untreated cells incorporated BrdU, indicating that the majority of NSCs are in S-
phase and proliferating.  Interestingly, > 90% of the cells treated with Aβ1-40 were 
BrdU-positive, while treatment with Aβ1-42 had no effect in BrdU incorporation, when 
compared with untreated cells (p < 0.05) (Fig.4.3B).  To validate our results, the DNA 
content distribution of NSCs was also analyzed by flow cytometry.  
In these experiments cells were stained with PI for determining DNA content 
after treatment with Aβ peptides.  As shown in Fig.4.3C, the percentage of cells in S-
phase raised ~ 15% after Aβ1-40 treatment (p < 0.05).  As expected, no significant 
increase in proliferation was observed following treatment with Aβ1-42.  Thus, our 
results suggest that Aβ1-40 and Aβ1-42 have distinct functions in mediating NSC 
proliferation.  While the effect of Aβ1-40 on neuronal-specific lineage may be partially 
the ultimate result of increased number of neural progenitors, Aβ1-42 appears to favor 
glial differentiation by a mechanism independent of NSC proliferation.   
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Figure 4.3.  Aβ1-40 increases the S-phase of the cell cycle and neuronal-promoter activity in 
NSCs.  Undifferentiated cells were preincubated with Aβ1-40 and Aβ1-42 for 24 h and pulse-
labeled for 6 h with BrdU to mark S-phase cells as described in Materials and Methods.  (A) 
Immunostaining with rabbit anti-BrdU in control untreated cells (a), and in cells exposed to 
either Aβ1-40 (b) or Aβ1-42 (c). Scale bar, 10 µm.  (B) Percentage of BrdU-positive cells analyzed 
by flow cytometry.  (C) S-phase cells analyzed by flow cytometry.  (D) Neuronal lineage-specific 
promoter activity.  NSCs were transfected with a βIII-tubulin (Tuj1) promoter-driven luciferase 
construct, 24 h before Aβ1-40 incubation.  After 48 h of Aβ1-40 treatment, luciferase activity was 
measured in cell lysates.  Aβ1-40 significantly increased BrdU-positive and S-phase cells as well 
as Tuj1 promoter activity.  Results were expressed as mean ± SEM for at least three different 
experiments.  *p < 0.01 and §p < 0.05 from controls. 
 
To further dissect the mechanism by which Aβ1-40 modulates increased neuronal 
fate, NSCs were transfected with a βIII-tubulin (Tuj1) promoter-driven luciferase 
construct, 24 h before Aβ1-40 incubation.  After 48 h of Aβ1-40 treatment, luciferase 
activity was measured in cell lysates.  Notably, Tuj1-promoter activity was markedly 
induced in Aβ1-40 treated cells, when compared with untreated NSCs (p < 0.01), 
validating data on the role of Aβ1-40 in the neurogenesis process (Fig. 4.3D).  Aβ1-42 had 
no major effect on Tuj1 promoter induction.  Thus, our results indicate that the pro-
neurogenic effect of Aβ1-40 results from its ability in maintaining a proliferative NSC 
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pool, and activating the βIII-tubulin promoter. 
 
4.4.4. Aβ1-40 and Aβ1-42 increase autophagy during differentiation of NSCs 
Autophagy is characterized by sequestration of cytoplasmic constituents in 
double or multimembrane autophagic vesicles, and their delivery to and subsequent 
degradation by the cell own lysosomal system (Chevallier et al., 2005; Jin et al., 2004; 
Wang et al., 2004; Wen et al., 2004).  LC3 was originally identified as a small subunit 
of microtubule-associated protein 1A and 1B from rat brain (Gozuacik and Kimchi, 
2004), and is usually associated to autophagosome membranes during the autophagic 
process (Mann and Hammarback, 1994).  Therefore, LC3 has been recently proposed as 
a marker for autophagic vesicles and autophagic activity (Kabeya et al., 2000).  A 
growing body of evidence points to a critical role for autophagy during proliferation and 
differentiation, as a response-survival mechanism to limit oxidative stress associated 
with these processes (Asanuma et al., 2003; Kamada et al., 2000).  However, the 
specific role of Aβ species in mediating autophagy is largely unknown.  To elucidate the 
role of autophagy and potential modulation by Aβ peptides in neural differentiation, we 
undertook various screening approaches.  We investigated the LC3-I/II conversion and 
used the autophagic marker GFP-LC3 in differentiating NSCs undergoing 
differentiation after Aβ1-40 and Aβ1-42 treatments.  Immediately after the synthesis, LC3 
carboxyl terminal region is cleaved by a protease to form LC3-I peptide (18 kDa) in the 
cytosol (Pua et al., 2007; Zhao et al., 2010; Zhuang et al., 2011).  For autophagosomal 
membrane localization, LC3 must be processed, by E1 and E2 enzymes, to a membrane-
bound form LC3-II (16 kDa), being subsequently conjugated to the preautophagosomal 
membrane (Kabeya et al., 2000).  Importantly, our results revealed that both Aβ1-40 and 
Aβ1-42 further increase LC3-I to -II conversion, when compared with non-treated cells 
(Fig. 4.4A) (p < 0.01).  Aβ-induced autophagy during NSC differentiation was 
confirmed by monitoring the accumulation of LC3 by immunofluorescence.  In fact, 
both Aβ1-40 and Aβ1-42 increased GFP-LC3 puncta in NSCs undergoing differentiation 
(Fig. 4.4B).  Moreover, the autophagy-related protein 9 (Atg9), a multi-pass membrane 
protein that localizes to the pre-autophagosomal structure, markedly augmented 
throughout differentiation in cells treated with Aβ1-40 or Aβ1-42 (p < 0.01) (Fig. r.4C).  
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Figure 4.4.  Autophagy is increased in Aβ1-40- and Aβ1-42-treated NSCs.  Cells were induced 
to differentiate, treated with either Aβ1-40 or Aβ1-42 for 24 h, and then collected for Western blot, 
apoptosis, confocal microscopy and flow cytometry analyses as described in Material and 
Methods.  (A) Representative immunoblots of LC3-I, LC3-II and Atg9 (top) and respective 
protein levels (bottom).  β-Actin was used as loading control.  (B) Representative confocal 
images of GFP-LC3 puncta in undifferentiated (a) or differentiated (b) conditions, and treated 
with Aβ1-40 (c) or Aβ1-42 (d).  Scale bar, 5 µm.  (C) Intracellular ROS quantification of 
fluorescent DCF by flow cytometry.  (D) Representative images of Hoechst staining in control 
cells (a), or cells treated with Aβ1-40 (b) or Aβ1-42 (c).  Scale bar, 10 µm.  Autophagy is increased 
after Aβ treatment; however, ROS levels and apoptosis were not altered.  Results were 
expressed as mean ± SEM for at least three different experiments.  *p < 0.01 from controls. 
 
Finally, in the concentrations used, Aβ peptides did not increase redox status 
(Fig. 4.4C) nor induced cell death throughout NSC differentiation, as detected by 
Hoechst (Fig. 4.4D) and PI and Annexin-V staining.  These data suggest that the 
protective mechanism of autophagy is potentially modulated by Aβ peptides to promote 
neural differentiation. 
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4.4.5. Inhibition of autophagy reverts the effects of Aβ1-40 and Aβ1-42 in enhancing 
lineage-specific markers in NSCs 
To clarify the contribution of autophagy in Aβ-regulated NSC fate, we tested the 
effects of autophagy inhibition on the ability of both Aβ1-40 and Aβ1-42 to increase 
lineage-specific markers.  We used the autophagy inhibitor 3-MA and re-evaluated the 
effects of Aβ1-40 and Aβ1-42 in neuronal and astrocytic differentiation, respectively.  
Confocal microscopy confirmed that treatment of NSCs with 3-MA markedly decreased 
the number of GFP-LC3-labeled puncta (Fig. 4.5A).  Similar results were obtained after 
treatment with a second autophagy inhibitor, wortmannin (data not shown).  Cell death 
increased in the presence of 3-MA in both Aβ-treated and untreated cells, as determined 
by the LDH assay (Fig. 4.5B) (p < 0.01) and PI and Annexin-V staining (data not 
shown).  In addition, flow cytometry analysis revealed that the effects of Aβ1-40 and Aβ1-
42 in NSC fate were completely reverted after incubation with 3-MA.  Notably, the 
inhibition of autophagy diminished the number of βIII-tubulin- and GFAP-positive cells 
in NSCs incubated with Aβ1-40 and Aβ1-42, when compared with control (Fig. 4.5C) (p < 
0.01).  Finally, immunocytochemistry analysis of both βIII-tubulin and GFAP 
confirmed the inhibitory effects of 3-MA in Aβ1-40 and Aβ1-42-induced neuronal and 
astrocytic-specific protein markers, respectively (Fig. 4.5D).  These results indicate that 
Aβ1-40 and Aβ1-42 may be important regulators of neural differentiation through an 
autophagy-dependent manner. 
 
4.5. Discussion  
Aβ peptides have important physiological functions before they aggregate and 
form amyloid fibrils (Tanida et al., 2002; Tanida et al., 2001).  However, our 
understanding of Aβ signals controlling these processes is limited.  In this study, we 
demonstrate that active fragments of Aβ1-40 and Aβ1-42 peptides, but not Aβ25-35 peptide, 
significantly stimulate neural-lineage in NSCs, through a mechanism at least in part 
dependent on autophagy signaling mechanisms. 
Much attention has been centered on toxic effects of Aβ peptides (Parihar and 
Brewer, 2010; Pearson and Peers, 2006; Plant et al., 2003; Ramsden et al., 2002).  In 
fact, Aβ peptides are strongly implicated in AD, promoting synaptic dysfunction and 
neuronal cell death by a mechanism involving increased oxidative stress and disruption 
of cellular calcium homeostasis (Klein, 2002; Pike et al., 1993).  However, Aβ peptides 
may also activate kinase enzymes, protect against oxidative stress (Mattson, 1997), 
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regulate cholesterol transport and function as transcription factors (Baruch-Suchodolsky 
and Fischer, 2009). 
 
Figure 4.5.  The autophagy inhibitor 3-MA abrogated the effects of Aβ1-40 and Aβ1-42 in 
neuronal and astrocytic differentiation of NSCs.  Mouse NSCs were induced to differentiate 
and treated with either 3-MA (5 mM), Aβ1-40 or Aβ1-42 for 24 h.  Cells were collected for LDH, 
flow citometry, confocal and immunocytochemistry analysis as described in Material and 
Methods.  (A) Representative confocal images of GFP-LC3 puncta in control cells (a), or in 
cells treated with either 3-MA (b), Aβ1-40 + 3-MA (c), Aβ1-42 + 3-MA (d) for 24 h.  Scale bar, 5 
µm.  (B) LDH release.  (C) Percentage of βIII-tubulin- and GFAP-positive assessed by flow 
cytometry analysis.  (D) Representative images of βIII-tubulin- and GFAP-positive cells in 
controls (a and e), and in cells treated with either 3-MA (b and f), Aβ1-40 + 3-MA (c and g), Aβ1-
42 + 3-MA (d and h) for 24 h. Results were expressed as mean ± SEM for at least three different 
experiments.  *p < 0.01 from controls; †p < 0.01 from Aβ alone. 
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The beneficial role for Aβ1-40 peptide in neurons has previously been reported in 
vivo, where Aβ1-40 was shown to inhibit amyloid deposition (Chen and Dong, 2009).  
Here, we first determined the effects of Aβ1-40, Aβ1-42 and Aβ25-35 in expression levels of 
neural markers during differentiation of mouse NSC.  Soluble Aβ1-40 and Aβ1-42 
increased both βIII-tubulin and GFAP levels; however, Aβ1-40 was preferentially pro-
neurogenic, while Aβ1-42 was pro-astrocytic.  In addition, we have shown that Aβ1-40 not 
only promotes NSC self-renewal but also enhances the activity of neuronal 
differentiation.  In fact, after Aβ1-40 treatment of NSCs, the S-phase of the cell cycle and 
BrdU labeling were markedly enhanced.  A potential direct effect of Aβ1-40 on βIII-
tubulin promoter activity and its influence on neurogenesis may be further clarified in 
knockdown experiments of III-tubulin after Aβ1-40 treatment. 
Our findings are in accordance with a previous report showing that non-
aggregated Aβ1-40 and Aβ1-42 promote neuronal and astrocytic cell fate in neural 
progenitor cells (Kim et al., 2007).  However, in that study, Aβ1-42 also increases NSC 
proliferation, while we did not observed significant alterations in self-renewal after Aβ1-
42 incubation.  Distinct cellular models and experimental conditions in both studies 
could account for this apparently discrepant result.  The authors have used NSCs 
derived from 18-dpc rat fetal brain, while we used NSC derived from 14.5-dpc mouse 
fetal brain.  Moreover, others have demonstrated a predominant effect of Aβ1-42 in 
neurogenesis (Chen and Dong, 2009).  In fact, the number of βIII-tubulin-positive 
neurons was increased by Aβ1-42 in one study (Calafiore et al., 2012; Heo et al., 2007; 
Lopez-Toledano and Shelanski, 2004), while others reported that low concentrations of 
oligomeric Aβ1-42 peptides enhance proliferation and neuronal differentiation of NSCs 
(Lopez-Toledano and Shelanski, 2004).  Hence, although the absence of Aβ25-35 effect 
in eliciting either self-renewal or neural differentiation appears to be consensual in the 
literature, the debate is still ongoing as to the role of different forms of Aβ on the 
neurogenesis process.  
On the other hand, studies using animal models of AD have proposed the 
opposite effect of Aβ peptides in neurogenesis (Heo et al., 2007).  However, these 
results appear to be correlated with the decreased levels of soluble Aβ peptide observed 
in AD.  In fact, Aβ peptide has already been reported to have differential effects on 
human embryonic stem cell proliferation depending on its aggregation level (Haughey 
et al., 2002a; Haughey et al., 2002b); the neurogenic functions of Aβ were greatly 
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reduced when this active peptide was in aggregated forms.  Consistent with this, others 
have demonstrated that higher levels of Aβ monomers, oligomers, and ﬁbrils in the 
brain microenvironment in individuals with amyloidosis-β induce oxidative stress and 
have a negative effect on endogenous neurogenesis (Porayette et al., 2009).  AD is a 
dynamic disease process, and it is plausible that an increase in neuronal differentiation 
is followed by an overall decline as Aβ aggregates and loses its neurogenic functions.  
By evaluating the lipidated LC3-II and Atg9 markers of autophagy, our results 
have also shown that low M levels of soluble Aβ1-40 and Aβ1-42 markedly increase 
autophagy throughout NSC differentiation.  In fact, autophagy has been shown to play a 
critical role in stem cell maintenance and in a variety of cell differentiation processes 
(Mazur-Kolecka et al., 2006).  Recently, it has been revealed that NSCs may activate 
autophagy to also fulfill their high energy demands (Asanuma et al., 2003; Vessoni et 
al., 2012; Zhao et al., 2010).  The link between Aβ peptides and autophagy has also 
previously been described.  Autophagy protects neurons from Aβ-induced toxicity 
(Vázquez et al., 2012) and serves as a mechanism that mediates clearance of 
ubiquitinated Aβ to clear molecular debris and restore neurotransmitter balance (Hung 
et al., 2009).  Nevertheless, the majority of studies relating Aβ peptide with autophagy 
have demonstrated that Aβ peptide triggers autophagic cell death by inducing ROS 
accumulation (Khandelwal et al., 2011; Zheng et al., 2006a).  However, although ROS 
play an important role in the induction of autophagy (Lipinski et al., 2010; Wang et al., 
2010; Yang et al., 2012), our results showed that autophagy induced by Aβ peptides 
during neural differentiation was not associated with increased levels of oxidative 
stress, and other Aβ-mediated events may account for this cellular outcome.  In 
addition, the autophagy inhibitor 3-MA significantly increased cell death, indicating 
that autophagy triggered by soluble low levels of Aβ might operate as a NSC survival 
response.  Indeed, autophagy was shown to inhibit apoptosis by several mechanisms 
(Gurusamy and Das, 2009).  Remarkably, 3-MA inhibited Aβ-mediated effects 
throughout differentiation, showing that neurogenesis and gliogenesis are favored in 
Aβ1-40- and Aβ1-42-treated NSC as the result of increased autophagy activity.  It would 
be interesting to dissect the molecular mechanisms by which soluble Aβ species 
promote neural differentiation, and to further understand how Aβ may induce autophagy 
through a ROS-independent manner.  In fact, Aβ peptide was already found in the 
nucleus to activate p53 promoter activity (Yang and Klionsky, 2010), possibly directly 
regulating the expression of many other genes.  
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Together, our results corroborate the beneficial role of soluble Aβ1-40 and Aβ1-42 
in mediating neurogenesis and astrogliogenesis, respectively, and identify autophagy as 
an essential mechanism of Aβ-induced neural differentiation. 
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5. General Discussion and Concluding Remarks 
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The studies presented in this thesis contribute to a better understanding of the 
apoptotic mechanisms implicated in AD and extend our knowledge on the role of 
apoptosis-related molecules and Aβ peptides as components of neural proliferation and 
differentiation processes.  
In brief, we demonstrated a role for p63 during Aβ-induced apoptosis and the 
existence of a c-Jun-dependent mechanism regulating the abundance of anti-apoptotic 
∆Np63 in the context of Aβ-induced stress.  Importantly, the anti-apoptotic bile acid 
TUDCA was efficient in partially modulating these effects.  Next, we implicated p63 in 
regulating neural differentiation by demonstrating that the TAp63γ isoform cross-talks 
with key regulators of neurogenesis, specifically with the histone H3 lysine 27-specific 
demethylase JMJD3.  Finally, we explored the effect of soluble Aβ fragments in 
modulating NSC fate, and identified autophagy as an essential mechanism of Aβ-
induced neural differentiation (Fig. 5.1).  The data presented here provide new insights 
into the regulation of Aβ-induced cell death and neural differentiation by apoptosis-
associated molecules, and represents a step forward in understanding the molecular 
mechanisms by which Aβ peptides mediate neural differentiation.  In this last 
concluding chapter, we integrate our findings, and address future perspectives arising 
from these studies. 
The p63 protein is a multi-isoform p53 family member that is involved in cell 
death (Gressner et al., 2005).  In the present work, we evaluated the effect of Aβ-
induced apoptosis in the regulation of p63 abundance.  Aβ treatment of PC12 neuronal-
like cells and rat cortical neurons caused an upregulation of the pro-apoptotic isoform 
TAp63γ and downregulation of the anti-apoptotic isoform ∆Np63γ, which allowed the 
manifestation of apoptosis.  In parallel, we showed that genotoxic drugs such as 
doxorubicin and cisplatin increased TAp63γ levels, concurrent with the reduction of 
∆Np63γ abundance in PC12 cells.  In fact, it is well documented that genotoxic signals 
regulate p63 protein levels, promoting phosphorylation-induced, proteasome-mediated 
degradation of the pro-survival isoform ∆Np63 (Chatterjee et al., 2008; Lazzari et al., 
2011).  However, this evidence was only reported for α isoforms.  Importantly, the bile 
acid TUDCA, a well characterized endogenous potent inhibitor of apoptosis in different 
cell types (Ramalho et al., 2004; Solá et al., 2006; Viana et al., 2010), strongly 
modulated Aβ-induced apoptosis, while preventing the changes in p63 levels, further 
suggesting that the reduction of ∆Np63 levels is important for apoptosis to occur. 
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Figure 5.1.  Graphical abstract.  In the context of Aβ-induced stress, the abundance of ∆Np63 
and TAp63 is regulated by a c-Jun-dependent mechanism.  Importantly, the bile acid TUDCA 
partially modulates these effects.  Aβ-mediated reduction of ∆Np63 protein levels may be 
influenced by the MAPK pathway and occurs in a proteasome-dependent manner.  The TAp63γ 
isoform cross-talks with key regulators of neurogenesis, namely the histone demethylase 
JMJD3, to redirect stem cells to differentiation, as an alternative to cell death.  Finally, low 
levels of soluble Aβ peptides may also modulate neural differentiation.  Autophagy appears to 
be an essential player in Aβ-induced neural differentiation.  Interactions that were suggested or 
shown indirectly are represented by dashed lines. 
 
c-Jun, a key regulator of stress-mediated cell death has been shown to play a role 
in Aβ-induced toxicity (Estus et al., 1997; Viana et al., 2010).  In addition, it has been 
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reported that this member of the AP-1 family of transcription factors modulates the 
abundance of TAp63 (Yao et al., 2010b).  Indeed, here we demonstrated that ∆Np63 
reduction was associated with increased c-Jun protein levels after Aβ treatment in PC12 
neuronal-like cells and cortical neurons.  Further, Aβ-mediated reduction of ∆Np63 
protein levels appeared to be influenced by the MAPK pathway and occur in a 
proteasome-dependent manner.  In fact, it has been reported that Aβ may inhibit the 
proteasome (Gregori et al., 1995; Tseng et al., 2008).  Nevertheless, our results are in 
accordance with other studies demonstrating that important mediators of AD are 
degraded in a proteasome-dependent fashion (Lanni et al., 2010; Roselli et al., 2005), 
thus contributing to AD pathogenesis.  Therefore, the use of distinct cell model systems 
and Aβ exposure conditions may help reconcile data from different studies.  Of note, 
while TUDCA rescued Aβ-induced decrease of ∆Np63 levels, it also prevented the 
increase in c-Jun levels promoted by the peptide.  Together, these findings demonstrate 
that the abundance of ∆Np63 and TAp63 in response to Aβ-induced cell stress is 
coordinately regulated by a c-Jun-dependent mechanism, and highlight the importance 
of discovering novel targets for potential therapeutic intervention.  Since TUDCA is a 
cholesterol-derived molecule and presents high affinity to lipid membranes (Solá et al., 
2006), it would be interesting to further explore in the future, whether this bile acid may 
also interfere with Aβ load (Nunes et al., 2012) and entrance in the cells. 
Curiously, it has been recently suggested that molecules involved in the core of 
the executing apoptosis machinery play a dual role in differentiation and cell death.  We 
have previously demonstrated the involvement of specific apoptosis-related miRNAs 
and proteins, including p53, caspases and calpains, in mouse NSC differentiation, and 
also showed that p53 interacts with key regulators of neurogenesis, such as JMJD3, to 
redirect stem cells to differentiation, as an alternative to cell death (Aranha et al., 2009; 
Santos et al., 2012b; Solá et al., 2011; Solá et al., 2012).  Given the functional and 
structural similarities of p63 and p53, we next investigated the role of p63 during mouse 
NSC differentiation and evaluated whether p63 interacts with JMJD3 in this cellular 
context.  In fact, in contrast with p53 and p73, there is still a breach in the literature 
regarding p63 potential involvement in neurogenesis by cell death-independent 
mechanisms.  In spite of other studies claiming that p63 is dispensable for neurogenesis, 
p63 was shown to be expressed in neurogenic niches, such as the SVZ of the lateral 
ventricle in postnatal mice, supporting the idea that p63 may have a key role during 
neurogenesis (Hernández-Acosta et al., 2011).  Our results reveal for the first time a role 
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for p63 in neural progenitors, directing NSCs to a neuronal phenotype.  In fact, our data 
support the hypothesis that JMJD3-induced TAp63γ nuclear translocation might direct 
NSCs to a neuronal fate specification, through the transcriptional activation of pro-
neuronal genes.  Overexpression of TAp63γ during early differentiation of NSCs 
resulted in increased β-III tubulin levels, whereas downregulation of TAp63γ expression 
by specific p63 siRNA abrogated the increase in β-III tubulin.  Interestingly, we showed 
that JMJD3 directly interacts with p63 to induce p63 demethylation and subsequent p63 
stabilization during mouse neural differentiation.  A deepest knowledge of the 
regulatory modifications of p63 protein will certainly improve our understanding of p63 
function during neural differentiation.  In this respect, future studies are warranted to 
determine the specific p63 residues demethylated by JMJD3 and to address the 
importance of TAp63γ demethylation in neurogenesis by modification of the identified 
residues.  On the other hand, since TUDCA modulates p63 during apoptosis, it would 
be interesting to also clarify whether this bile acid regulates p63 in this cellular context, 
also affecting NSC fate. 
At last, we investigated whether low levels of soluble Aβ peptides may also 
modulate neural differentiation.  In fact, several studies have shown that classical 
triggers of apoptosis may positively influence neural differentiation (Solá et al., 2012).  
In addition, Aβ species are highly multifunctional peptides with significant non-
pathological activities.  However, the precise molecular pathways underlying the 
regulation of NSC proliferation and differentiation by different Aβ peptides are still not 
fully defined.  Our results demonstrate that Aβ1-40 promotes NSC self-renewal and 
enhances mostly neuronal differentiation.  In fact, after Aβ1-40 treatment of NSCs, S-
phase of the cell cycle, BrdU labeling, and βIII-tubulin promoter-driven luciferase 
activity were markedly enhanced.  In contrast, Aβ1-42 promoted mostly astrocytic cell 
fate in NSCs, having no effect in NSC proliferation.  These results are in part in 
discordance with other previous reports (Chen and Dong, 2009; Heo et al., 2007; 
López-Toledano and Shelanski, 2004).  Indeed, there is variance in the literature 
regarding the experimental conditions used to address the neurogenic effects of Aβ, 
which can apparently explain these discrepancies in the results.  
Due to the involvement of autophagy in cellular survival and differentiation, 
development and homeostasis (Aburto et al., 2012; Levine and Kroemer, 2008; 
Mizushima and Levine, 2010; Vessoni et al., 2012), and since autophagy is involved in 
Aβ-mediated effects (Hung et al., 2009), we explored the role of autophagy in Aβ-
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induced alterations of neural fate.  In fact, the correlation between pro-neurogenic 
effects of Aβ peptides and autophagy has not been explored before.  Our results 
demonstrated that low levels of soluble Aβ1-40 and Aβ1-42 markedly increase autophagy 
throughout NSC differentiation.  Surprisingly, neurogenesis and gliogenesis were 
favored in Aβ1-40- and Aβ1-42-treated NSCs as the result of enhanced autophagy activity, 
without increased levels of oxidative stress and apoptosis.  The inhibition of autophagy 
in this cellular context significantly increased cell death, indicating that autophagy 
triggered by soluble low levels of Aβ might operate as a NSC survival response. 
As a final note, it is important to look beyond the role Aβ peptides during neural 
differentiation and to further dissect the precise molecular targets of soluble Aβ species 
during this process.  Taking into account the role of apoptosis-related proteins during 
neural differentiation, namely the p63 protein, it is tempting to think that Aβ-induced 
effect on NSCs might be partially dependent on p63 and c-Jun.  Finally, it would be 
interesting to explore how low levels of Aβ regulate p63 expression in neural 
differentiation; how Aβ may induce autophagy through a ROS-independent manner; 
and whether TUDCA regulates the survival process of autophagy in both apoptotic and 
differentiation contexts. 
The poor survival and differentiation levels of stem cells after either 
transplantation or neural injury have been one of the major problems of stem cell-based 
therapy.  With the growing identification of the regulatory networks between neural 
apoptosis and differentiation, it is likely that we will witness relevant advances in 
potential therapeutic tools that contribute to a more efficient use of stem cells in neural-
replacement therapies.  
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